Page last updated: 2024-08-23

bromocriptine and ergoline

bromocriptine has been researched along with ergoline in 662 studies

Research

Studies (662)

TimeframeStudies, this research(%)All Research%
pre-1990453 (68.43)18.7374
1990's74 (11.18)18.2507
2000's67 (10.12)29.6817
2010's64 (9.67)24.3611
2020's4 (0.60)2.80

Authors

AuthorsStudies
Birkenhäger, JC; Lamberts, SW3
Fahn, S; Hutt, C; Prasad, AL; Snider, SR; Stein, B1
Acharya, S; Saran, BM1
Goldstein, M; Hata, F; Lew, JY; Ohashi, T1
Adler, H; Calne, DB; Kennedy, S; Silbergeld, EK1
Frantz, AG; Kleinberg, DL1
Battista, AF; Fuxe, K; Goldstein, M; Lew, JY; Lieberman, A; Nakamura, S1
Angrist, B; Lieberman, A; Serby, M2
Hungerbühler, JP; Regli, F1
Blackburn, KJ; Bremner, RM; Davey, MJ; Greengrass, PM; Morville, M1
Calne, DB; Eisler, T; Neophytides, A; Nutt, JG; Teychenne, PF; Williams, AC1
Besser, GM; Jones, A; Lowry, PJ; Thorner, MO; Yeo, T1
Estey, E; Goldstein, M; Goodgold, A; Gopinathan, G; Kupersmith, M; Lieberman, AN1
Da Prada, M; Keller, HH1
Horowski, R1
Parkes, JD1
Agnati, LF; Coyle, JT; Fuxe, K; Hökfelt, T; Schwarcz, R1
Danzeisen, M; Gygax, P; Meier-Ruge, W; Wiernsperger, N1
Sethy, VH1
Heuson, JC; Rozencweig, M1
Cassar, J; Edwards, R; Kohner, EM; Mashiter, K1
Lees, AJ; Shaw, KM; Stern, GM1
Davis, RH; Griffiths, K; Groom, G; Hibbard, BM; Walker, S1
Al-Dujaili, EA; Besser, GM; Edwards, CR; Hanker, JP; Miall, PA; Thorner, MO1
Debono, AG; Donaldson, I; Marsden, CD; Parkes, JD1
Duns, A; Gomez-Pan, A; Goolamali, SK; Hall, R; Sachdev, Y; Tunbridge, WM; Weightman, DR1
Hayes, S; Lees, AJ; Ross, EJ; Shaw, KM; Stern, GM; Thompson, BD1
Barrett, A; Hobbs, JR; Morgan, L1
Hirvonen, E; Ranta, T; Seppälä, M4
Teasdale, G1
Benedek-Jaszmann, LJ; Hearn-Sturtevant, MD1
Besser, GM; Thorner, MO; Wass, JA1
Farrar, DJ; Pryor, JS1
Kaye, SB; Ross, EJ; Shaw, KM1
Bennink, HJ; Haspels, AA; Snuiverink, H1
Franks, S; Hull, MG; Jacobs, HS; Nabarro, JD; Steele, SJ1
Calne, DB; Gielen, AC; Gillespie, MM; Kartzinel, R; Perlow, M; Sadowsky, DA; TEYCHENNE, P1
Crockford, PM; Morrish, DW1
Besser, GM; Chiodini, PG; Liuzzi, A; Mason, AS; Morris, D; Thorner, MO; Wass, JA1
del Pozo, E; Maclay, WP1
Hagen, C; Hummer, L; Madsen, S; Olgaard, K2
Davis, JC; Hipkin, LJ; O'Mullane, NM; Walker, BA1
Horky, K; Marek, J1
Saidi, K; Sharif, F; Wenn, RV1
Cowan, GO1
Bennink, HJ; van der Steeg, HJ1
Martin, P; Roulier, R; Serment, G1
Fraser, IS; Shearman, RP1
Adams, E; Beard, M; Holley, A; Mashiter, K1
Jürgensen, O; Taubert, HD1
Higuchi, M; Kolloch, R; Krück, F; Stumpe, KO; Vetter, H1
Brosens, IA1
Cionini, R; Maneschi, F; Navalesi, R; Rolla, M1
Cooke, ID; Lachman, E; Singer, A1
Szabo, S1
Blackstock, J; Dick, JP; George, RJ; Marsden, CD; Parkes, JD; Schachter, M1
Anlezark, G; Meldrum, B1
Asper, H; Bürki, HR; Ruch, W; Züger, PE1
Botalla, L; Chiodini, PG; Colussi, G; De Stefano, L; Gräf, KJ; Horowski, R; Liuzzi, A; Oppizzi, G; Verde, G1
Calne, DB; Hunt, RD; Kartzinel, R1
Caraceni, T; Cocchi, D; Müller, EE; Panerai, AE; Paratl, EA1
Calne, DB; Carter, AC; Chase, TN; Kartzinel, R; Perlow, MD; Shoulson, I1
Albiazzati, MG; Frattola, L; Spano, PF; Trabucchi, M1
Horrobin, DF; Mahajan, KK; Robinson, CJ1
Flaks, A; Hamilton, JM; Maguire, S; Saluja, PG1
Martin, RJ; Meier, AH; Wheeland, RA1
Benker, G; Hackenberg, K; Hamburger, B; Reinwein, D1
Calne, DB; Kartzinel, R; Shoulson, I3
Benker, G; Günnewig, H; Hackenberg, K; Hamburger, B; Reinwein, D; Zäh, W1
Frattola, L; Spano, PF; Tonon, GC; Trabucchi, M1
Kennedy, AL; Montgomery, DA1
Andreoli, VM; Frattola, L; Spano, PF; Trabucchi, M1
Gullino, PM1
Saiani, L; Spano, PF; Tonon, GC; Trabucchi, M1
Castegnaro, E; Pontiroli, AE; Pozza, G; Vettaro, MP; Viberti, GC1
Coppen, A; Ghose, K1
Durand, JP; Gautier, JC1
Bricaire, H; Strauch, G1
Hammond, CB; Handwerger, S; Wiebe, RH1
Asfour, M; Fossati, P; Hedouin-Quincampoix, M; L'Hermite, M1
Bolton, AE; Colhoun, EM; Willmott, MP1
O'Donoghue, RF1
Etreby, MF; Gräf, KJ; Horowski, R1
Cabezas, A; Canales, ES; Forsbach, G; Guzman, V; Soria, J; Zárate, A1
Hardt, W; Michel, E; Nevinny-Stickel, J; Schmidt-Gollwitzer, K; Schmidt-Gollwitzer, M1
Andersen, AN; Larsen, JF; Nielsen, J; Steenstrup, OR; Svendstrup, B1
Godwin-Austen, RB; Smith, NJ1
Estey, E; Goldstein, M; Gopinathan, G; Kupersmith, M; Lieberman, A1
Dirks, H; Köbberling, J; McIntosh, C; Schwinn, G1
Davajan, V; Kletzky, OA; March, CM1
Caccamo, A; Crosignani, PG; Lombroso, GC; Peracchi, M; Reschini, E; Trojsi, L1
Belforte, L; Camanni, F; Chiodini, PG; Liuzzi, A; Massara, F; Molinatti, GM; Müller, EE; Silvestrini, F1
Canales, ES; Fonseca, E; Lasso, P; Murrieta, S; Soria, J; Zárate, A1
Harrower, AD; Nairn, IM; Strong, JA; Yap, PL1
Felt, V; Hainer, V; Krejcík, L; Nedvídková, J1
Devinoy, E; Houdebine, LM1
Ishibashi, M; Kosaka, K; Yamaji, T1
Felt, V; Nedvdková, J1
Bowie, M; Boyar, RM; Budinger, JM; Hellman, L; Mountain, IM; Rosenberg, BJ; Stock, CC; Teller, MN1
Fell, LR; Findlay, JK; Hooley, RD1
Bagnoli, P; Zocchi, G1
Battaini, F; Hofmann, M; Spano, P; Tonon, G; Trabucchi, M1
Loeffler, LJ; Schran, HF; Schwarz, HJ; Talbot, KC1
Caldara, R; Crosignani, PG; Faglia, G; Ferrari, C; Mattei, A; Moriondo, P; Travaglini, P1
Dogliotti, L; Mussa, A; Sandrucci, S1
Kellams, JJ; Lemberger, L; Rowe, H; Small, JG1
Jaton, AL; Loew, DM; Vigouret, JM2
Bürki, HR; Jaton, AL; Loew, DM; Vigouret, JM; Züger, PE1
Klawans, HL; Nausieda, PA; Weiner, WJ1
Briner, U; Doepfner, W; Flückiger, E; Kovacs, E; Marbach, P; Wagner, HR1
Birkenhäger, JC; Kwa, HG; Lamberts, SW; Seldenrath, HJ1
Abe, H; Chihara, K; Furumoto, M; Kato, Y; Maeda, K1
Mroueh, AM; Siler-Khodr, TM2
Hainer, V; Krejcík, L; Tvaroh, F; Urbánek, J1
Bricaire, H; Mahoudeau, JA; Strauch, G; Valcke, JC1
Elithorn, A; Jakobovits, A; James, IM; Morgan, MY; Sherlock, S1
Brown, JB; Burger, HG; Evans, JH; Healy, D; Pepperell, RJ; Smith, MA1
Dolphin, AC; Jenner, P; Marsden, CD; Sawaya, MC1
Lachelin, GC; Leblanc, H; Yen, SS1
Medina, D1
Hassett, CC; Lambrecht, LK; Welsch, CW1
Cassar, J; Joplin, GF; Mashiter, K1
Adams, C; Brooks, CL; Hassett, CC; Lambrecht, LK; Welsch, CW1
Besser, GM; Jones, AE; Mason, AS; Morris, DV; Rees, LH; Thorner, MO; Wass, JA1
Monteiro, JC; Palmer, BV1
Advis, JP; Alvarez, EO; Hancke, JL1
Hughes, LE; Mansel, RE; Preece, PE1
Fahn, S; Hutt, CS; Snider, SR1
Boissier, JR; Chermat, R; Puech, AJ; Simon, P1
Andersen, AN1
Briand, P; Daehnfeldt, JL; Thorpe, SM1
Craig, A; Harrower, AD; Nairn, IM; Strong, JA; Walton, HJ; Yap, PL1
Pfeiffer, RF; Silbergeld, EK1
Di Carlo, F; Dogliotti, L; Mussa, A1
Corbey, RS; Cruysberg, JR; Rolland, R1
Shapiro, AG1
Lipper, S1
Jotkowitz, S1
Birkenhäger, JC; de Lange, SA; Lamberts, SW1
Distiller, LA; Joffe, BI; Seftel, HC1
Di Chiara, G; Gessa, GL; Porceddu, ML; Vargiu, L1
Bright, MI; Brown, JB; Burger, HG; Evans, JH; Healy, D; Pepperell, RJ; Smith, MA1
Courot, M; Garnier, D; Pelletier, J; Ravault, JP; Terqui, M1
Hosoki, H1
Agnoli, A; Carolei, A; Masturzo, P; Meco, G; Polleri, A; Rolandi, E1
Hogh, J1
Delitala, G1
Anlezark, GM; Horton, RW; Meldrum, BS1
Loizzo, A; Longo, VG1
Calne, DB2
Bern, SM; Calne, DB; McInturff, D; Pfeiffer, RF; Teychenne, PF1
Bertazzoni, A; Caldara, R; Crosignani, PG; Ferrari, C; Mattei, A; Polloni, G; Rampini, P; Romussi, M; Telloli, P1
Carminati, R; Cocchi, D; Locatelli, V; Müller, EE1
Abildgaard, U; Meling, AB; Nilsen, PA1
Gerlach, J1
Lees, A; Shaw, KM; Stern, GM1
Benedek-Jaszmann, LJ; Sternthal, V1
Walker, S2
Kunz, F; Lörincz, P; Ludin, HP; Ringwald, E1
Dirks, H; Köbberling, J; Schwinn, G2
Benker, G; Günnewig, H; Hackenberg, K; Reinwein, D; Werner, U; Zäh, W1
Gala, RR; Jaques, S1
Alagna, S; Delitala, G; Devilla, L; Masala, A; Rovasio, PP1
Calne, DB; Pfeiffer, RF; Teychenne, PF1
Dickey, RP; Stone, SC1
Chetri, G; Dammacco, A; Dammacco, F; Gagliardi, F; Rigillo, N; Tafaro, E1
Johnson, AM; Loew, DM; Vigouret, JM1
Clemens, R; Naftolin, F; Pallotta, J; Spark, RF1
Calne, DB; Kartznel, R1
Cassar, J; Joplin, GF; Mashiter, K; Sullivan, G1
Vaisurb, S1
Billeter, E; Flückiger, E; Wagner, HR1
Hirvonen, E; Laatikainen, T; Ranta, T; Seppälä, M; Unnérus, HA1
Botalla, L; Chiodini, PG; Cremascoli, G; Liuzzi, A; Muller, EE; Oppizzi, G; Silvestrini, F; Verde, G1
Hirvonen, E; Ranta, T; Seppälä, M; Unnérus, HA1
Horrobin, DF; James, MF; Karmali, RA; Robinson, CJ1
Knowles, PA1
Bories, F; Bousser, MG; Conard, J; Samama, M1
Besser, GM; Thorner, MO2
Cooke, I; Foley, M; Jenkins, A; Kennedy, G; Lenton, E; McNeilly, A; Millar, D; Obiekwe, B; Parsons, J; Preston, E1
Stempel, LE1
Farrar, DJ; Osborne, JL1
Kullander, S1
Brown, WB; Driver, PM; Forbes, JM; Jones, R1
Hockaday, JM; Hockaday, TD; Peet, KM1
Chandler, JA; Danutra, V; Griffiths, K; Harper, ME1
McLellan, DL1
Dolecek, R1
Canales, ES; Forsbach, G; Soria, J; Zárate, A1
Salocks, CB; Sinha, YN; VanderLaan, WP1
Browne, AD; Darragh, A; del Pozo, E; O'Kelly, DA1
Estey, E; Goldstein, M; Kupersmith, M; Lieberman, A1
Naftolin, F; Tolis, G1
Del Pozo, E; Geiger, W; Künzig, HJ; Lancranjan, I; Lose, KH; Schulz, KD1
Alagna, S; Delitala, G; Devilla, L; Lotti, G; Masala, A1
Nagasawa, H; Yanai, R1
Welsch, CW2
Agnoli, A; Carolei, A; Casacchia, M; Meco, G; Ruggieri, S; Zamponi, A1
Cararach, V; Davi, E; Martin-Comin, J; Pujol-Amat, P; Robyn, C1
Dipalma, JR1
del Pozo, E; Ohnhaus, EE1
Martin, FI; Perry-Keene, DA; Warne, GL1
Gomez-Pan, A; Hirst, BH; Labib, LA; Reed, JD1
Debono, AG; Marsden, CD; Parkes, JD1
Altwein, JE; Helmerich, D1
Balestreri, R; Barban, G; Bertolini, S; Castello, C; Elicio, N; Jacopino, GE; Pistocchi, G1
Barreca, T; Gallamini, A; Gianrossi, R; Nizzo, MC; Queirolo, A1
Gallamini, A; Gianrossi, R; Murialdo, G; Nizzo, MC; Peirano, L1
Lionel, ND1
Barrett, A; Hobbs, JR; Morgan, L; Raggatt, PR1
Aljinovic, A; Gunti, J; Pusterla, E1
Bories, F; Bousser, MG; Castaigne, P; Laplane, D1
Sathanandan, M; Visvanathan, T1
Calne, DB; Kartzinel, R; Perlow, M; Pfeiffer, R; Teychenne, PF1
Blair, CM; Fraser, TR; Gordon, H; Kjeld, JM; Nader, S; Tooley, M1
Begg, G; Paul, M; Shuman, L; Utian, WH; Vinik, AI1
Coustenoble, G; Engelmann, P; Gueris, D; Morin, P1
Canales, ES; de la Peña, RO; González-Colindres, J; Levinson, G; Zárate, A1
Davis, JC; Diver, MH; Hipkin, LJ; Summers, VK1
Jacobi, J; Lloyd, HM; Meares, JD1
Calne, DB; Claveria, LE; Reid, JL1
Horrobin, DF; Karmali, RA3
Camanni, F; Isaia, GC; Massara, F; Molinatti, GM1
Boss, RS; Gala, RR1
Gorins, A; Netter, A; Netter, AL1
Friesen, HG; Pinter, EJ; Tolis, G1
Kühn, ER; Vandoren, GE1
Alagna, S; Delitala, G; Devilla, L; Masala, A1
Archer, DF; Josimovich, JB; Lloyd, SJ1
Lequin, RM; Roland, R; Schellekens, LA1
Boyd, AE; Reighlin, S1
Okumura, T; Seki, K; Seki, M1
Geiger, W; Künzig, HJ; Lose, KH; Schulz, KD1
Besser, GM; Dacie, J; Jones, A; Jones, AE; Thorner, MO1
Ben-David, M; Polishuk, WZ; Spitz, J; Yarkoni, S1
Duns, A; Gomez-Pan, A; Hall, R; Sachdev, Y; Tunbridge, WM1
Dony, JM; Rolland, R1
Camanni, F; Fassio, V; Massara, F; Molinatti, GM; Müller, EE1
Kuhn, NJ; Rodway, RG1
Peaker, M; Taylor, JC1
Del Pozo, E; Geiger, W; Künzig, HJ; Lose, KH; Schulz, KD1
Handforth, A; Sourkes, TL1
del Pozo, E1
Coulam, CB; Hammond, CB1
Davidson, H; Horrobin, DF; James, MF; Mahajan, KK; Manku, MS; Robinson, CJ1
Schneider, D1
Kanis, JA; Ledingham, JG; Nairn, IM; Oliver, DO; Walton, RJ1
Andre, JM; Jacquier, A; Kissel, P1
Dorr, C; Sathananthan, K1
Canales, ES; Fonesca, E; González, J; Levinson, G; Soria, J; Zárate, A1
Hollister, AM; Malven, PV; Morningstar, JE1
Allan, NC; Harrower, AD; Yap, PL1
Cao, Y; Eberwine, J; Kitai, ST; Stefani, A; Surmeier, DJ; Wilson, CJ1
Chang, JP; Peter, RE; Wong, AO1
Demedts, M; Dom, R; Frans, E1
Muscat, R; Papp, M; Willner, P1
Samini, M; Shokravi, S; Zarrindast, MR1
Pawlikowski, M; Pisarek, H; Stepien, H1
Pisarek, H; Stepien, H1
Crosignani, P; D'Alberton, A; de Vincentiis, S; Ferrari, C; Mattei, AM; Paracchi, A1
Kruk, ZL; Millar, J; Stamford, JA1
Amenta, F; Collier, WL; Ricci, A; Rossodivita, I1
Horn, PT; Kohli, JD1
Demichel, P; Moran, A; Roquebert, J; Sauvage, MF1
Nikulina, EM; Popova, NK; Skrinskaya, JA1
Hosseini-Nia, T; Owji, AA; Zarrindast, MR1
Minaian, A; Zarrindast, MR1
Eliassi, A; Zarrindast, MR1
Georgiev, V; Kambourova, T; Petkova, B1
Davis, A; Jenner, P; Marsden, CD1
Amenta, F; Cavallotti, C; Collier, WL; De Michele, M; Ricci, A1
Iuvone, PM; Zawilska, J1
Barone, D; Benedetti, MS; Dostert, P; Efthymiopoulos, C; Peretti, G; Roncucci, R1
Casazza, S; D'Alberton, A; de Vincentiis, S; Fadin, M; Giorda, G; Motta, T1
Corrales Hernández, JJ; García Díez, LC; Terroba, C1
Dominoni, P; Ferrari, L; Gianola, D; Gualteroni, L; Montini, M; Pagani, G; Pagani, MD; Sileo, F; Stroppa, S; Tengattini, F1
Balabolkin, MI; Gerasimov, GA; Gorokhova, TR; Liubimov, AV1
Gessa, GL; Olianas, MC; Onali, P1
Brown, A; Dali, H; Neumeyer, JL; Pihan, G; Szabo, S1
Beaulieu, M; Felder, R; Kebabian, JW1
Dieguez, C; Hall, R; Lewis, BM; Lewis, M; Scanlon, MF1
Camanni, F; Ciccarelli, E; Giordano, G; Giusti, M; Miola, C; Potenzoni, F; Sghedoni, D1
Balabolkin, MI; Gerasimov, GA; Gorokhova, TR; Snigireva, RIa1
Al-Sereiti, MR; Turner, P1
Uilenbroek, JT1
Edwards, SR; Jackson, DM; Ross, SB1
Chiodini, PG; Dallabonzana, D; Liuzzi, A; Oppizzi, G; Verde, GG1
Harvey, NS1
Barton, AC; Demarest, KT; Moore, KE1
Chagraoui, A; Protais, P; Vasse, M1
Battaglia, G; Creese, I; Hess, EJ; Norman, AB1
Ohno, Y; Sasa, M; Takaori, S1
Cubeddu, LX; Hoffmann, IS; Talmaciu, RK1
Robertson, GS; Robertson, HA1
Bidzinski, A; Consolo, S; Forloni, G; Fusi, R; Ladinsky, H1
Millington, WR; Mueller, GP; O'Donohue, TL1
Beninger, RJ; Dickson, PR; Hoffman, DC1
Feuerstein, TJ; Hertting, G; Jackisch, R; Moll, S1
Corenblum, B1
Kletzky, OA; Shangold, GA1
Borenstein, R; Kletzky, OA; Mileikowsky, GN1
Burchill, SA; Thody, AJ1
Rinne, UK2
De Pasqua, A; Di Micco, R; Pontiroli, AE; Sartani, A; Zanardi, E1
Besser, M; Ciccarelli, E; Grossman, A; Touzel, R1
Svensson, L1
Churg, A; Fleetham, JA; McElvaney, NG; Wilcox, PG1
Baroldi, P; Cavioni, V; Crosignani, PG; Ferrari, C; Galparoli, C; Gerevini, G; Mattei, AM; Paracchi, A; Romano, C; Spellecchia, D1
Lang, AE1
Bohnet, HG; De Moll, H; Kato, K1
Cancio, E; Cocchi, D; Dall'Ara, A; Devesa, J; Di Salle, E; Lima, L; Müller, EE1
Benedetti, M; Bernardi, G; Calabresi, P; Mercuri, NB1
Crosignani, PG; Ferrari, C1
Caballero, A; Caballero-Asensi, A; Caballero-Díaz, JL; Mena, P1
Heinlein, W; Horowski, R; Schatz, H; Stracke, H1
Ståhle, L; Ungerstedt, U1
Claudi, F; Cristalli, G; Martelli, S; Massi, M; Perlini, V; Venturi, F1
Booth, NH; Hatch, RC; Jernigan, AD; Lipham, LB; Robbins, JD1
Klawans, HL; Paleologos, N1
Golda, V; Petr, R; Rozsíval, V; Suba, P1
Ahmed, SR; Shalet, SM1
Barbieri, C; Boghen, M; Caldara, R; Codecasa, F; Dubini, A; Ferrari, C; Mucci, M; Paracchi, A; Romano, C1
Caselitz, J; Lüdecke, DK; Saeger, W; Schottke, H1
Giannetti, LM; Manfellotto, G; Tessitore, A1
Casey, DE1
Jankovic, J1
Bratty, PJ; Burton, K; Calne, DB; Larsen, TA; Martin, WR; Robinson, RG; Schulzer, M1
Goldstein, M; Lieberman, AN1
Buvat, J; Dewailly, D; Fossati, P; Fourlinnie, JC; Lemaitre, G; Mazzuca, M; Thomas, P; Wemeau, JL1
Belchetz, PE; Casson, IF; Hipkin, LJ; Walker, BA1
Pepperell, RJ1
Agid, Y; Dubois, B1
Horvath, E; Kovacs, KT; Laws, ER; Randall, RV; Scheithauer, BW; Whitaker, MD1
Glantz, RH; Goetz, CG; Klawans, HL; Tanner, CM1
Baas, H; Fischer, PA; Japp, G; Schneider, E2
Chiodini, P; Cozzi, R; Dallabonzana, D; Liuzzi, A; Luccarelli, G; Oppizzi, G; Verde, GG1
Adams, CB; Besser, GM; Charlesworth, M; Doniach, I; Grossman, A; Ross, R; Wass, JA1
Chiodini, PG; Dallabonzana, D; Dorow, R; Horowski, R; Liuzzi, A; Oppizzi, G; Verde, G1
Brabant, G; Brennecke, I; Friedrich, H; Herrmann, H; Hesch, RD; von zur Mühlen, A; Wagner, TO1
Zaccheo, T1
Mattox, JH1
Luquin, MR; Martínez Lage, JM; Obeso, JA1
Acosta Delgado, D; Astorga Jiménez, R; García-Luna, PP; Leal Cerro, A; Santos Español, C; Villamil, F1
Bamji, AN; Calne, DB; Greenacre, JK; Leigh, PN; Teychenne, PF1
Bartke, A1
Burton, K; Calne, DB1
Jewelewicz, R; Vande Wiele, RL1
Calne, DB; Plotkin, CN; Rosin, AJ; Teychenne, PF1
Buylaert, WA; Green, AR; Heal, DJ1
Goldfine, ID; Vigneri, R1
Chase, TN; Tamminga, CA1
Everett, JW1
Crabtree, RE; Lemberger, L1
Calne, DB; Eisler, T; Gopinathan, G; Williams, A1
Agnati, LF; Andersson, K; Fredholm, B; Fuxe, K; Hall, H; Köhler, C; Ogren, SO1
Carruba, MO; Mantegazza, P; Müller, EE; Ricciardi, S1
Gianutsos, G; Moore, KE1
Hruska, RE; Silbergeld, EK1
Bo, P; Maurelli, M; Nappi, G; Savoldi, F1
Dhahir, P; Lemberger, L; Rubin, A1
Butt, WR; Franks, S; Horrocks, PM; London, DR; Lynch, SS1
Vesely, DL1
Ross, ED; Stewart, RM1
Enna, SJ; Lake, CR; Teychenné, PF; Ziegler, MG1
Bergmann, F1
Duvoisin, RC; Heikkila, RE; Manzino, L1
Kanto, J1
Gianutsos, G; Palmeri, JL1
Reichlin, S; Szabo, S1
Ferrer, JM; Mora, F; Sanguinetti, AM; Vives, F1
de Belleroche, J; Gardiner, IM1
Novak, PJ; Tadepalli, AS1
Burke, JA; Chang, FW; Potter, DE1
Arnerić, SP; Chow, SA; Fischer, LJ; Long, JP1
Bendesky, RJ; Martin, GE1
Cook, DB; Hall, K; Johnston, DG; Kendall-Taylor, P; Patrick, D; Watson, M1
Goldberg, LI1
Esplugues, J; Morales-Olivas, FJ; Palop, V; Rubio, E1
Kopecká, J; Marek, J1
Jellinger, K1
Biesemeyer, H; Ludin, HP; Ringwald, E1
Király, I; Van Ree, JM1
Beckman, J; Burton, K; Calne, DB; Martin, WR1
Fingerová, H; Gazárek, F; Stehlíková, J; Talas, M; Zenísek, L2
Kobilková, J; Kucera, E; Marek, J; Srámková, J; Zivný, J1
Markstein, R1
Kolena, J; Seböková, E1
Locatelli, V; Panerai, AE; Penalva, A; Petraglia, F1
McPherson, GA1
Blackwell, RE; Bradley, EL; Chang, RJ; DeVane, GW; Duvall, ER; Kline, LB; Vitek, JJ1
Burns, RS; Calne, DB; LeWitt, PA1
Calne, DB; Dambrosia, JM; Foster, N; Larsen, TA; LeWitt, PA; Newman, RP; Raphaelson, MI; Ward, CD1
Borges, JL; Boyett, RL; Elton, RL; Evans, WS; Kaiser, DL; MacLeod, RM; Rogol, AD; Schran, HF; Thorner, MO1
Frau, MI; Gessa, GL; Meloni, M; Rossetti, ZL; Tissari, AH1
Blackwell, RE; Bradley, EL; Rodgers-Neame, NT1
Besser, GM; Cookson, JC; Drury, PL; Price, PA; Turner, TH; Wass, JA1
Da Prada, M; Haefely, WE; Keller, HH; Kettler, R; Pieri, L1
Finer, N; Herbert, LC; Hicks, BH1
Draganova, S; Georgiev, V; Getova, D; Lazarova, M; Markovska, V; Petkov, V; Petkova, B; Roussinov, K; Shopova, S1
Abate, F; Baviera, G; Bellinvia, G; La Spada, R; Leonardi, R; Oliva, A1
Ruckebusch, Y1
Klÿn, JG; Lamberts, SW; Oosterom, R1
Luquin, MR; Obeso, JA1
Login, IS1
Falsetti, L; Loda, G; Pontiroli, AE; Roggia, A; Scagliola, T; Schimberni, M; Turla, R1
de Vries, JB; Feenstra, MG; Goedemoed, JH; Horn, AS; Rollema, H; Sumners, C1
Fischer, PA; Hubener, K; Schneider, E2
Caraceni, T; Carella, F; Giovannini, P; Grassi, MP; Parati, E; Scigliano, G2
Benco, R; Caldara, R; Crosignani, PG; Ferrari, C; Mattei, AM; Picciotti, MC; Ragni, G; Rampini, P1
Borghi, G; Chiodini, P; Dallabonzana, D; Liuzzi, A; Oppizzi, G; Silvestrini, F; Spelta, B; Tonon, C1
Brincat, S; Lang, AE; Marsden, CD; Parkes, JD; Quinn, N1
Caldara, R; Farrari, C; Rampini, P; Telloli, P1
Noonan, JJ; Rose, DP1
Hruska, RE; Silbergeld, EK; Weir, RL1
Ambrosi, B; Bochicchio, D; Faglia, G; Moriondo, P; Nava, C; Nissim, M; Travaglini, P1
Felt, V; Nedvídková, J1
Gopinathan, G; Hiesiger, E; Leibowitz, M; Lieberman, AN; Neophytides, A; Walker, R1
Ford, J; Jackson, JA; Jankovic, J1
Goldstein, M; Goodgold, A; Gopinathan, G; Leibowitz, M; Lieberman, AN; Neophytides, A; Pact, V; Walker, R1
Lang, AE; Marsden, CD; Parkes, JD; Quinn, NP; Toone, B1
Maurer, RA1
Mann, M; Michael, SD; Svare, B1
Harrison, DJ; McNeilly, AS; Russell, JA1
Ausková, M; Bílek, J; Krejcí, P; Madej, A; Rezábek, K; Stupnicki, R1
Mann, MA; Michael, SD; Svare, B1
Kikuyama, S; Seki, T1
De Cecco, L; Horowski, R; Maganza, C; Morano, S; Pedretti, E; Ragni, N; Semino, F; Venturini, PL1
Baccolo, M; Vecchione, A1
Calne, DB; Teräväinen, H1
Calne, DB; Dambrosia, JM; Durso, R; Gopinathan, G; LeWitt, PA; Sanes, JN; Ward, CD1
Marek, J; Schreiberová, O; Schüllerová, M; Srámková, J; Stĕpán, J1
Buonaccorsi, S; Pellicciotta, G; Pontiroli, AE; Scapin, F; Tronconi, G1
Albarrán, FJ; Caballero, A; Mena, P; Molina, CE; Palomo, A1
Fuller, RW; Perry, KW1
Ahlenius, S; Engel, J; Larsson, K; Svensson, L1
Johnels, B1
Callaghan, JT; Crabtree, R; Lemberger, L1
Calne, DB; Dambrosia, JM; Evarts, EV; Gopinathan, G; Sanes, JN; Stuart, WK; Teräväinen, H; Ward, CD1
Cardinali, S; Russo, S1
Benco, R; Crosignani, PG; Dellabonzana, D; Ferrari, C; Liuzzi, A; Mattei, A; Rampini, P; Scarduelli, C; Spelta, B1
Fernández Pardal, MM; Leiguarda, RC; Micheli, F1
Besser, GM; Delitala, G; Grossman, A; Hathway, NR; Yeo, T1
Reynolds, GP; Riederer, P1
Agnati, LF; Andersson, K; Fuxe, K; Hökfelt, T; Köhler, C; Kuonen, D; Ogren, SO1
Camerman, A; Camerman, N1
Borghi, G; Chiodini, P; Cozzi, R; Dallabonzana, D; Horowski, R; Liuzzi, A; Luccarelli, G; Oppizzi, G; Rainer, E; Silvestrini, F; Spelta, B; Verde, G1
Albertazzi, E; Bartolotti, A; Turci, M1
Rolland, R; Van Dam, LJ1
Marsden, CD; Parkes, JD; Schachter, M; Sheehy, MP1
Arvigo, M; Barreca, A; Cariola, G; Foppiani, L; Giordano, G; Minuto, F; Ponzani, P1
Arita, K; Eguchi, K; Ito, A; Kawamoto, K; Kurisu, K; Uozumi, T2
Ahlenius, S; Alster, P; Hillegaart, V; Uvnäs-Moberg, K2
Bryson, HM; Fitton, A; Rains, CP1
Riva di Sanseverino, L; Sabatino, P; Tonani, R1
Bosc, M; Leclere, J; Pascal-Vigneron, V; Weryha, G1
Levavi-Sivan, B; Ofir, M; Yaron, Z1
Mark, MH; Sage, JI1
Hoffman, DC; Wise, RA1
Shibata, S; Tanaka, T; Watanabe, S; Yamamoto, Y1
Kitai, ST; Surmeier, DJ1
Cestari, R; Lojacono, L; Missale, C; Missale, G; Raddino, R; Sigala, S; Spano, PF1
Fraser, RB; Jones, TH1
Ferrari, CI; Ismail, I; Piscitelli, G; Polli, A; Scanlon, MF; Webster, J1
Serri, O1
Gomez, A; Gonzalez, M; Motles, E; Tetas, M1
Aranyi, A; Bihari, M; Brlik, J; Csehi, A; Kassai, A; Szántay, C1
Delaforge, M; Mansuy, D; Peyronneau, MA; Renaud, JP; Riviere, R1
Boulton, AA; Juorio, AV; Paterson, IA; Zhu, MY1
Kamijo, N; Nagao, T; Ono, H1
Casy, AF2
Colombo, N; D'Alberton, A; de Vincentiis, S; Marchini, M; Motta, T1
Crosignani, PG; Ferrari, C; Piscitelli, G1
Arai, N; Fukuyama, J; Isaji, M; Kuno, S; Miyata, H; Mizuta, E1
Delgrange, E; Donckier, J; Maiter, D1
Webster, J1
Catz, T; Inzelberg, R; Kippervasser, S; Korczyn, AD; Nisipeanu, P; Orlov, E; Rabey, JM; Schechtman, E1
Deroche, V; Koob, GF; Weiss, F; Weissenborn, R1
Arai, N; Isaji, M; Itoh, F; Kojima, M; Miyagi, M; Taya, F; Ujiie, A1
Cerbone, G; Cirillo, S; Colao, A; Di Sarno, A; Ferone, D; Lombardi, G; Marzullo, P; Merola, B; Sarnacchiaro, F1
Korczyn, AD; Nisipeanu, P1
Marsden, CD1
Colao, A; Di Sarno, A; Di Somma, C; Facciolli, G; Klain, M; Landi, ML; Lombardi, G; Panza, N; Pivonello, R; Salvatore, M1
Conner, P; Fried, G1
Colao, A; De Rosa, M; Di Sarno, A; Ferone, D; Landi, ML; Lombardi, G; Merola, B; Paesano, L; Zarrilli, S1
Crabbé, J; Delgrange, E; Donckier, J1
Kuno, S; Mizuta, E; Yoshida, O; Yoshimura, N1
Chervin, A; Fideleff, HL; Gurucharri, C; Holland, ME; Sinai, I1
Ichihara, K; Kamei, H; Mizukoshi, K; Nagasaka, M; Okumura, K1
Inada, Y; Kojima, M; Komatsu, H; Miyata, H; Moro, M; Torii, R1
Abs, R; Beckers, A; Coremans, P; Lamberigts, G; Mahler, C; Maiter, D; Mockel, J; Petrossians, P; Raftopoulos, C; Stevenaert, A; van den Bruel, A; Vandeweghe, M; Velkeniers, B; Verhelst, J; Verlooy, J1
Larson, BT; Rowell, PP1
Montastruc, JL; Rascol, O; Senard, JM1
Atkin, SL; Foy, PM; Hadden, DR; Leong, KS; MacFarlane, IA; Swift, AC1
Colao, A; Di Sarno, A; Di Somma, C; Klain, M; Loche, S; Lombardi, G; Pietrosante, M; Pivonello, R; Salvatore, M1
Brannan, T; Prikhojan, A; Yahr, MD1
Tollin, SR1
De Santis, L; Doldi, N; Ferrari, A; Papaleo, E1
Agostini, S; Billeci, D; Conte, N; De Menis, E; Marton, E; Tramontin, P; Visentin, A1
Clarke, CE; Deane, KD1
de la Sota, RL; Gobello, C; Goya, RG1
Atkinson, AB; Bell, PM; Courtney, CH; Ellis, PK; Hadden, DR; Leslie, H; McCance, DR; Sheridan, B1
Diroma, C; Fraddosio, A; Iliceto, G; Lamberti, S; Moramarco, A; Palagano, G; Zenzola, A1
Arikan, E; Hatemi, H; Sabuncu, T; Tasan, E1
Cappabianca, P; Colao, A; Di Salle, F; Di Sarno, A; Di Somma, C; Faggiano, A; Landi, ML; Lombardi, G; Pivonello, R; Rossi, FW1
Colao, A; di Sarno, A; di Somma, C; Lombardi, G; Pivonello, R1
Liu, C; Tyrrell, JB1
Freed, DJ; Gillam, MP; Middler, S; Molitch, ME1
Gekht, AB1
Mah, PM; Webster, J1
Cavallero, D; Fazzuoli, L; Giusti, M; Valenti, S1
Goadsby, PJ; Levy, MJ; Matharu, MS1
Fujinami, A; Kuno, S; Matsui, H; Mizuta, I; Ohta, K; Ohta, M1
Bankowski, BJ; Zacur, HA1
Broglia, G; Castex, G; Corrada, Y; Gobello, C1
Ball, SG; Hall, K; James, RA; Kendall-Taylor, P; Pearce, SH; Quinton, R; Sibal, L; Ugwu, P1
Molitch, ME4
Braucks, GR; Gadelha, MR; Naliato, EC; Tabet, AL; Violante, AH1
Chang, JY; Kattah, JC; Orth, EH; Talkad, AV; Xu, MY1
Hotta, M; Kamo, T; Kawakami, M; Nemoto, S; Oshima, J; Shimojo, S; Shiraishi, M; Sugihara, H; Takahashi, Y; Yasaki, S1
Couldwell, WT; Liu, JK1
Grosset, D; Grosset, K; Macphee, G; Needleman, F1
Baran, AS; Rack, MJ; Richert, AC; Roffwarg, HP1
Basu, S; Chaudhuri, KR; Dhawan, V; Jackson, G; Odin, P1
Trifonov, I1
Casulari, LA; Mello, PA; Naves, LA; Papadia, C; Pereira Neto, A1
Brooks, PL; Vella, ET; Wynne-Edwards, KE1
Newell-Price, J; Ross, R; Selvarajah, D; Webster, J1
Goetz, CG; Poewe, W; Rascol, O; Sampaio, C1
Abs, R; Verhelst, J1
Goadsby, PJ; Levy, MJ; Matharu, MS; Meeran, K; Powell, M1
Howell, DL; Hudgins, RJ; Mazewski, CM; Meacham, LR; Wasilewski, K1
Biswas, M; Davies, JS; Evans, LM; Jadon, D; McEwan, P; Rees, DA; Scanlon, MF; Smith, J1
Crosignani, PG1
Góth, MI; Iván, G; Nagy, GM; Oláh, M; Szigeti-Csúcs, N1
Bronstein, MD2
Boulos, PT; Hamilton, DK; Laws, ER; Vance, ML1
Barlier, A; Jaquet, P1
Colao, A; De Leo, M; Di Sarno, A; Guerra, E; Lombardi, G; Mentone, A1
Burger, E; Härtter, S; Kvernmo, T1
Mascarell, S; Sarne, DH1
Tokhunts, KA1
Colao, A; Di Somma, C; Lombardi, G; Pivonello, R; Savastano, S; Tauchmanovà, L1
Chuang, E; Molitch, ME1
Greenman, Y1
Horikawa, F; Kawabata, Y; Miki, N; Miyake, H; Ono, M; Ueno, Y1
Casanueva, FF; Giustina, A; Mancini, T1
Caldas, D; Cesar de Oliveira Naliato, E; Colao, A; Dutra Violante, AH; Fontes, R; Gomes de Souza, R; Guerra, E; Lamounier Filho, A; Rezende Loureiro, C; Schrank, Y; Sebastian, A; Vaisman, M1
Daida, H; Hatano, T; Hattori, N; Iwama, Y; Komine-Kobayashi, M; Mizuno, Y; Mochizuki, H; Nakayama, T; Sakai, M; Urabe, T; Yamashiro, K1
Acharya, SV; Bandgar, TR; Gopal, RA; Joshi, SR; Menon, PS; Shah, NS1
Doi, K; Isono, T; Kawamura, T; Kitagawa, N; Kuno, S; Masaki, M; Mizuta, E; Oeda, T; Sawada, H; Taniguchi, S; Yaku, H; Yamamoto, K; Yutani, C1
Andersohn, F; Garbe, E1
Martin, NM; Meeran, K; Tan, T1
Fujioka, S; Iwamoto, K; Kawamura, M; Nakajima, M; Ohno, H1
Pullan, PT1
Bahuleyan, B; Easwer, HV; Krishna, K; Menon, G; Nair, S; Rao, BR1
Ajitkumar, G; Ghosh, KN; Mercy, KA; Praseeda, R; Sreekumaran, T1
Albuquerque, JL; Azevedo, MF; Boguszewski, CL; Bronstein, MD; Casulari, LA; de Oliveira, AR; Dos Santos Faria, M; Gadelha, MR; Montenegro, RM; Musolino, NR; Naves, LA; Pinho Barbosa, FR; Ramos, AJ; Serfaty, FM; Vilar, L1
Atis, A; Aydin, Y; Goker, N; Kaleli, S; Uludağ, S1
Amano, K; Hori, T; Izumi, S; Kawamata, T; Makino, R; Miki, N; Okada, Y; Ono, M; Seki, T; Takano, K1
Klibanski, A1
Bahceci, M; Sismanoglu, A; Ulug, U1
Babakhani, L; Fereshtehnejad, SM; Mojthahedi, K; Motazedian, S1
Barbosa, FR; Domingues, RC; dos Santos Silva, CM; Fontes, R; Gadelha, MR; Lima, GA; Warszawski, L1
Burger, P; Menucci, M; Quiñones-Hinojosa, A; Salvatori, R1
Freudenmann, RW; Gahr, M; Kölle, MA1
Boguszewski, CL; dos Santos Nunes, V; El Dib, R; Nogueira, CR1
Adamidou, F; Anagnostis, P; Efstathiadou, Z; Karathanassi, E; Kita, M; Polyzos, SA1
Azevedo, M; Boguszewski, CL; de Souza, AM; dos Santos, CM; Marini, LC; Sakamoto, KS1
Bernard, N; Descotes, J; Gillet, A; Gouraud, A; Mirkou, A; Suchovsky, D; Vial, T1
Abad, A; Aller, J; Batista, E; Doltra, A; García-Pavía, P; Halperin, I; Lucas, T; Mirelis, JG; Mora, M; Puig-Domingo, M; Santos, AE; Sitges, M; Varela, C1
Elenkova, A; Kalinov, K; Shabani, R; Zacharieva, S1
Berardini, A; Biagini, E; Graziosi, M; Pazzi, C; Rapezzi, C; Rosmini, S1
Bilge, A; Kurtulmus, N; Yarman, S1
Kumar, JB; Luthra, PM1
Deukmedjian, AR; Hann, S; Morrison, AD; Shah, V; Vale, FL1
Bancroft, T; Burton, T; Le Nestour, E; Neary, M1
Ahtiainen, P; Calandra, RS; Di Giorgio, NP; Gonzalez, B; Huhtaniemi, IT; Poutanen, M; Ratner, LD; Rulli, SB1
Alkabbani, A; Doshi, K; Hamrahian, A; Hatipoglu, B; Kennedy, L; Makin, V; Mon, SY; Olansky, L; Thorton, JN; Weil, R1
Abaci, A; Altincik, A; Bober, E; Buyukgebiz, A; Can, S; Catli, G; Demir, K1
Hashida, H; Hattori, N; Iijima, M; Kano, O; Kubo, S; Matsumura, M; Murakami, H; Nanri, K; Okuma, Y; Suzuki, M; Suzuki, Y; Tomimitsu, H; Utsumi, H1
Agúndez, JA; Alonso-Navarro, H; García-Martín, E; Jiménez-Jiménez, FJ1
Góth, M1
Cuevas, JL; Fernández, V; González, O; Rojas, D; Torche, E; Wohllk, N1
Hisanaga, R; Nakamura, M; Nomoto, S; Sato, T1
Descamps, P; Jeanneteau, P; Mercier, MB; Parot-Schinkel, E; Sentilhes, L1
Barkan, A; Benbassat, C; Bronstein, MD; Shapiro, J; Shimon, I; Tsvetov, G1
Figueroa-Núñez, C; González, E; Gutierrez, M; Hernán Martínez, J; Mangual-García, M; Mansilla-Letelier, P; Miranda, Mde L; Palermo-Garofalo, C; Sánchez, A; Santiago, M; Torres, O; Trinidad, R1
Bonadei, I; Curnis, A; D'Aloia, A; Metra, M; Piovanelli, B; Rovetta, R; Vizzardi, E1
Beketić-Orešković, L; Ježek, D; Kasum, M; Orešković, S; Pekez, M; Stanić, P; Vrčić, H1
Krysiak, R; Okopien, B1
Aydogan, U; Cengiz, M; Ercan, CM; Ergun, A; Ide, T; Kayaalp, O; Keskin, U; Yumusak, N1
Akbaba, G; Arduc, A; Aydin, Y; Berker, D; Gokay, F; Guler, S; Isik, S; Kucukler, FK; Ozuguz, U; Tutuncu, Y1
Elenkova, A; Gerenova, J; Hristozov, K; Kalinov, K; Kamenov, Z; Kirilov, G; Marinov, M; Natchev, E; Orbetzova, M; Tcharaktchiev, D; Tsinlikov, I; Vandeva, S; Yaneva, M; Zacharieva, S1
Cámara Gómez, R; Del Olmo García, M; Merino Torres, JF; Querol Ripoll, R; Simal Julián, JA1
Couldwell, WT; Eloy, JA; Liu, JK; Wong, A1
Krysiak, R; Okopien, B; Okrzesik, J1
Couldwell, WT; Eloy, JA; Hajart, AF; Jethwa, PR; Liu, JK; Patel, TD1
Lamos, EM; Levitt, DL; Munir, KM1
Dogansen, SC; Selcukbiricik, OS; Tanrikulu, S; Yarman, S1
Alfieri, A; Ballarino, MC; Boero, L; Chervin, A; Danilowicz, K; Diez, S; Fainstein Day, P; García-Basavilbaso, N; Glerean, M; Guitelman, M; Katz, D; Loto, MG; Mallea-Gil, MS; Manavela, M; Martinez, M; Miragaya, K; Moncet, D; Rogozinski, AS; Servidio, M; Stalldecker, G; Vitale, M1
Bronstein, MD; Espinosa, E; Glezer, A; Greenman, Y; Mendoza, V; Mercado, M; Popovic, V; Shimon, I; Sosa, E; Tirosh, A1
Cooper, O; Gertych, A; Greenman, Y; Jonas-Kimchi, T; Melmed, S; Ram, Z; Robenshtok, E; Sagiv, N; Shimon, I; Stern, N; Yaish, I; Yuan, X1
Blankley, G; Galbally, M; Power, J; Snellen, M1
Chapman, IM; De Sousa, SM; Falhammar, H; Torpy, DJ1
Atkinson, JL; Donegan, D; Erickson, B; Erickson, D; Jentoft, M; Meyer, F; Natt, N; Nippoldt, TB1
Andereggen, L; Andres, RH; Beck, J; Christ, E; El-Koussy, M; Frey, J; Seiler, RW1
Hart, RJ; Mourad, S; Tang, H; Zhai, SD1
Dhanjal, MK; Knight, M; Lambert, K; McCance, DR; Rees, K; Seed, PT; Williamson, C1
Beckers, A; Bonneville, JF; Brue, T; Castinetti, F; Cuny, T; Dufour, H; Eroukhmanoff, J; Potorac, I; Tejedor, I; Touraine, P; Weryha, G1
Carvalho, D; Souteiro, P; Teixeira, M1
Araujo, B; Belo, S; Carvalho, D1
Ji, MJ; Kim, JH; Kim, SY; Kim, YH; Lee, JH; Paek, SH; Shin, CS1
Cha, HJ; Kim, JH; Kim, SW; Kim, YH; Lee, JH; Lee, SY; Paek, SH; Shin, CS1
Čehić, E; Franulić, D; Grgić, F; Kasum, M; Lila, A; Orešković, S; Vujić, G1
Bilbao, I; Egaña, N; García, C; Olaizola, I1
Arlt, W; Ayuk, J; Fountas, A; Gittoes, N; Karavitaki, N; Santharam, S; Tampourlou, M; Toogood, A1
Hart, RJ; Mourad, SM; Tang, H; Wang, A; Zhai, SD1
Arastu, MI; Curiale, AM; Lipton, BA; Longo, S; Nanda, S; Tessier, S1
Cescato, VAS; Cunha-Neto, MBC; Glezer, A; Musolino, NRC; Pinheiro, FMM; Silva, GO; Stumpf, MAM1
Attanasio, R; Basile, M; Bozzao, A; Cappabianca, P; Caputo, M; Cozzi, R; Cruciani, F; De Menis, E; Doglietto, F; Esposito, F; Ferrante, E; Ferraù, F; Grimaldi, F; Iatì, G; Lania, AG; Laureti, S; Lello, S; Locatelli, D; Maffei, P; Mazzatenta, D; Minniti, G; Mitrova, Z; Paoletta, A; Papini, E; Peri, A; Persichetti, A; Poggi, M; Rudà, R; Ruini, C; Samperi, I; Saulle, R; Scoppola, A; Settanni, F; Silvani, A; Simona Auriemma, R; Tortora, F; Vecchi, S; Veronese, N1

Reviews

57 review(s) available for bromocriptine and ergoline

ArticleYear
[Considerations in the drug treatment of parkinsonism (author's transl)].
    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1978, Nov-07, Volume: 67, Issue:45

    Topics: Amantadine; Apomorphine; Bromocriptine; Dopamine; Ergolines; Extrapyramidal Tracts; Female; Humans; Levodopa; Male; Monoamine Oxidase Inhibitors; Neurotransmitter Agents; Parkinson Disease; Phosphodiesterase Inhibitors; Piribedil; Tremor

1978
Bromocriptine in the treatment of parkinsonism.
    Drugs, 1979, Volume: 17, Issue:5

    Topics: Apomorphine; Bromocriptine; Catecholamines; Drug Interactions; Ergolines; Humans; Kinetics; Motor Activity; Movement Disorders; Parkinson Disease; Piribedil; Receptors, Drug; Stereotyped Behavior

1979
Comparative effects of a series of prolactin inhibitors, 17beta-estradiol and 2alpha-methyldihydrotestosterone propionate, on growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas.
    Cancer research, 1977, Volume: 37, Issue:11

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Acetonitriles; Androstanols; Animals; Breast Neoplasms; Bromocriptine; Drug Evaluation, Preclinical; Ergolines; Ergot Alkaloids; Estradiol; Female; Humans; Lisuride; Mammary Neoplasms, Experimental; Prolactin; Rats; Urea

1977
[Drug treatment of male infertility].
    Medicina clinica, 1990, Jun-02, Volume: 95, Issue:1

    Topics: Androgens; Bromocriptine; Ergolines; Estrogen Antagonists; Glucocorticoids; Gonadotropin-Releasing Hormone; Gonadotropins; Humans; Immunosuppressive Agents; Infertility, Male; Kallikreins; Male; Pentoxifylline; Prostaglandin Antagonists; Testolactone; Testosterone

1990
Medical treatment of pituitary adenomas: effects on tumor growth.
    Journal of endocrinological investigation, 1985, Volume: 8, Issue:3

    Topics: Adenoma; Adrenocorticotropic Hormone; Bromocriptine; Dihydroergotoxine; Dopamine; Drug Administration Schedule; Ergolines; Growth Hormone; Levodopa; Lisuride; Metergoline; Methysergide; Pergolide; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed

1985
Psychiatric disorders in parkinsonism: 2. Organic cerebral states and drug reactions.
    Psychosomatics, 1986, Volume: 27, Issue:3

    Topics: Amantadine; Antiparkinson Agents; Atrophy; Brain; Bromocriptine; Cognition; Dementia; Dreams; Drug Interactions; Ergolines; Humans; Levodopa; Libido; Memory; Parasympatholytics; Parkinson Disease; Receptors, Dopamine; Sexual Behavior; Substance-Related Disorders; Visual Perception

1986
Update on dopamine agonists in Parkinson's disease: "beyond bromocriptine".
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1987, Volume: 14, Issue:3 Suppl

    Topics: Antiparkinson Agents; Bromocriptine; Dopamine; Ergolines; Humans; Parkinson Disease; Piperazines

1987
Medical treatment of hyperprolactinaemic disorders.
    Human reproduction (Oxford, England), 1986, Volume: 1, Issue:8

    Topics: Acromegaly; Bromocriptine; Delayed-Action Preparations; Dopamine; Ergolines; Female; Humans; Hyperprolactinemia; Lisuride; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Psychoses, Substance-Induced; Tamoxifen

1986
Long-term use of dopamine agonists in Parkinson's disease.
    Clinical neuropharmacology, 1985, Volume: 8, Issue:2

    Topics: Bromocriptine; Corpus Striatum; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Movement Disorders; Parkinson Disease; Pergolide; Receptors, Dopamine; Time Factors

1985
Bromocriptine in Parkinson disease.
    Pharmacological reviews, 1985, Volume: 37, Issue:2

    Topics: Aged; Animals; Bromocriptine; Drug Administration Schedule; Ergolines; Humans; Levodopa; Lisuride; Middle Aged; Parkinson Disease; Pergolide; Time Factors

1985
Pharmacologic therapy of patients with pituitary tumors secreting prolactin, growth hormone and adrenocorticotropin.
    Advances in internal medicine, 1980, Volume: 25

    Topics: Adrenergic alpha-Antagonists; Adrenocorticotropic Hormone; Amenorrhea; Antineoplastic Agents; Bromocriptine; Cyproheptadine; Ergolines; Estrogens; Female; Galactorrhea; Growth Hormone; Humans; Hypothalamus; Levodopa; Pituitary Gland; Pituitary Neoplasms; Pregnancy; Prolactin

1980
Clinical pharmacokinetics of ergotamine, dihydroergotamine, ergotoxine, bromocriptine, methysergide, and lergotrile.
    International journal of clinical pharmacology, therapy, and toxicology, 1983, Volume: 21, Issue:3

    Topics: Absorption; Animals; Bromocriptine; Dihydroergotamine; Ergolines; Ergot Alkaloids; Ergotamine; Half-Life; Humans; Kinetics; Methysergide

1983
Dopamine receptors and hypertension. Physiologic and pharmacologic implications.
    The American journal of medicine, 1984, Oct-05, Volume: 77, Issue:4A

    Topics: Animals; Benzazepines; Blood Pressure; Bromocriptine; Domperidone; Dopamine; Ergolines; Fenoldopam; Humans; Hypertension; Levodopa; Quinpirole; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Vasoconstriction; Vasodilation

1984
The pharmacology of Parkinson's disease: basic aspects and recent advances.
    Experientia, 1984, Nov-15, Volume: 40, Issue:11

    Topics: Animals; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Brain; Bromocriptine; Carbidopa; Corpus Striatum; Dopamine; Ergolines; Humans; Kidney; Kinetics; Levodopa; Lisuride; Liver; Methyldopa; Norepinephrine; Parkinson Disease; Pergolide; Receptors, Dopamine; Selegiline; Serotonin; Stereotyped Behavior; Substantia Nigra; Tyramine

1984
New drugs for hyperprolactinaemia.
    Drug and therapeutics bulletin, 1995, Volume: 33, Issue:9

    Topics: Aminoquinolines; Bromocriptine; Cabergoline; Clinical Trials as Topic; Ergolines; Hormone Antagonists; Humans; Hyperprolactinemia

1995
Cabergoline. A review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinaemia and inhibition of lactation.
    Drugs, 1995, Volume: 49, Issue:2

    Topics: Administration, Oral; Antineoplastic Agents; Biological Availability; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Female; Humans; Hyperprolactinemia; Lactation; Prolactin; Tissue Distribution

1995
D1 and D2 dopamine receptor modulation of sodium and potassium currents in rat neostriatal neurons.
    Progress in brain research, 1993, Volume: 99

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Bromocriptine; Dopamine Agents; Embryo, Mammalian; Ergolines; In Vitro Techniques; Neostriatum; Neurons; Potassium Channels; Quinpirole; Rats; Receptors, Dopamine D1; Receptors, Dopamine D2; RNA, Messenger; Sodium Channels

1993
Cabergoline: a new drug for the treatment of hyperprolactinaemia.
    Human reproduction (Oxford, England), 1995, Volume: 10, Issue:7

    Topics: Bromocriptine; Cabergoline; Clinical Trials as Topic; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Ergolines; Female; Humans; Hyperprolactinemia; Lactation; Postpartum Period; Randomized Controlled Trials as Topic

1995
A comparative review of the tolerability profiles of dopamine agonists in the treatment of hyperprolactinaemia and inhibition of lactation.
    Drug safety, 1996, Volume: 14, Issue:4

    Topics: Aminoquinolines; Animals; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Lactation; Male; Pregnancy

1996
Newer therapies for Parkinson's disease.
    Neurologia i neurochirurgia polska, 1996, Volume: 30 Suppl 2

    Topics: Antiparkinson Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Humans; Indoles; Parkinson Disease

1996
Clinical experience with cabergoline in patients with advanced Parkinson's disease treated with levodopa.
    Drugs, 1998, Volume: 55 Suppl 1

    Topics: Antiparkinson Agents; Bromocriptine; Cabergoline; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Randomized Controlled Trials as Topic

1998
Hyperprolactinemia; etiology, diagnosis and treatment alternatives.
    Acta obstetricia et gynecologica Scandinavica, 1998, Volume: 77, Issue:3

    Topics: Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Pergolide; Prolactin; Receptors, Prolactin

1998
Treatment of Parkinson's disease should begin with a dopamine agonist.
    Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:5

    Topics: Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ergolines; Humans; Indoles; Levodopa; Lisuride; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine D2; Thiazoles

1999
CSF rhinorrhoea following treatment with dopamine agonists for massive invasive prolactinomas.
    Clinical endocrinology, 2000, Volume: 52, Issue:1

    Topics: Adult; Bromocriptine; Cabergoline; Cerebrospinal Fluid Rhinorrhea; Dopamine Agonists; Ergolines; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Tomography, X-Ray Computed

2000
Cabergoline versus bromocriptine for levodopa-induced complications in Parkinson's disease.
    The Cochrane database of systematic reviews, 2001, Issue:1

    Topics: Antiparkinson Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Dyskinesia, Drug-Induced; Ergolines; Humans; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic

2001
Dopamine receptor agonists for treating prolactinomas.
    Expert opinion on investigational drugs, 2002, Volume: 11, Issue:6

    Topics: Aminoquinolines; Animals; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance, Neoplasm; Ergolines; Ergot Alkaloids; Female; Humans; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma

2002
DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17 Suppl 4

    Topics: Benzophenones; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Therapy, Combination; Enzyme Inhibitors; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Nitrophenols; Parkinson Disease; Pergolide; Randomized Controlled Trials as Topic; Tolcapone

2002
[Use of dopamine agonists in the treatment of Parkinson's disease].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2002, Volume: 102, Issue:9

    Topics: Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Controlled Clinical Trials as Topic; Dopamine Agonists; Ergolines; Humans; Indoles; Lisuride; Parkinson Disease; Pergolide; Piribedil; Placebos; Pramipexole; Serotonin Receptor Agonists; Thiazoles; Time Factors

2002
Hyperprolactinemia: etiology, diagnosis, and management.
    Seminars in reproductive medicine, 2002, Volume: 20, Issue:4

    Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Humans; Hyperprolactinemia; Neurosurgical Procedures; Prevalence

2002
Dopamine agonist therapy for hyperprolactinemia.
    Clinical obstetrics and gynecology, 2003, Volume: 46, Issue:2

    Topics: Aminoquinolines; Benzothiazoles; Bromocriptine; Cabergoline; Clinical Trials as Topic; Dopamine Agonists; Ergolines; Ergoloid Mesylates; Female; Humans; Hyperprolactinemia; Indoles; Pergolide; Pramipexole; Thiazoles

2003
Dopamine resistance of prolactinomas.
    Pituitary, 2003, Volume: 6, Issue:1

    Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance; Ergolines; Humans; Pituitary Neoplasms; Prolactinoma

2003
Contemporary management of prolactinomas.
    Neurosurgical focus, 2004, Apr-15, Volume: 16, Issue:4

    Topics: Bromocriptine; Cabergoline; Contraindications; Diagnosis, Differential; Ergolines; Female; Humans; Hypophysectomy; Magnetic Resonance Imaging; Male; Pituitary Diseases; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma; Radiosurgery; Remission Induction

2004
[Prolactinoma and pregnancy].
    Akusherstvo i ginekologiia, 2004, Volume: 43 Suppl 2

    Topics: Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma

2004
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
    Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:5

    Topics: Amantadine; Antiparkinson Agents; Apomorphine; Benzophenones; Benzothiazoles; Bromocriptine; Cabergoline; Catechol O-Methyltransferase Inhibitors; Deep Brain Stimulation; Dihydroergocryptine; Ergolines; Fetal Tissue Transplantation; Globus Pallidus; Humans; Indans; Indoles; Levodopa; Lisuride; Mesencephalon; Monoamine Oxidase Inhibitors; Neurosurgical Procedures; Nitrophenols; Parkinson Disease; Pergolide; Piribedil; Pramipexole; Selegiline; Thiazoles; Tolcapone

2005
Hyperprolactinemia: pathophysiology and management.
    Treatments in endocrinology, 2003, Volume: 2, Issue:1

    Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Estrogens; Female; Humans; Hyperprolactinemia; Male; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma; Radiotherapy; Surgical Procedures, Operative

2003
Current treatment issues in female hyperprolactinaemia.
    European journal of obstetrics, gynecology, and reproductive biology, 2006, Apr-01, Volume: 125, Issue:2

    Topics: Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Male; Pituitary Neoplasms; Pregnancy; Prolactinoma

2006
Treatment of pituitary tumors: dopamine agonists.
    Endocrine, 2005, Volume: 28, Issue:1

    Topics: Adenoma; Bromocriptine; Cabergoline; Dopamine; Dopamine Agonists; Ergolines; Humans; Pituitary Neoplasms; Receptors, Dopamine

2005
Prolactinomas and pregnancy.
    Pituitary, 2005, Volume: 8, Issue:1

    Topics: Aminoquinolines; Bromocriptine; Cabergoline; Child; Dopamine Agonists; Ergolines; Female; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma

2005
Pharmacologic resistance in prolactinoma patients.
    Pituitary, 2005, Volume: 8, Issue:1

    Topics: Bromocriptine; Cabergoline; Cell Proliferation; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Resistance; Ergolines; Estrogens; Female; Humans; Male; Pergolide; Pituitary Neoplasms; Prolactin; Prolactinoma; Receptors, Dopamine D2

2005
Quinagolide--a valuable treatment option for hyperprolactinaemia.
    European journal of endocrinology, 2006, Volume: 154, Issue:2

    Topics: Administration, Oral; Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Male; Patient Compliance

2006
Drug insight: Cabergoline and bromocriptine in the treatment of hyperprolactinemia in men and women.
    Nature clinical practice. Endocrinology & metabolism, 2006, Volume: 2, Issue:4

    Topics: Adenoma; Antineoplastic Agents; Bromocriptine; Cabergoline; Ergolines; Female; Humans; Hyperprolactinemia; Male; Prolactin; Prolactinoma; Sex Characteristics

2006
A review of the receptor-binding and pharmacokinetic properties of dopamine agonists.
    Clinical therapeutics, 2006, Volume: 28, Issue:8

    Topics: Animals; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Interactions; Dyskinesia, Drug-Induced; Ergolines; Heart Valve Diseases; Humans; Indoles; Pergolide; Pulmonary Fibrosis; Receptors, Dopamine

2006
Hyperprolactinemia and prolactinomas.
    Endocrinology and metabolism clinics of North America, 2008, Volume: 37, Issue:1

    Topics: Bromocriptine; Dopamine Agonists; Ergolines; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactinoma

2008
Clinical practice. Prolactinomas.
    The New England journal of medicine, 2010, Apr-01, Volume: 362, Issue:13

    Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma; Visual Fields

2010
Cabergoline versus bromocriptine in the treatment of hyperprolactinemia: a systematic review of randomized controlled trials and meta-analysis.
    Pituitary, 2011, Volume: 14, Issue:3

    Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Humans; Hyperprolactinemia; Randomized Controlled Trials as Topic

2011
Prolactinoma in pregnancy.
    Best practice & research. Clinical endocrinology & metabolism, 2011, Volume: 25, Issue:6

    Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Fetus; Humans; Hyperprolactinemia; Infertility, Female; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma

2011
Plausible improvements for selective targeting of dopamine receptors in therapy of Parkinson's disease.
    Mini reviews in medicinal chemistry, 2012, Volume: 12, Issue:14

    Topics: Animals; Antiparkinson Agents; Apomorphine; Bromocriptine; Dopamine Agonists; Drug Delivery Systems; Ergolines; Humans; Parkinson Disease; Receptors, Dopamine

2012
Anti-Parkinson's disease drugs and pharmacogenetic considerations.
    Expert opinion on drug metabolism & toxicology, 2013, Volume: 9, Issue:7

    Topics: Aryl Hydrocarbon Hydroxylases; Benzothiazoles; Benztropine; Bromocriptine; Cabergoline; Catechols; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Ergolines; Genetic Markers; Humans; Indans; Indoles; Levodopa; Lisuride; Nitriles; Parkinson Disease; Pergolide; Pharmacogenetics; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Reproducibility of Results; Selegiline

2013
[Drug therapy for acromegaly].
    Orvosi hetilap, 2013, Sep-29, Volume: 154, Issue:39

    Topics: Acromegaly; Aminoquinolines; Antineoplastic Agents, Hormonal; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Administration Schedule; Drug Therapy, Combination; Ergolines; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Interdisciplinary Communication; Membrane Proteins; Octreotide; Patient Care Team; Peptides, Cyclic; Pituitary Neoplasms; Somatostatin

2013
Dopamine agonists in prevention of ovarian hyperstimulation syndrome.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2014, Volume: 30, Issue:12

    Topics: Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Ovarian Hyperstimulation Syndrome; Ovulation Induction

2014
Update on prolactinomas. Part 2: Treatment and management strategies.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2015, Volume: 22, Issue:10

    Topics: Bromocriptine; Cabergoline; Disease Management; Dopamine Agonists; Drug Administration Schedule; Drug Resistance, Neoplasm; Ergolines; Female; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neuroendoscopy; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma; Radiosurgery; Sphenoid Sinus

2015
A review of dopamine agonist therapy in type 2 diabetes and effects on cardio-metabolic parameters.
    Primary care diabetes, 2016, Volume: 10, Issue:1

    Topics: Animals; Biomarkers; Blood Glucose; Bromocriptine; Cabergoline; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus, Type 2; Dopamine Agonists; Ergolines; Humans; Hypoglycemic Agents; Risk Factors; Treatment Outcome

2016
Pharmacological lactation suppression with D2 receptor agonists and risk of postpartum psychosis: A systematic review.
    The Australian & New Zealand journal of obstetrics & gynaecology, 2016, Volume: 56, Issue:4

    Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Lactation; Psychoses, Substance-Induced; Receptors, Dopamine D2; Risk Factors

2016
Dopamine agonists for preventing ovarian hyperstimulation syndrome.
    The Cochrane database of systematic reviews, 2016, 11-30, Volume: 11

    Topics: Abortion, Spontaneous; Administration, Oral; Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Ovarian Hyperstimulation Syndrome; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic; Reproductive Techniques, Assisted

2016
Current Medical Strategies in the Prevention of Ovarian Hyperstimulation Syndrome
    Acta clinica Croatica, 2017, Volume: 56, Issue:1

    Topics: Aminoquinolines; Bromocriptine; Buserelin; Cabergoline; Chorionic Gonadotropin; Dopamine Agonists; Ergolines; Estradiol; Estrogens; Female; Fertility Agents, Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Oocyte Retrieval; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Pregnancy Rate; Progesterone; Progestins; Triptorelin Pamoate

2017
Dopamine agonists for preventing ovarian hyperstimulation syndrome.
    The Cochrane database of systematic reviews, 2021, 04-14, Volume: 4

    Topics: Abortion, Spontaneous; Administration, Oral; Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Fertilization in Vitro; Humans; Live Birth; Ovarian Hyperstimulation Syndrome; Placebos; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic; Sperm Injections, Intracytoplasmic

2021
How to manage intolerance to dopamine agonist in patients with prolactinoma.
    Pituitary, 2023, Volume: 26, Issue:2

    Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactinoma

2023

Trials

82 trial(s) available for bromocriptine and ergoline

ArticleYear
Editorial: Bromocriptine.
    Lancet (London, England), 1975, May-10, Volume: 1, Issue:7915

    Topics: Acromegaly; Bromocriptine; Clinical Trials as Topic; Ergolines; Female; Galactorrhea; Humans; Lactation; Parkinson Disease; Pregnancy

1975
Letter: Bromocriptine in parkinsonism.
    Lancet (London, England), 1975, Oct-11, Volume: 2, Issue:7937

    Topics: Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Ergolines; Humans; Parkinson Disease

1975
Controlled trial of bromocriptine, quinoestrol, and placebo in suppression of puerperal lactation.
    Lancet (London, England), 1975, Nov-01, Volume: 2, Issue:7940

    Topics: Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Ergolines; Female; Humans; Lactation; Milk, Human; Norpregnatrienes; Placebos; Pregnancy; Prolactin; Quinestrol; Time Factors

1975
Inhibition of the plasma-aldosterone response to frusemide by bromocriptine.
    Lancet (London, England), 1975, Nov-08, Volume: 2, Issue:7941

    Topics: Aldosterone; Bromocriptine; Dopamine; Ergolines; Furosemide; Humans; Injections, Intravenous; Mineralocorticoid Receptor Antagonists; Potassium; Renin; Sodium

1975
Letter: Bromocriptine in parkinsonism.
    Lancet (London, England), 1975, Nov-15, Volume: 2, Issue:7942

    Topics: Bromocriptine; Drug Evaluation; Ergolines; Humans; Levodopa; Parkinson Disease

1975
Bromocriptine therapy in acromegaly.
    Lancet (London, England), 1975, Dec-13, Volume: 2, Issue:7946

    Topics: 11-Hydroxycorticosteroids; Acromegaly; Administration, Oral; Adult; Aged; Blood Glucose; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Ergolines; Female; Follicle Stimulating Hormone; Growth Hormone; Humans; Luteinizing Hormone; Male; Middle Aged; Pituitary Function Tests; Thyrotropin; Thyrotropin-Releasing Hormone; Time Factors

1975
Premenstrual tension and functional infertility. Aetiology and treatment.
    Lancet (London, England), 1976, May-22, Volume: 1, Issue:7969

    Topics: Adult; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Ergolines; Female; Humans; Infertility, Female; Menstruation; Placebos; Premenstrual Syndrome; Prolactin

1976
The effect of bromocriptine in patients with benign prostatic hypertrophy.
    British journal of urology, 1976, Volume: 48, Issue:1

    Topics: Aged; Bromocriptine; Clinical Trials as Topic; Ergolines; Humans; Male; Middle Aged; Placebos; Prostatic Hyperplasia; Urinary Tract; Urination; Urination Disorders

1976
Bromocriptine and levodopa (with or without carbidopa) in parkinsonism.
    Lancet (London, England), 1976, Aug-07, Volume: 2, Issue:7980

    Topics: Aged; Bromocriptine; Carbidopa; Clinical Trials as Topic; Disability Evaluation; Dose-Response Relationship, Drug; Drug Combinations; Drug Evaluation; Ergolines; Female; Follow-Up Studies; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Placebos; Time Factors

1976
Lisuride in Parkinson's disease.
    Lancet (London, England), 1979, Nov-24, Volume: 2, Issue:8152

    Topics: Administration, Oral; Antiparkinson Agents; Bromocriptine; Clinical Trials as Topic; Drug Therapy, Combination; Ergolines; Humans; Lisuride; Parkinson Disease

1979
Bromocriptine in Huntington chorea.
    Archives of neurology, 1976, Volume: 33, Issue:7

    Topics: Adult; Bromocriptine; Dose-Response Relationship, Drug; Ergolines; Female; Humans; Huntington Disease; Male; Middle Aged

1976
Treatment of Huntington's chorea with bromocriptine.
    Acta neurologica Scandinavica, 1977, Volume: 56, Issue:1

    Topics: Adult; Aged; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Ergolines; Female; Gait; Humans; Huntington Disease; Male; Middle Aged; Placebos; Spatial Behavior; Speech

1977
Studies with bromocriptine: III. Concomitant administration of caffeine to patients with idiopathic parkinsonism.
    Neurology, 1976, Volume: 26, Issue:8

    Topics: Bromocriptine; Caffeine; Clinical Trials as Topic; Drug Synergism; Drug Therapy, Combination; Ergolines; Female; Humans; Male; Middle Aged; Parkinson Disease; Phosphodiesterase Inhibitors

1976
An ergot derivative in the treatment of Parkinson's disease.
    Postgraduate medical journal, 1976, Volume: 52suppl 1

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Bromocriptine; Clinical Trials as Topic; Ergolines; Humans; Levodopa; Parkinson Disease

1976
Stimulatory effect of the dopa-decarboxylase inhibitor Ro 4-4602 on prolactin release; inhibition by l-dopa, metergoline, methysergide and 2-Br-alpha-ergocryptine.
    Acta endocrinologica, 1977, Volume: 84, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Benserazide; Bromocriptine; Clinical Trials as Topic; Drug Interactions; Ergolines; Female; Humans; Hydrazines; Levodopa; Male; Metergoline; Methysergide; Middle Aged; Pituitary Gland; Pituitary Gland, Anterior; Prolactin; Secretory Rate; Stimulation, Chemical; Time Factors

1977
Bromocriptine and premenstrual syndrome: controlled study.
    British medical journal, 1977, Jan-15, Volume: 1, Issue:6054

    Topics: Adult; Bromocriptine; Clinical Trials as Topic; Ergolines; Female; Humans; Premenstrual Syndrome

1977
[Treatment of parkinsonian syndromes by bromocriptin].
    La Nouvelle presse medicale, 1977, Jan-22, Volume: 6, Issue:3

    Topics: Aged; Amantadine; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Ergolines; Female; Humans; Hypotension; Levodopa; Male; Movement Disorders; Nausea; Parkinson Disease, Secondary

1977
The suppression of puerperal lactation with bromocryptine.
    Acta obstetricia et gynecologica Scandinavica, 1977, Volume: 56, Issue:2

    Topics: Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Ergolines; Estradiol; Female; Follicle Stimulating Hormone; Humans; Lactalbumin; Lactation; Placebos; Postpartum Period; Pregnancy

1977
The suppression of puerperal lactation with bromocriptine.
    Irish medical journal, 1977, Apr-09, Volume: 70, Issue:5

    Topics: Bromocriptine; Clinical Trials as Topic; Ergolines; Female; Humans; Lactation; Norpregnatrienes; Postpartum Period; Pregnancy; Quinestrol

1977
[The effect of several sexual steroids, 2-bromo-ergokryptin and lisurid-hydrogenmaleate an the postpartum concentration of serum prolactin and lactation (author's transl)].
    Geburtshilfe und Frauenheilkunde, 1977, Volume: 37, Issue:6

    Topics: Bromocriptine; Clinical Trials as Topic; Ergolines; Estrogens; Female; Humans; Lactation; Nandrolone; Placebos; Postpartum Period; Pregnancy; Prolactin; Quinestrol; Serotonin Antagonists; Testosterone

1977
Effect of bromocriptine on the premenstrual syndrome. A double-blind clinical trial.
    British journal of obstetrics and gynaecology, 1977, Volume: 84, Issue:5

    Topics: Adolescent; Adult; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Ergolines; Estradiol; Female; Humans; Middle Aged; Premenstrual Syndrome; Progesterone; Prolactin

1977
Comparison of the effects of bromocriptine and levodopa in Parkinson's disease.
    Journal of neurology, neurosurgery, and psychiatry, 1977, Volume: 40, Issue:5

    Topics: Aged; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Ergolines; Humans; Individuality; Levodopa; Male; Middle Aged; Parkinson Disease

1977
Treatment of Parkinson's disease with lergotrile mesylate.
    JAMA, 1977, Nov-28, Volume: 238, Issue:22

    Topics: Acetonitriles; Antiparkinson Agents; Bromocriptine; Carbidopa; Carboxy-Lyases; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Ergolines; Ergot Alkaloids; Female; Humans; Hypotension, Orthostatic; Levodopa; Male; Parkinson Disease

1977
Inhibition of prolactin release by serotonin antagonists in hyperprolactinemic subjects.
    Metabolism: clinical and experimental, 1978, Volume: 27, Issue:10

    Topics: Adult; Bromocriptine; Ergolines; Female; Humans; Male; Metergoline; Methysergide; Pituitary Diseases; Prolactin

1978
Study of the suppression of lactation and the influence on blood clotting with bromocriptine (CB 154) (Parlodel): a double blind comparison with diethylstilboestrol.
    Acta obstetricia et gynecologica Scandinavica, 1976, Volume: 55, Issue:1

    Topics: Blood Coagulation; Bromocriptine; Clinical Trials as Topic; Depression, Chemical; Diethylstilbestrol; Drug Evaluation; Ergolines; Female; Humans; Lactation; Postpartum Period; Pregnancy

1976
Effect of CB 154 (2-bromo-alpha-ergocryptine) on paralysis agitans compared with Madopar in a double-blind, cross-over trial.
    Acta neurologica Scandinavica, 1976, Volume: 53, Issue:3

    Topics: Aged; Azides; Benserazide; Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Combinations; Ergolines; Female; Humans; Hydrazines; Hyperkinesis; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Psychoses, Substance-Induced

1976
Letter: Bromocriptine and spasmodic torticollis.
    British medical journal, 1976, May-29, Volume: 1, Issue:6021

    Topics: Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Ergolines; Humans; Male; Middle Aged; Placebos; Torticollis

1976
Late suppression of lactation with bromocriptine.
    The Practitioner, 1976, Volume: 216, Issue:1294

    Topics: Breast; Bromocriptine; Clinical Trials as Topic; Depression, Chemical; Ergolines; Female; Humans; Lactation; Placebos; Pregnancy

1976
Studies with bromocriptine. Part 2. Double-blind comparison with levodopa in idiopathic parkinsonism.
    Neurology, 1976, Volume: 26, Issue:6 PT 1

    Topics: Aged; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Tremor

1976
A comparison of 2 bromo alpha ergocryptine, quinoestrol and placebo in suppression of puerperal lactation [proceedings].
    British journal of clinical pharmacology, 1975, Volume: 2, Issue:4

    Topics: Bromocriptine; Clinical Trials as Topic; Depression, Chemical; Drug Evaluation; Ergolines; Female; Humans; Lactation; Norpregnatrienes; Placebos; Postpartum Period; Pregnancy; Prolactin; Quinestrol

1975
[Clinical experience with bromocriptine, a central dopaminergic stimulator].
    Der Nervenarzt, 1976, Volume: 47, Issue:11

    Topics: Aged; Amantadine; Bromocriptine; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Dose-Response Relationship, Drug; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Placebos; Trihexyphenidyl

1976
[Treatment of acromegaly with bromocriptine (CB 154)].
    Verhandlungen der Deutschen Gesellschaft fur Innere Medizin, 1976, Volume: 82 Pt 2

    Topics: Acromegaly; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Ergolines; Humans

1976
[Drug therapy of acromegaly using bromocriptine: results after a 1-year therapy].
    Verhandlungen der Deutschen Gesellschaft fur Innere Medizin, 1976, Volume: 82 Pt 2

    Topics: Acromegaly; Adult; Aged; Bromocriptine; Clinical Trials as Topic; Ergolines; Female; Humans; Male; Middle Aged; Time Factors

1976
The treatment of puerperal lactation with bromocriptine.
    Postgraduate medical journal, 1976, Volume: 52suppl 1

    Topics: Bromocriptine; Ergolines; Female; Humans; Lactation; Placebos; Postpartum Period; Pregnancy; Prolactin

1976
The use of bromocriptine in the treatment of the unstable bladder.
    British journal of urology, 1976, Volume: 48, Issue:4

    Topics: Adolescent; Adult; Aged; Bromocriptine; Ergolines; Female; Humans; Male; Middle Aged; Urinary Bladder; Urination Disorders

1976
Effect of bromocriptine and chlorotrianisene on inhibition of lactation and serum prolactin. A comparative double-blind study.
    British journal of obstetrics and gynaecology, 1975, Volume: 82, Issue:9

    Topics: Bromocriptine; Chlorotrianisene; Clinical Trials as Topic; Ergolines; Female; Humans; Lactation; Pregnancy; Prolactin

1975
Suppression of puerperal lactation using 2 brom-ergocryptine.
    British journal of obstetrics and gynaecology, 1975, Volume: 82, Issue:10

    Topics: Bromocriptine; Clinical Trials as Topic; Ergolines; Female; Humans; Lactation; Pregnancy; Quinestrol; Volition

1975
[Letter: Inhibition of lactation by an antiprolactin substance, CB 154].
    La Nouvelle presse medicale, 1975, Nov-15, Volume: 4, Issue:39

    Topics: Bromocriptine; Clinical Trials as Topic; Depression, Chemical; Ergolines; Female; Humans; Lactation; Pregnancy; Prolactin

1975
Single dose cabergoline versus bromocriptine in inhibition of puerperal lactation: randomised, double blind, multicentre study. European Multicentre Study Group for Cabergoline in Lactation Inhibition.
    BMJ (Clinical research ed.), 1991, Jun-08, Volume: 302, Issue:6789

    Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agents; Double-Blind Method; Drug Administration Schedule; Ergolines; Female; Humans; Lactation; Pregnancy; Prospective Studies

1991
Cabergoline versus bromocriptine in suppression of lactation after cesarean delivery.
    Gynecologic and obstetric investigation, 1991, Volume: 31, Issue:2

    Topics: Administration, Oral; Adult; Bromocriptine; Cabergoline; Cesarean Section; Ergolines; Female; Humans; Lactation; Postpartum Period; Prolactin; Single-Blind Method

1991
The effects of lisuride, terguride and bromocriptine on intraocular pressure (IOP).
    British journal of clinical pharmacology, 1989, Volume: 27, Issue:2

    Topics: Adult; Bromocriptine; Double-Blind Method; Ergolines; Humans; Intraocular Pressure; Lisuride; Random Allocation

1989
Pergolide and bromocriptine for the treatment of patients with hyperprolactinemia.
    American journal of obstetrics and gynecology, 1986, Volume: 154, Issue:2

    Topics: Adult; Blood Pressure; Bromocriptine; Dopamine Antagonists; Ergolines; Female; Follicle Stimulating Hormone; Humans; Hyperprolactinemia; Luteinizing Hormone; Pergolide; Prolactin; Prospective Studies; Random Allocation; Time Factors

1986
Terguride--a new dopamine agonist drug: a comparison of its neuroendocrine and side effect profile with bromocriptine.
    Fertility and sterility, 1988, Volume: 49, Issue:4

    Topics: Adult; Blood Pressure; Bromocriptine; Double-Blind Method; Drug Evaluation; Ergolines; Follicle Stimulating Hormone; Growth Hormone; Humans; Hydrocortisone; Lisuride; Male; Prolactin; Pulse; Random Allocation; Thyrotropin

1988
Prolactin-lowering effect of acute and once weekly repetitive oral administration of cabergoline at two dose levels in hyperprolactinemic patients.
    The Journal of clinical endocrinology and metabolism, 1988, Volume: 66, Issue:1

    Topics: Adolescent; Adult; Amenorrhea; Bromocriptine; Cabergoline; Clinical Trials as Topic; Ergolines; Female; Humans; Hyperprolactinemia; Kinetics; Male; Middle Aged; Prolactin

1988
Metergoline as an inhibitor of prolactin release.
    The Journal of reproductive medicine, 1987, Volume: 32, Issue:2

    Topics: Bromocriptine; Double-Blind Method; Ergolines; Female; Humans; Lactation; Metergoline; Pregnancy; Prolactin; Random Allocation; Sucking Behavior; Time Factors

1987
Dopamine agonists in the treatment of hyperprolactinemia. Comparison between bromocriptine and lisuride.
    Arzneimittel-Forschung, 1986, Volume: 36, Issue:12

    Topics: Bromocriptine; Dopamine; Ergolines; Female; Humans; Lisuride; Male; Prolactin

1986
Parkinson's disease: a comparison of mesulergine and bromocriptine.
    Neurology, 1985, Volume: 35, Issue:8

    Topics: Adult; Aged; Bromocriptine; Clinical Trials as Topic; Ergolines; Female; Humans; Male; Middle Aged; Movement; Nervous System; Parkinson Disease

1985
Treatment of human hyperprolactinaemia with a new dopamine agonist: CU 32085 (mesulergin).
    Acta endocrinologica, 1985, Volume: 110, Issue:4

    Topics: Administration, Oral; Adolescent; Adult; Aged; Bromocriptine; Clinical Trials as Topic; Ergolines; Female; Gonads; Humans; Hyperprolactinemia; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin; Receptors, Dopamine; Tomography, X-Ray Computed

1985
Mesulergine and bromocriptine in long-term treatment of advanced parkinsonism.
    Journal of neural transmission, 1985, Volume: 64, Issue:1

    Topics: Adult; Aged; Blood Pressure; Bromocriptine; Drug Administration Schedule; Ergolines; Female; Heart Rate; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors

1985
Adjuvant treatment of Parkinson's disease with dopamine agonists: open trial with bromocriptine and CU 32-085.
    Journal of neurology, 1982, Volume: 227, Issue:2

    Topics: Aged; Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Receptors, Dopamine

1982
Comparison of dopamine agonists in the treatment of hyperprolactinemic syndromes: a multicenter study.
    Fertility and sterility, 1983, Volume: 39, Issue:6

    Topics: Adolescent; Adult; Aged; Amenorrhea; Bromocriptine; Clinical Trials as Topic; Dopamine; Ergolines; Female; Galactorrhea; Humans; Middle Aged; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Random Allocation

1983
Lisuride treatment in Parkinson's disease: clinical and pharmacokinetic studies.
    Advances in neurology, 1983, Volume: 37

    Topics: Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Ergolines; Female; Humans; Lisuride; Male; Middle Aged; Parkinson Disease

1983
Comparison of pergolide and bromocriptine therapy in parkinsonism.
    Neurology, 1983, Volume: 33, Issue:8

    Topics: Aged; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide

1983
Metergoline as an alternative to bromocriptine in amenorrhoea.
    Acta endocrinologica, 1984, Volume: 107, Issue:4

    Topics: Adult; Amenorrhea; Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Ergolines; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menstruation; Metergoline; Ovulation; Progesterone; Prolactin; Random Allocation; Time Factors

1984
Pergolide in late-stage Parkinson disease.
    Annals of neurology, 1982, Volume: 12, Issue:3

    Topics: Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Sleep Wake Disorders

1982
Effects of lisuride and bromocriptine on inhibition of lactation and on serum prolactin levels: comparative double-blind study.
    European journal of obstetrics, gynecology, and reproductive biology, 1981, Volume: 11, Issue:6

    Topics: Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Ergolines; Female; Humans; Lactation; Lisuride; Pregnancy; Prolactin

1981
[Our experience in the inhibition of lactation (Controlled clinical study with bromocriptine, methergoline and pyridoxine)].
    Rivista italiana di ginecologia, 1980, Volume: 59, Issue:2-3

    Topics: Adult; Bromocriptine; Clinical Trials as Topic; Ergolines; Female; Humans; Lactation; Metergoline; Pregnancy; Prolactin; Pyridoxine

1980
Assessment of hypokinesia in Parkinsonism.
    Journal of neural transmission, 1981, Volume: 51, Issue:1-2

    Topics: Adult; Aged; Bromocriptine; Clinical Trials as Topic; Ergolines; Humans; Levodopa; Lisuride; Male; Middle Aged; Motor Activity; Movement; Parkinson Disease; Placebos; Posture; Time Factors

1981
Lisuride versus bromocriptine treatment in Parkinson disease: a double-blind study.
    Neurology, 1982, Volume: 32, Issue:1

    Topics: Adult; Aged; Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Ergolines; Female; Humans; Lisuride; Male; Middle Aged; Parkinson Disease; Random Allocation

1982
Metergoline versus bromocriptine in the prevention of puerperal lactation. A double-blind clinical trial.
    European journal of clinical pharmacology, 1982, Volume: 22, Issue:2

    Topics: Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Ergolines; Female; Humans; Lactation; Metergoline; Postpartum Period; Pregnancy

1982
[Hyperprolactinemic amenorrhea:treatment with cabergoline versus bromocriptine. Results of a national multicenter randomized double-blind study].
    Presse medicale (Paris, France : 1983), 1995, Apr-29, Volume: 24, Issue:16

    Topics: Adolescent; Adult; Amenorrhea; Bromocriptine; Cabergoline; Dopamine Agonists; Double-Blind Method; Ergolines; Female; France; Humans; Hyperprolactinemia; Middle Aged; Prolactin; Prospective Studies

1995
A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group.
    The New England journal of medicine, 1994, Oct-06, Volume: 331, Issue:14

    Topics: Adolescent; Adult; Amenorrhea; Bromocriptine; Cabergoline; Dopamine Agents; Double-Blind Method; Ergolines; Female; Humans; Hyperprolactinemia; Middle Aged; Prolactin

1994
Effects of the dopamine agonist cabergoline in patients with prolactinoma intolerant or resistant to bromocriptine.
    European journal of endocrinology, 1996, Volume: 134, Issue:4

    Topics: Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance, Neoplasm; Ergolines; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Pregnancy; Prolactinoma

1996
Double-blind comparison of cabergoline and bromocriptine in Parkinson's disease patients with motor fluctuations.
    Neurology, 1996, Volume: 47, Issue:3

    Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Bromocriptine; Cabergoline; Double-Blind Method; Ergolines; Female; Humans; Male; Middle Aged; Movement Disorders; Parkinson Disease

1996
Cabergoline for hyperprolactinemia.
    The Medical letter on drugs and therapeutics, 1997, Jun-20, Volume: 39, Issue:1003

    Topics: Abnormalities, Drug-Induced; Bromocriptine; Cabergoline; Costs and Cost Analysis; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Ergolines; Female; Humans; Intestinal Absorption; Prolactin

1997
Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males.
    The Journal of clinical endocrinology and metabolism, 1998, Volume: 83, Issue:3

    Topics: Adult; Aminoquinolines; Biomarkers; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Bone Remodeling; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Humans; Hyperprolactinemia; Male; Middle Aged; Prospective Studies

1998
Cabergoline treatment rapidly improves gonadal function in hyperprolactinemic males: a comparison with bromocriptine.
    European journal of endocrinology, 1998, Volume: 138, Issue:3

    Topics: Adult; Bromocriptine; Cabergoline; Cohort Studies; Dopamine Agonists; Ergolines; Follow-Up Studies; Hormones; Humans; Hyperprolactinemia; Libido; Male; Penile Erection; Prolactin; Semen; Time Factors

1998
[Treatment of hyperprolactinemic amenorrhea with cabergoline].
    Medicina, 1997, Volume: 57, Issue:6

    Topics: Adolescent; Adult; Amenorrhea; Bromocriptine; Cabergoline; Dopamine Agonists; Double-Blind Method; Drug Tolerance; Ergolines; Female; Humans; Hyperprolactinemia; Prolactin; Treatment Outcome

1997
Study of the change of prolactin and progesterone during dopaminergic agonist treatments in pseudopregnant bitches.
    Animal reproduction science, 2001, May-31, Volume: 66, Issue:3-4

    Topics: Animals; Bromocriptine; Cabergoline; Dog Diseases; Dogs; Dopamine Agonists; Ergolines; Female; Placebos; Progesterone; Prolactin; Pseudopregnancy

2001
Comparison of the effects of cabergoline and bromocriptine on prolactin levels in hyperprolactinemic patients.
    Internal medicine (Tokyo, Japan), 2001, Volume: 40, Issue:9

    Topics: Adult; Antineoplastic Agents, Hormonal; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Treatment Outcome

2001
Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: prevalence, clinical definition, and therapeutic strategy.
    The Journal of clinical endocrinology and metabolism, 2001, Volume: 86, Issue:11

    Topics: Adenoma; Adolescent; Adult; Aged; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance; Ergolines; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Hypopituitarism; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Radioimmunoassay; Retrospective Studies

2001
Circulating nitric oxide changes throughout the menstrual cycle in healthy women and women affected by pathological hyperprolactinemia on dopamine agonist therapy.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2002, Volume: 16, Issue:5

    Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Estradiol; Female; Humans; Hyperprolactinemia; Luteal Phase; Menstrual Cycle; Nitric Oxide; Ovulation; Pituitary Neoplasms; Progesterone; Prolactinoma; Reference Values

2002
Coat colour changes associated with cabergoline administration in bitches.
    The Journal of small animal practice, 2003, Volume: 44, Issue:8

    Topics: Animals; Bromocriptine; Cabergoline; Dog Diseases; Dogs; Dopamine Agonists; Ergolines; Estrous Cycle; Female; Hair Color; Melanocyte-Stimulating Hormones; Pedigree; Pigmentation; Pseudopregnancy

2003
Medical therapy of macroprolactinomas in males: I. Prevalence of hypopituitarism at diagnosis. II. Proportion of cases exhibiting recovery of pituitary function.
    Pituitary, 2002, Volume: 5, Issue:4

    Topics: Adrenocorticotropic Hormone; Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Follicle Stimulating Hormone; Humans; Hypopituitarism; Luteinizing Hormone; Male; Middle Aged; Pergolide; Pituitary Function Tests; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Testosterone; Thyrotropin

2002
Usefulness of switching to cabergoline from other dopamine agonists in patients with advanced Parkinson's disease.
    Journal of neural transmission (Vienna, Austria : 1996), 2004, Volume: 111, Issue:6

    Topics: Aged; Antiparkinson Agents; Bromocriptine; Cabergoline; Ergolines; Humans; Parkinson Disease; Pergolide; Prospective Studies; Treatment Outcome

2004
[Comparative evaluation of effectiveness of treatment of hyperprolactinemia].
    Georgian medical news, 2007, Issue:142

    Topics: Adenoma; Adolescent; Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Administration Schedule; Ergolines; Female; Humans; Hyperprolactinemia; Ovulation; Pituitary Neoplasms; Treatment Outcome

2007
Quality of life in women with microprolactinoma treated with dopamine agonists.
    Pituitary, 2008, Volume: 11, Issue:3

    Topics: Adult; Antineoplastic Agents; Brazil; Bromocriptine; Cabergoline; Case-Control Studies; Cross-Sectional Studies; Dopamine Agonists; Ergolines; Female; Health Status Indicators; Humans; Hyperprolactinemia; Middle Aged; Multivariate Analysis; Pituitary Neoplasms; Prolactin; Prolactinoma; Quality of Life; Reproducibility of Results; Surveys and Questionnaires; Treatment Outcome

2008
Overnight switching from ergot-derived dopamine agonists to pramipexole in patients with Parkinson's disease: an open preliminary trial in Japan.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2009, Volume: 16, Issue:6

    Topics: Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Ergolines; Humans; Japan; Outcome Assessment, Health Care; Parkinson Disease; Pergolide; Pramipexole; Severity of Illness Index; Time Factors; Treatment Outcome

2009
Cabergoline versus bromocriptine for symptomatic treatment of premenstrual mastalgia: a randomised, open-label study.
    European journal of obstetrics, gynecology, and reproductive biology, 2010, Volume: 150, Issue:2

    Topics: Adult; Analysis of Variance; Breast; Bromocriptine; Cabergoline; Drug Administration Schedule; Ergolines; Female; Hormone Antagonists; Humans; Middle Aged; Pain; Pain Measurement; Premenstrual Syndrome; Prolactin; Quality of Life; Severity of Illness Index; Treatment Outcome

2010
A comparison of bromocriptine & cabergoline on fertility outcome of hyperprolactinemic infertile women undergoing intrauterine insemination.
    The Indian journal of medical research, 2010, Volume: 131

    Topics: Adult; Bromocriptine; Cabergoline; Ergolines; Female; Humans; Hyperprolactinemia; Infertility, Female; Insemination, Artificial

2010
Evaluation of the efficacy of pramipexole for treating levodopa-induced dyskinesia in patients with Parkinson's disease.
    Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:3

    Topics: Aged; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Dyskinesia, Drug-Induced; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3

2013
Different effects of cabergoline and bromocriptine on metabolic and cardiovascular risk factors in patients with elevated prolactin levels.
    Basic & clinical pharmacology & toxicology, 2015, Volume: 116, Issue:3

    Topics: Adult; Blood Glucose; Bromocriptine; Cabergoline; Cardiovascular Diseases; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Insulin Resistance; Insulin-Like Growth Factor I; Lipids; Middle Aged; Prolactin; Risk Factors

2015

Other Studies

523 other study(ies) available for bromocriptine and ergoline

ArticleYear
Prolactin, bromocriptine and dopaminergic neurotransmission.
    The Netherlands journal of medicine, 1976, Volume: 19, Issue:3

    Topics: Bromocriptine; Dopamine; Endocrine System Diseases; Ergolines; Humans; Prolactin; Prolactin Release-Inhibiting Factors; Receptors, Drug; Synaptic Transmission

1976
Correlation of behavioural inhibition or excitation produced by bromocriptine with changes in brain catecholamine turnover.
    The Journal of pharmacy and pharmacology, 1976, Volume: 28, Issue:7

    Topics: Animals; Behavior, Animal; Brain; Bromocriptine; Catecholamines; Ergolines; Male; Methyltyrosines; Motor Activity; Rats; Stimulation, Chemical; Sympathetic Nervous System; Time Factors

1976
Bromocriptine in treating mania.
    The American journal of psychiatry, 1977, Volume: 134, Issue:6

    Topics: Adrenergic Agonists; Bipolar Disorder; Bromocriptine; Ergolines; Female; Humans; Male; Prolactin; Receptors, Dopamine

1977
The interactions of bromocriptine and lergotrile with dopamine and alpha-adrenergic receptors.
    Journal of neural transmission, 1977, Volume: 41, Issue:2-3

    Topics: Acetonitriles; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Apomorphine; Binding Sites; Brain; Bromocriptine; Butaclamol; Cattle; Cerebral Cortex; Corpus Striatum; Dihydroergotoxine; Dopamine; Ergolines; Haloperidol; In Vitro Techniques; Osmolar Concentration; Rats; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Synaptosomes; Tyrosine 3-Monooxygenase

1977
The roles of presynaptic function and hepatic drug metabolism in the hypothermic actions of two novel dopaminergic agonists.
    The Journal of pharmacy and pharmacology, 1977, Volume: 29, Issue:10

    Topics: Acetonitriles; Animals; Body Temperature; Bromocriptine; Dopamine; Ergolines; In Vitro Techniques; Liver; Male; Proadifen; Pyridines; Rats; Synapses; Time Factors

1977
The pathophysiology of hyperprolactinemic states and the role of newer ergot compounds in their treatment.
    Federation proceedings, 1978, Volume: 37, Issue:8

    Topics: Acetonitriles; Amenorrhea; Bromocriptine; Dopamine; Ergolines; Ergot Alkaloids; Female; Galactorrhea; Humans; Levodopa; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactin Release-Inhibiting Factors

1978
Dopaminephilic properties of ergot alkaloids.
    Federation proceedings, 1978, Volume: 37, Issue:8

    Topics: Acetonitriles; Animals; Bromocriptine; Corpus Striatum; Ergolines; Ergot Alkaloids; Haplorhini; Humans; Levodopa; Parkinson Disease; Receptors, Dopamine; Spiperone; Substantia Nigra; Synaptosomes; Tremor; Tyrosine 3-Monooxygenase

1978
Mental disturbances during bromocriptine and lergotrile treatment of Parkinson's disease.
    The American journal of psychiatry, 1978, Volume: 135, Issue:10

    Topics: Aged; Bromocriptine; Confusion; Depression; Ergolines; Female; Hallucinations; Humans; Male; Mental Disorders; Middle Aged; Neurocognitive Disorders; Parkinson Disease; Schizophrenia, Paranoid

1978
Selective affinities of bromocriptine and lergotrile for rat limbic dopamine binding sites [proceedings].
    British journal of pharmacology, 1978, Volume: 64, Issue:3

    Topics: Animals; Bromocriptine; Ergolines; Limbic System; Male; Rats; Receptors, Dopamine

1978
Ergot derivatives for Parkinsonism.
    The Medical journal of Australia, 1978, Nov-04, Volume: 2, Issue:3 Suppl

    Topics: Bromocriptine; Ergolines; Humans; Parkinson Disease; Pyridines

1978
The effects of dopamine, bromocriptine, lergotrile and metoclopramide on prolactin release from continuously perfused columns of isolated rat pituitary cells.
    Clinical endocrinology, 1979, Volume: 10, Issue:2

    Topics: Animals; Bromocriptine; Dopamine; Ergolines; Female; In Vitro Techniques; Metoclopramide; Perfusion; Pituitary Gland, Anterior; Prolactin; Rats

1979
Lergotrile in Parkinson disease: further studies.
    Neurology, 1979, Volume: 29, Issue:2

    Topics: Aged; Bromocriptine; Chemical Phenomena; Chemistry; Dopa Decarboxylase; Ergolines; Humans; Levodopa; Middle Aged; Parkinson Disease

1979
Central dopamine agonistic activity and microsomal biotransformation of lisuride, lergotrile and bromocriptine.
    Life sciences, 1979, Mar-26, Volume: 24, Issue:13

    Topics: Animals; Biotransformation; Body Temperature; Brain; Bromocriptine; Dopamine; Ergolines; Homovanillic Acid; Lisuride; Male; Microsomes; Rats

1979
Hypothermic action of lisuride in rats and differences to bromocriptine in the antagonistic effect of neuroleptics.
    Naunyn-Schmiedeberg's archives of pharmacology, 1979, Volume: 306, Issue:2

    Topics: Animals; Antipsychotic Agents; Body Temperature; Bromocriptine; Cold Temperature; Depression, Chemical; Ergolines; Female; Haloperidol; Lisuride; Rats; Sulpiride; Time Factors

1979
Rotational behaviour in rats with unilateral striatal kainic acid lesions: a behavioural model for studies on intact dopamine receptors.
    Brain research, 1979, Jul-20, Volume: 170, Issue:3

    Topics: Animals; Apomorphine; Behavior; Bromocriptine; Corpus Striatum; Denervation; Dominance, Cerebral; Efferent Pathways; Ergolines; Humans; Hydroxydopamines; Kainic Acid; Male; Pyrrolidines; Rats; Receptors, Dopamine; Stereotyped Behavior; Substantia Nigra

1979
Improvement of brain tissue oxygenation during cerebrovascular insufficiency by interfering with the catecholaminergic system.
    Bibliotheca anatomica, 1979, Issue:18

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Apomorphine; Blood Volume; Brain; Bromocriptine; Cats; Cerebrovascular Disorders; Ergolines; Oxygen; Phenoxybenzamine

1979
Regulation of striatal acetylcholine concentration by D2-dopamine receptors.
    European journal of pharmacology, 1979, Dec-20, Volume: 60, Issue:4

    Topics: Acetylcholine; Animals; Bromocriptine; Corpus Striatum; Ergolines; Male; Metoclopramide; Molindone; Neurons; Rats; Receptors, Dopamine

1979
Letter: Prolactin, levodopa, and migraine.
    Lancet (London, England), 1975, Apr-05, Volume: 1, Issue:7910

    Topics: Bromocriptine; Ergolines; Humans; Levodopa; Migraine Disorders; Prolactin

1975
Letter: Bromocritine and serum-growth-hormone levels in diabetes mellitus.
    Lancet (London, England), 1975, Jul-26, Volume: 2, Issue:7926

    Topics: Adult; Bromocriptine; Diabetes Mellitus, Type 1; Ergolines; Growth Hormone; Humans; Male; Physical Exertion; Rest

1975
Letter: Growth-hormone response to bromocriptine in parkinsonism.
    Lancet (London, England), 1976, Jan-24, Volume: 1, Issue:7952

    Topics: Bromocriptine; Ergolines; Growth Hormone; Humans; Parkinson Disease

1976
Letter: Bromocriptine and growth hormone.
    Lancet (London, England), 1976, Jan-24, Volume: 1, Issue:7952

    Topics: Adult; Breast Neoplasms; Bromocriptine; Ergolines; Female; Growth Hormone; Humans; Middle Aged

1976
Hyperprolactinaemia and luteal insufficiency.
    Lancet (London, England), 1976, Jan-31, Volume: 1, Issue:7953

    Topics: Adult; Amenorrhea; Bromocriptine; Ergolines; Female; Galactorrhea; Humans; Luteal Phase; Menstruation; Ovulation; Pregnancy; Prolactin; Syndrome; Time Factors

1976
Letter: Bromocriptine in acromegaly.
    Lancet (London, England), 1976, Feb-28, Volume: 1, Issue:7957

    Topics: Acromegaly; Bromocriptine; Ergolines; Evaluation Studies as Topic; Humans

1976
Letter: Digital vasospasm with bromocriptine.
    Lancet (London, England), 1976, May-22, Volume: 1, Issue:7969

    Topics: Acromegaly; Bromocriptine; Cold Temperature; Ergolines; Fingers; Humans; Vasoconstrictor Agents

1976
Bromocriptine treatment of secondary amenorrhoea.
    Lancet (London, England), 1976, May-29, Volume: 1, Issue:7970

    Topics: Adolescent; Adult; Amenorrhea; Bromocriptine; Drug Evaluation; Ergolines; Female; Follow-Up Studies; Galactorrhea; Humans; Menstruation; Ovulation; Pregnancy; Prolactin; Puerperal Disorders

1976
Letter: Bromocriptine and hypertension.
    Lancet (London, England), 1976, May-29, Volume: 1, Issue:7970

    Topics: Acromegaly; Adult; Blood Pressure; Bromocriptine; Drug Therapy, Combination; Ergolines; Humans; Hydralazine; Hypertension; Male; Propranolol

1976
Letter: Bromocriptine regimen for restoration of ovulatory function.
    Lancet (London, England), 1976, May-29, Volume: 1, Issue:7970

    Topics: Bromocriptine; Chiari-Frommel Syndrome; Ergolines; Female; Humans; Infertility, Female; Ovulation; Pregnancy

1976
Letter: Bromocriptine and secondary amenorrhoea.
    Lancet (London, England), 1976, Jun-26, Volume: 1, Issue:7974

    Topics: Amenorrhea; Bromocriptine; Ergolines; Female; Humans; Ovulation; Prolactin

1976
Letter: Bromocriptine and secondary amenorrhoea.
    Lancet (London, England), 1976, Jul-31, Volume: 2, Issue:7979

    Topics: Amenorrhea; Bromocriptine; Ergolines; Female; Humans; Prolactin

1976
Bromocriptine in Nelson's syndrome and Cushing's disease.
    Lancet (London, England), 1976, Oct-09, Volume: 2, Issue:7989

    Topics: Adrenalectomy; Adrenocorticotropic Hormone; Adult; Bromocriptine; Cushing Syndrome; Ergolines; Female; Humans; Male; Postoperative Complications; Prolactin; Syndrome

1976
Acrocyanosis treated with bromocriptine.
    Lancet (London, England), 1976, Oct-16, Volume: 2, Issue:7990

    Topics: Adolescent; Bromocriptine; Cyanosis; Ergolines; Female; Foot; Hand; Humans

1976
Gastrointestinal bleeding in patients on bromocriptine.
    Lancet (London, England), 1976, Oct-16, Volume: 2, Issue:7990

    Topics: Acromegaly; Adult; Aged; Bromocriptine; Ergolines; Female; Humans; Male; Middle Aged; Peptic Ulcer; Peptic Ulcer Hemorrhage

1976
Gastrointestinal bleeding in patients on bromocriptine.
    Lancet (London, England), 1976, Oct-23, Volume: 2, Issue:7991

    Topics: Acromegaly; Bromocriptine; Ergolines; Humans; Peptic Ulcer; Peptic Ulcer Hemorrhage

1976
Aldosterone and prolactin.
    Lancet (London, England), 1976, Oct-30, Volume: 2, Issue:7992

    Topics: Aldosterone; Bromocriptine; Ergolines; Humans; Nephrectomy; Potassium; Prolactin; Renal Dialysis

1976
Hypotension and bromocriptine.
    Lancet (London, England), 1976, Dec-18, Volume: 2, Issue:7999

    Topics: Acromegaly; Aged; Bromocriptine; Ergolines; Humans; Hypotension; Male

1976
Bromocriptine and plasma-aldosterone.
    Lancet (London, England), 1976, Dec-25, Volume: 2, Issue:8000

    Topics: Adult; Aldosterone; Bromocriptine; Ergolines; Female; Humans; Hyperaldosteronism; Male; Prolactin

1976
Bromocriptine for male infertility.
    Lancet (London, England), 1977, Jan-29, Volume: 1, Issue:8005

    Topics: Bromocriptine; Cell Count; Ergolines; Follicle Stimulating Hormone; Humans; Infertility, Male; Luteinizing Hormone; Male; Prolactin; Semen; Spermatozoa; Testosterone

1977
Bromocriptine and gastric acid output.
    Lancet (London, England), 1977, Feb-19, Volume: 1, Issue:8008

    Topics: Adolescent; Adult; Bromocriptine; Ergolines; Gastric Acidity Determination; Gastric Juice; Humans; Male; Stimulation, Chemical

1977
Bromocriptine for induction of ovulation in normoprolactinaemic post-pill anovulation.
    Lancet (London, England), 1977, Mar-05, Volume: 1, Issue:8010

    Topics: Adolescent; Adult; Amenorrhea; Anovulation; Bromocriptine; Contraceptives, Oral; Drug Evaluation; Ergolines; Female; Follow-Up Studies; Humans; Menstruation Disturbances; Oligomenorrhea; Prolactin

1977
[Bromocriptine (CB 154) in the treatment of prostatic adenoma].
    La Nouvelle presse medicale, 1977, Volume: 6, Issue:13

    Topics: Bromocriptine; Ergolines; Humans; Male; Prostatic Hyperplasia

1977
Bromocriptine, gastric acid output, and gastrin secretion.
    Lancet (London, England), 1977, Apr-23, Volume: 1, Issue:8017

    Topics: Administration, Oral; Adult; Animals; Bromocriptine; Cats; Ergolines; Female; Gastric Juice; Gastrins; Humans; Male; Middle Aged; Pentagastrin; Placebos; Stimulation, Chemical

1977
Impact of new diagnostic methods on the differential diagnosis and treatment of secondary amenorrhoea.
    Lancet (London, England), 1977, Jun-04, Volume: 1, Issue:8023

    Topics: Amenorrhea; Bromocriptine; Contraceptives, Oral; Diagnosis, Differential; Ergolines; Female; Galactorrhea; Humans; Lactation Disorders; Pituitary Function Tests; Pituitary Neoplasms; Pneumoencephalography; Pregnancy; Prolactin; Tomography; Tomography, X-Ray Computed

1977
Bromocriptine inhibits prolactin and growth-hormone release by human pituitary tumours in culture.
    Lancet (London, England), 1977, Jul-23, Volume: 2, Issue:8030

    Topics: Adenoma; Bromocriptine; Culture Techniques; Ergolines; Growth Hormone; Humans; Pituitary Neoplasms; Prolactin

1977
Cervical incompetence and premature delivery after bromocriptine therapy for infertility.
    Lancet (London, England), 1977, Jul-23, Volume: 2, Issue:8030

    Topics: Adult; Bromocriptine; Ergolines; Female; Humans; Infertility, Female; Obstetric Labor, Premature; Pregnancy; Uterine Cervical Incompetence

1977
Hyperprolactinaemia and antihypertensive effect of bromocriptine in essential hypertension. Identification of abnormal central dopamine control.
    Lancet (London, England), 1977, Jul-30, Volume: 2, Issue:8031

    Topics: Adult; Antihypertensive Agents; Blood Pressure; Bromocriptine; Dopamine; Ergolines; Humans; Hypertension; Male; Prolactin; Sodium

1977
Fainting and bromocriptine: Danger when motoring.
    Lancet (London, England), 1977, Jul-30, Volume: 2, Issue:8031

    Topics: Accidents, Traffic; Adult; Bromocriptine; Ergolines; Female; Humans; Infertility, Female; Syncope

1977
Shock syndrome after bromocriptine.
    Lancet (London, England), 1977, Aug-27, Volume: 2, Issue:8035

    Topics: Anaphylaxis; Bromocriptine; Ergolines; Female; Humans; Middle Aged; Syndrome

1977
Cervical incompetence and premature delivery after bromocriptine therapy for infertility.
    Lancet (London, England), 1977, Sep-03, Volume: 2, Issue:8036

    Topics: Bromocriptine; Ergolines; Female; Humans; Infertility, Female; Obstetric Labor, Premature; Pregnancy; Prolactin; Risk; Uterine Cervical Incompetence

1977
Dopamine disorder in duodenal ulceration.
    Lancet (London, England), 1979, Oct-27, Volume: 2, Issue:8148

    Topics: Animals; Anti-Ulcer Agents; Apomorphine; Bromocriptine; Chemical Phenomena; Chemistry; Cysteamine; Dopamine; Drug Synergism; Duodenal Ulcer; Ergolines; Female; Gastric Juice; Haloperidol; Pimozide; Rats; Receptors, Dopamine

1979
Blockade of photically induced epilepsy by 'dopamine agonist' ergot alkaloids.
    Psychopharmacology, 1978, Apr-14, Volume: 57, Issue:1

    Topics: Allyl Compounds; Animals; Bromocriptine; Dopamine; Electroencephalography; Epilepsy; Ergolines; Ergonovine; Ergot Alkaloids; Haplorhini; Lysergic Acid Diethylamide; Papio; Photic Stimulation

1978
Bromocriptine, dihydroergotoxine, methysergide, d-LSD, CF25--397, and 29--712: effects on the metabolism of the biogenic amines in the brain of the rat.
    Psychopharmacology, 1978, May-31, Volume: 57, Issue:3

    Topics: Animals; Biogenic Amines; Brain; Bromocriptine; Dihydroergotoxine; Dopamine; Ergolines; Lysergic Acid Diethylamide; Male; Methysergide; Nitriles; Pyridines; Rats; Receptors, Drug; Reserpine; Serotonin

1978
Lisuride hydrogen maleate: evidence for a long lasting dopaminergic activity in humans.
    The Journal of clinical endocrinology and metabolism, 1978, Volume: 46, Issue:2

    Topics: Acromegaly; Adult; Bromocriptine; Dose-Response Relationship, Drug; Ergolines; Female; Growth Hormone; Humans; Lisuride; Male; Middle Aged; Pimozide; Placebos; Prolactin; Thyrotropin-Releasing Hormone

1978
Altered growth hormone and prolactin responses to dopaminergic stimulation in Huntington's chorea.
    The Journal of clinical endocrinology and metabolism, 1977, Volume: 44, Issue:5

    Topics: Adult; Aged; Bromocriptine; Ergolines; Female; Growth Hormone; Humans; Huntington Disease; Kinetics; Male; Middle Aged; Prolactin

1977
Metabolic studies with bromocriptine in patients with idiopathic parkinsonism and Huntington's chorea.
    Transactions of the American Neurological Association, 1976, Volume: 101

    Topics: Bromocriptine; Ergolines; Growth Hormone; Homovanillic Acid; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Parkinson Disease; Prolactin

1976
Metabolic effects of 2-bromo ergocryptine-methane-sulphonate (CB 154) in the rat.
    The Journal of endocrinology, 1975, Volume: 64, Issue:3

    Topics: Animals; Bromocriptine; Calcium; Creatinine; Ergolines; Male; Mesylates; Potassium; Rats; Sodium

1975
Hormonally induced renal neoplasia in the male Syrian hamster and the inhibitory effect of 2-bromo-alpha-ergocryptine methanesulfonate.
    Journal of the National Cancer Institute, 1975, Volume: 54, Issue:6

    Topics: Animals; Body Weight; Bromocriptine; Cell Count; Cricetinae; Diethylstilbestrol; Ergolines; Growth Hormone; Hyperplasia; Kidney Neoplasms; Kidney Tubules, Proximal; Male; Mesylates; Organ Size; Pituitary Gland; Pituitary Neoplasms; Prolactin; Testis

1975
The effect of prolactin and CB154 on in vivo lipogenesis and enzyme patterns in the Japanese quail, Coturnix coturnix japonica and of photositmulation on enzyme patterns in the white-throated sparrow, Zonotrichia albicollis.
    Comparative biochemistry and physiology. B, Comparative biochemistry, 1976, Volume: 53, Issue:3

    Topics: Alanine Transaminase; Animals; ATP Citrate (pro-S)-Lyase; Birds; Body Weight; Bromocriptine; Coturnix; Ergolines; Fructose-Bisphosphatase; Glucose; Glucosephosphate Dehydrogenase; Hexokinase; Lipids; Liver; Malate Dehydrogenase; Male; Mitochondria, Liver; Organ Size; Phosphogluconate Dehydrogenase; Prolactin; Proteins; Quail

1976
Effects of growth hormone release-inhibiting hormone and bromocryptine (CB 154) in states of abnormal pituitary-adrenal function.
    Clinical endocrinology, 1976, Volume: 5, Issue:2

    Topics: Adrenal Gland Diseases; Adrenocorticotropic Hormone; Adult; Bromocriptine; Ergolines; Female; Humans; Hydrocortisone; Male; Middle Aged; Pituitary Diseases; Somatostatin

1976
Long-term treatment of acromegaly with bromocryptine: postprandial HGH levels and response to TRH and glucose administration.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1976, Volume: 8, Issue:4

    Topics: Acromegaly; Adrenocorticotropic Hormone; Adult; Aged; Bromocriptine; Diet; Ergolines; Female; Follicle Stimulating Hormone; Glucose; Glucose Tolerance Test; Growth Hormone; Humans; Luteinizing Hormone; Male; Middle Aged; Thyrotropin; Thyrotropin-Releasing Hormone; Time Factors; Vasopressins

1976
Effects of bromocriptine on central dopaminergic receptors.
    Life sciences, 1976, Jul-15, Volume: 19, Issue:2

    Topics: Adenylyl Cyclases; Animals; Bromocriptine; Corpus Striatum; Cyclic AMP; Dopamine Antagonists; Enzyme Activation; Ergolines; Male; Rats; Receptors, Drug

1976
Effect of bromocriptine in pituitary-dependent Cushing's syndrome.
    The Journal of endocrinology, 1976, Volume: 70, Issue:2

    Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Bromocriptine; Cushing Syndrome; Ergolines; Female; Humans; Hydrocortisone; Male; Middle Aged

1976
Bromocriptine for Cushing's disease.
    British medical journal, 1977, Apr-23, Volume: 1, Issue:6068

    Topics: Adrenocorticotropic Hormone; Adult; Bromocriptine; Cushing Syndrome; Dexamethasone; Ergolines; Humans; Hydrocortisone; Male

1977
Lack of effect of prolactin inhibition by alpha-bromoergocriptine (CB 154) on plasma aldosterone in anephric and non-nephrectomized patients on regular haemodialysis.
    Acta endocrinologica, 1977, Volume: 85, Issue:3

    Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Bromocriptine; Depression, Chemical; Ergolines; Female; Humans; Hydrocortisone; Kidney Failure, Chronic; Male; Middle Aged; Potassium; Prolactin; Renal Dialysis; Renin

1977
Pre- and postsynaptic action of bromocriptine: its pharmacological effects on shcizophrenia and neurological diseases.
    Advances in biochemical psychopharmacology, 1977, Volume: 16

    Topics: Animals; Bromocriptine; Cyclic AMP; Ergolines; Female; Humans; Huntington Disease; Male; Middle Aged; Motor Activity; Nervous System Diseases; Parkinson Disease; Rats; Schizophrenia; Stereotyped Behavior; Synapses

1977
Considerations on the preneoplastic lesions of the mammary gland.
    The American journal of pathology, 1977, Volume: 89, Issue:2

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Breast; Breast Neoplasms; Bromocriptine; Cell Transformation, Neoplastic; Cells, Cultured; Ergolines; Female; Humans; Hyperplasia; Mammary Neoplasms, Experimental; Mammary Tumor Virus, Mouse; Mice; Neoplasm Transplantation; Precancerous Conditions; Transplantation, Heterologous; Urethane

1977
Bromocriptine and lisuride stimulate the accumulation of cyclic AMP in intact slices but not in homogenates of rat neostriatum.
    Neuroscience letters, 1979, Volume: 14, Issue:1

    Topics: Animals; Bromocriptine; Corpus Striatum; Cyclic AMP; Dopamine Antagonists; Ergolines; Fluphenazine; In Vitro Techniques; Lisuride; Male; Rats

1979
[Dynamics of hormonal modifications induced by bromocryptin during hyperprolactinemia].
    La Nouvelle presse medicale, 1977, Jan-22, Volume: 6, Issue:3

    Topics: Adolescent; Adult; Amenorrhea; Bromocriptine; Erectile Dysfunction; Ergolines; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Humans; Luteinizing Hormone; Male; Pituitary Gland; Prolactin; Secretory Rate; Testosterone; Time Factors

1977
Treatment of functional amenorrhea-galactorrhea with 2-bromoergocryptine.
    Fertility and sterility, 1977, Volume: 28, Issue:4

    Topics: Adult; Amenorrhea; Bromocriptine; Ergolines; Evaluation Studies as Topic; Female; Galactorrhea; Gonadotropin-Releasing Hormone; Humans; Lactation Disorders; Pituitary Gland; Pregnancy; Prolactin

1977
Hypogonadism, galactorrhoea and hyper-prolactinaemia: Evaluation of pituitary gonadotrophins reserve before and under bromocriptine.
    Acta endocrinologica, 1977, Volume: 84, Issue:4

    Topics: Adolescent; Adult; Bromocriptine; Ergolines; Female; Follicle Stimulating Hormone; Galactorrhea; Humans; Hypogonadism; Lactation Disorders; Luteinizing Hormone; Male; Pituitary Hormone-Releasing Hormones; Pregnancy; Prolactin

1977
Effect of prolactin inhibitory agents on the ectopic anterior pituitary and the mammary gland in rats.
    Acta endocrinologica, 1977, Volume: 85, Issue:2

    Topics: Animals; Bromocriptine; DNA; Ergolines; Estradiol; Female; Histocytochemistry; Hypophysectomy; Immunoenzyme Techniques; Maleates; Mammary Glands, Animal; Organ Size; Pituitary Gland; Pituitary Gland, Anterior; Progesterone; Prolactin; Rats; Transplantation, Autologous

1977
Gonadotropic responsiveness to clomiphene, LRH, estradiol, and bromocriptine in galactorrheic women.
    Obstetrics and gynecology, 1977, Volume: 50, Issue:2

    Topics: Bromocriptine; Clomiphene; Depression, Chemical; Drug Administration Schedule; Ergolines; Estradiol; Feedback; Female; Follicle Stimulating Hormone; Galactorrhea; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Humans; Hypothalamus; Lactation Disorders; Luteinizing Hormone; Pregnancy; Progesterone; Prolactin

1977
Metabolic and clinical studies on patients with acromegaly treated with bromocriptine over 22 months.
    European journal of clinical investigation, 1977, Volume: 7, Issue:2

    Topics: Acromegaly; Adult; Aged; Bromocriptine; Diabetes Mellitus; Ergolines; Female; Growth Hormone; Humans; Male; Middle Aged; Pimozide; Thyrotropin-Releasing Hormone

1977
Clinical response to CB-154 and the pituitary response to thyrotropin-releasing hormone-gonadotropin-releasing hormone in patients with galactorrhea-amenorrhea.
    Fertility and sterility, 1977, Volume: 28, Issue:5

    Topics: Adult; Amenorrhea; Bromocriptine; Ergolines; Female; Follicle Stimulating Hormone; Galactorrhea; Humans; Lactation Disorders; Luteinizing Hormone; Pituitary Gland; Pituitary Hormone-Releasing Hormones; Pregnancy; Prolactin; Thyrotropin-Releasing Hormone

1977
Prolactin response to TRH during inhibition of puerperal lactation with ergolinic drugs.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1977, Volume: 9, Issue:2

    Topics: Bromocriptine; Ergolines; Female; Humans; Lactation; Metergoline; Pregnancy; Prolactin; Thyrotropin-Releasing Hormone; Time Factors

1977
Long-term treatment with 2-Br-alpha-ergocryptine in acromegaly.
    Acta endocrinologica, 1977, Volume: 85, Issue:2

    Topics: Acromegaly; Adult; Blood Glucose; Bromocriptine; Calcium; Drug Evaluation; Ergolines; Female; Glycosuria; Growth Hormone; Humans; Hydroxyproline; Insulin; Insulin Secretion; Male; Middle Aged; Phosphates; Phosphorus; Prolactin; Thyrotropin-Releasing Hormone; Time Factors

1977
Feasibility of suppressing and reinitiating lactation in women with premature infants.
    American journal of obstetrics and gynecology, 1977, Jul-15, Volume: 128, Issue:6

    Topics: Adult; Bromocriptine; Ergolines; Female; Humans; Infant, Newborn; Lactation; Postpartum Period; Pregnancy; Prolactin; Thyrotropin-Releasing Hormone

1977
Bromocriptine and TRH-induced growth hormone release in anorexia nervosa.
    British medical journal, 1977, Jul-23, Volume: 2, Issue:6081

    Topics: Adolescent; Adult; Anorexia Nervosa; Bromocriptine; Ergolines; Female; Growth Hormone; Humans; Stimulation, Chemical; Thyrotropin-Releasing Hormone

1977
[Bromocryptin effect on growth hormone and prolactin secretion after administration of thyrotropin-releasing hormone in patients with primary hypothyroidism and acromegaly (author's transl)].
    Casopis lekaru ceskych, 1977, May-13, Volume: 116, Issue:19

    Topics: Acromegaly; Adult; Aged; Bromocriptine; Ergolines; Growth Hormone; Humans; Hypothyroidism; Middle Aged; Prolactin; Thyrotropin-Releasing Hormone

1977
Effects of glucocorticoids on casein gene expression in the rabbit.
    European journal of biochemistry, 1977, May-16, Volume: 75, Issue:2

    Topics: Animals; Bromocriptine; Caseins; DNA Replication; Ergolines; Female; Galactosyltransferases; Hydrocortisone; Kinetics; Lactose Synthase; Mammary Glands, Animal; Nucleic Acid Hybridization; Polyribosomes; Prolactin; Protein Biosynthesis; Pseudopregnancy; Rabbits; RNA, Messenger; Transcription, Genetic

1977
Effect of bromoergocriptine on TRH-induced growth hormone and prolactin release in acromegalic patients.
    The Journal of clinical endocrinology and metabolism, 1977, Volume: 45, Issue:2

    Topics: Acromegaly; Adult; Bromocriptine; Ergolines; Female; Growth Hormone; Humans; Kinetics; Male; Middle Aged; Prolactin; Radioimmunoassay; Thyrotropin-Releasing Hormone

1977
Effect of bromocryptine on the secretion of thyrotropic hormone (TSH), prolactin (Pr), human growth hormone (HGH), thyroxine (T4) and triiodothyroxine (T3) in hypothyroidism.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1977, Volume: 9, Issue:4

    Topics: Adult; Aged; Bromocriptine; Ergolines; Female; Growth Hormone; Humans; Hypothyroidism; Middle Aged; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine; Triiodothyronine

1977
The effect of 2-bromo-alpha-ergocryptine and 2-chloro-alpha-methylergoline-8beta-acetonitrile (lergotrile mesylate) on the prolactin secretion of the ewe.
    Acta endocrinologica, 1977, Volume: 86, Issue:4

    Topics: Acetonitriles; Animals; Bromocriptine; Ergolines; Female; Lactation; Pituitary Gland, Anterior; Pregnancy; Prolactin; Secretory Rate; Sheep; Thyrotropin-Releasing Hormone

1977
[The new lactation inhibitors].
    Minerva ginecologica, 1979, Volume: 31, Issue:4

    Topics: Adult; Bromocriptine; Ergolines; Female; Humans; Lactation; Metergoline; Pregnancy

1979
Interaction of sulfpride and ergot derivatives on rat brain DOPAC concentration and prolactin secretion in vivo.
    European journal of pharmacology, 1979, Volume: 56, Issue:1-2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Bromocriptine; Corpus Striatum; Ergolines; Male; Metergoline; Nucleus Accumbens; Phenylacetates; Prolactin; Rats; Sulpiride

1979
Specific radioimmunoassay of ergot peptide alkaloids in plasma.
    Clinical chemistry, 1979, Volume: 25, Issue:11

    Topics: Bromocriptine; Cross Reactions; Dihydroergotamine; Ergolines; Ergotamine; Humans; Radioimmunoassay; Structure-Activity Relationship

1979
Restoration of the prolactin response to sulpiride by metergoline administration in hyperprolactinemic patients.
    Neuroendocrinology, 1979, Volume: 29, Issue:5

    Topics: Adenoma; Adult; Amenorrhea; Bromocriptine; Dopamine; Ergolines; Female; Humans; Metergoline; Pituitary Gland; Pituitary Neoplasms; Prolactin; Sulpiride

1979
[Antiprolactin therapy in the treatment of benign lesions of the breast. Comparison of bromocryptine and methergoline].
    Minerva medica, 1979, Nov-17, Volume: 70, Issue:51

    Topics: Adult; Breast Diseases; Bromocriptine; Ergolines; Female; Fibrocystic Breast Disease; Humans; Metergoline; Middle Aged; Prolactin

1979
The effect of L-dopa and lergotrile mesylate on the interaction of fluphenazine decanoate and amphetamine-induced stereotypy and mortality.
    Communications in psychopharmacology, 1977, Volume: 1, Issue:5

    Topics: Acetonitriles; Amphetamine; Animals; Behavior; Bromocriptine; Dopamine Antagonists; Drug Interactions; Ergolines; Fluphenazine; Humans; Levodopa; Male; Rats; Stereotyped Behavior

1977
A comparison of apomorphine, bromocriptine and Sandoz CM 29-712 (6-methyl-8a-cyanomethyl-ergoline-l) in four different turning models in the rat [proceedings].
    British journal of pharmacology, 1978, Volume: 62, Issue:3

    Topics: Animals; Apomorphine; Behavior; Bromocriptine; Ergolines; Humans; Nitriles; Rats; Stereotyped Behavior

1978
Neurochemical and neuropharmacological investigations with four ergot derivatives: bromocriptine, dihydroergotoxine, CF 25-397 and CM 29-712.
    Pharmacology, 1978, Volume: 16 Suppl 1

    Topics: Animals; Behavior, Animal; Brain; Bromocriptine; Catecholamines; Chemical Phenomena; Chemistry; Dihydroergotoxine; Electroencephalography; Ergolines; Humans; Locomotion; Male; Mice; Morphine; Movement Disorders; Rabbits; Rats; Receptors, Dopamine; Reserpine; Sleep; Stereotyped Behavior

1978
The effect of levodopa, lergotrile, and bromocriptine on brain iron, manganese, and copper.
    Neurology, 1978, Volume: 28, Issue:7

    Topics: Acetonitriles; Animals; Brain Chemistry; Bromocriptine; Copper; Ergolines; Guinea Pigs; Iron; Levodopa; Male; Manganese; Metals

1978
Prolactin secretion inhibition by a new 8alpha-amino-ergoline, CH 29-171.
    Experientia, 1978, Oct-15, Volume: 34, Issue:10

    Topics: Animals; Bromocriptine; Dose-Response Relationship, Drug; Embryo Implantation; Ergolines; Female; Lactation; Methyltyrosines; Pregnancy; Prolactin; Rats; Reserpine; Secretory Rate

1978
Transient bitemporal hemianopsia during pregnancy after treatment of galactorrhea-amenorrhea syndrome with bromocriptine.
    The Journal of clinical endocrinology and metabolism, 1977, Volume: 44, Issue:1

    Topics: Adult; Amenorrhea; Bromocriptine; Ergolines; Estradiol; Female; Follicle Stimulating Hormone; Galactorrhea; Hemianopsia; Humans; Lactation Disorders; Luteinizing Hormone; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin; Syndrome; Visual Fields

1977
Sleep-related growth hormone release following 2-bromo-alpha-ergocriptine treatment in acromegalic patients.
    The Journal of clinical endocrinology and metabolism, 1977, Volume: 44, Issue:1

    Topics: Acromegaly; Adult; Bromocriptine; Circadian Rhythm; Electroencephalography; Ergolines; Female; Growth Hormone; Humans; Male; Middle Aged; Sleep; Wakefulness

1977
Bromocryptine therapy in cases of amenorrhea-galactorrhea.
    American journal of obstetrics and gynecology, 1977, Feb-01, Volume: 127, Issue:3

    Topics: Adult; Amenorrhea; Bromocriptine; Ergolines; Female; Follicle Stimulating Hormone; Galactorrhea; Humans; Hypothyroidism; Lactation Disorders; Luteinizing Hormone; Pituitary Neoplasms; Pregnancy; Prolactin; Thyrotropin

1977
[Dopaminergic blockage using pimozide and dopaminergic stimulation using bromocryptin. Effect on secretion of somatotropin].
    Casopis lekaru ceskych, 1977, Jan-07, Volume: 116, Issue:2

    Topics: Acromegaly; Adult; Aged; Bromocriptine; Ergolines; Female; Growth Hormone; Humans; Male; Middle Aged; Pimozide; Receptors, Dopamine; Stimulation, Chemical

1977
Hormonal changes induced by bromocriptine (CB-154) at the early stage of treatment.
    The Journal of clinical endocrinology and metabolism, 1977, Volume: 44, Issue:3

    Topics: Adult; Amenorrhea; Bromocriptine; Ergolines; Estradiol; Female; Follicle Stimulating Hormone; Humans; Hyperpituitarism; Luteinizing Hormone; Pituitary Hormones, Anterior; Prolactin

1977
Successful use of bromocriptine in the treatment of a patient with chronic portasystemic encephalopathy.
    The New England journal of medicine, 1977, Apr-07, Volume: 296, Issue:14

    Topics: Bromocriptine; Cerebrovascular Circulation; Chronic Disease; Ergolines; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Male; Middle Aged; Oxygen Consumption

1977
Serum prolactin levels and the value of bromocriptine in the treatment of anovulatory infertility.
    British journal of obstetrics and gynaecology, 1977, Volume: 84, Issue:1

    Topics: Adult; Anovulation; Bromocriptine; Ergolines; Female; Humans; Infertility, Female; Prolactin

1977
Central dopaminergic and noradrenergic components of bromocryptine-induced locomotor activity in mice [proceedings].
    British journal of pharmacology, 1977, Volume: 59, Issue:3

    Topics: Animals; Bromocriptine; Dopamine; Ergolines; Mice; Motor Activity; Norepinephrine; Stimulation, Chemical

1977
The inhibitory effect of dopamine agonists on LH release in women.
    The Journal of clinical endocrinology and metabolism, 1977, Volume: 44, Issue:4

    Topics: Amenorrhea; Bromocriptine; Ergolines; Female; Follicle Stimulating Hormone; Humans; Levodopa; Luteinizing Hormone; Prolactin

1977
Tumor formation in preneoplastic mammary nodule lines in mice treated with nafoxidine, testosterone, and 2-bromo-alpha-ergocryptine.
    Journal of the National Cancer Institute, 1977, Volume: 58, Issue:4

    Topics: Animals; Bromocriptine; Ergolines; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nafoxidine; Neoplasm Transplantation; Ovary; Precancerous Conditions; Pyrrolidines; Receptors, Androgen; Receptors, Estrogen; Testosterone; Transplantation, Isogeneic

1977
Suppression of mammary tumorigenesis in C3H/He mice by ovariectomy or treatment with 2-bromo-alpha-ergocryptine: a comparison.
    Journal of the National Cancer Institute, 1977, Volume: 58, Issue:4

    Topics: Adrenal Glands; Animals; Bromocriptine; Castration; Ergolines; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Precancerous Conditions; Prolactin

1977
Bromocriptine treatment of acromegaly.
    Metabolism: clinical and experimental, 1977, Volume: 26, Issue:5

    Topics: Acromegaly; Adult; Bromocriptine; Dose-Response Relationship, Drug; Drug Evaluation; Ergolines; Female; Glucose Tolerance Test; Growth Hormone; Humans; Male; Middle Aged; Pituitary Neoplasms

1977
17beta-oestradiol and Enovid mammary tumorigenesis in C3H/HeJ female mice: counteraction by concurrent 2-bromo-alpha-ergocryptine.
    British journal of cancer, 1977, Volume: 35, Issue:3

    Topics: Animals; Bromocriptine; Contraceptives, Oral; Contraceptives, Oral, Combined; Ergolines; Estradiol; Estrogen Antagonists; Female; Mammary Neoplasms, Experimental; Mestranol; Mice; Norethynodrel

1977
Bromocriptine--fact or expensive fancy.
    British medical journal, 1977, Apr-02, Volume: 1, Issue:6065

    Topics: Bromocriptine; Costs and Cost Analysis; Endocrine System Diseases; Ergolines; Female; Humans; United Kingdom

1977
Long-term treatment of acromegaly with bromocriptine.
    British medical journal, 1977, Apr-02, Volume: 1, Issue:6065

    Topics: Acromegaly; Adolescent; Adult; Aged; Bromocriptine; Ergolines; Female; Growth Hormone; Humans; Male; Middle Aged; Time Factors

1977
Bromocriptine for severe mastalgia.
    British medical journal, 1977, Apr-23, Volume: 1, Issue:6068

    Topics: Adult; Breast Diseases; Bromocriptine; Ergolines; Female; Humans; Pain

1977
Indirect evidences of prolactin involvement in precocious puberty induced by hypothalamic lesions in female rats.
    Acta endocrinologica, 1977, Volume: 85, Issue:1

    Topics: Animals; Body Weight; Bromocriptine; Ergolines; Female; Hypothalamus; Lactation; Milk; Pregnancy; Prolactin; Rats; Secretory Rate; Sexual Maturation

1977
Bromocriptine for severe mastalgia.
    British medical journal, 1977, May-21, Volume: 1, Issue:6072

    Topics: Breast Diseases; Bromocriptine; Ergolines; Female; Humans; Premenstrual Syndrome; Research Design

1977
Interaction between bromocriptine and levodopa. Biochemical basis for an improved treatment for parkinsonism.
    Neurology, 1977, Volume: 27, Issue:6

    Topics: Animals; Brain; Bromocriptine; Carbidopa; Dopamine; Drug Interactions; Ergolines; gamma-Aminobutyric Acid; Hydroxyindoleacetic Acid; Levodopa; Male; Parkinson Disease; Rats; Serotonin

1977
Bromocriptin and methylergometrine: pharmacological approach of the mechanism of their central effects.
    Pharmacological research communications, 1977, Volume: 9, Issue:3

    Topics: Animals; Behavior, Animal; Body Temperature; Bromocriptine; Catalepsy; Drug Interactions; Ergolines; Ergotamines; Humans; Male; Mice; Motor Activity; Prochlorperazine; Reserpine; Social Environment; Stereotyped Behavior

1977
[Bromocriptine (Parlodel). A prolactin inhibiting dopamine receptor agonist].
    Ugeskrift for laeger, 1977, May-30, Volume: 139, Issue:22

    Topics: Amenorrhea; Bromocriptine; Ergolines; Female; Galactorrhea; Humans; Lactation; Pregnancy

1977
Effect of prolactin and bromocriptine on growth of transplanted hormone-dependent mouse mammary tumours.
    British journal of cancer, 1977, Volume: 35, Issue:6

    Topics: Animals; Bromocriptine; Castration; Ergolines; Estrone; Female; Mammary Neoplasms, Experimental; Mice; Neoplasm Transplantation; Progesterone; Prolactin; Transplantation, Homologous

1977
Growth hormone, insulin, and prolactin secretion in anorexia nervosa and obesity during bromocriptine treatment.
    British medical journal, 1977, Jul-16, Volume: 2, Issue:6080

    Topics: Adolescent; Adult; Anorexia Nervosa; Bromocriptine; Ergolines; Female; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Insulin Secretion; Obesity; Prolactin

1977
Differential effects of three dopamine agonists: apomorphine, bromocriptine and lergotrile.
    Journal of neurochemistry, 1977, Volume: 28, Issue:6

    Topics: Acetonitriles; Animals; Apomorphine; Brain; Bromocriptine; Dopamine; Ergolines; Humans; Male; Methyltyrosines; Rats; Stereotyped Behavior

1977
[Preliminary results of treatment of hormone-dependent metastatic carcinoma of the breast with the bromocriptin-medroxyprogesterone acetate combination].
    Minerva medica, 1977, Jun-30, Volume: 68, Issue:32

    Topics: Adult; Aged; Breast Neoplasms; Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Ergolines; Female; Humans; Medroxyprogesterone; Middle Aged; Neoplasm Metastasis; Receptors, Estrogen

1977
Visual abnormalities in a pregnancy following bromocriptin medication.
    Obstetrics and gynecology, 1977, Volume: 50, Issue:1 Suppl

    Topics: Adult; Amenorrhea; Bromocriptine; Cesarean Section; Ergolines; Female; Follicle Stimulating Hormone; Humans; Infertility, Female; Luteinizing Hormone; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin; Sella Turcica; Thyrotropin; Tomography, X-Ray; Vision Disorders; Visual Acuity; Visual Fields

1977
Use of brom-ergocryptine in treating amenorrhea/galactorrhea.
    Southern medical journal, 1977, Volume: 70, Issue:6

    Topics: Adult; Amenorrhea; Bromocriptine; Ergolines; Female; Galactorrhea; Humans; Lactation Disorders; Pregnancy; Prolactin

1977
Bromocriptine in encephalopathy.
    The New England journal of medicine, 1977, Aug-25, Volume: 297, Issue:8

    Topics: Bromocriptine; Chronic Disease; Ergolines; Hepatic Encephalopathy; Humans

1977
Treatment of Parkinson's disease with bromocriptine.
    The New England journal of medicine, 1977, Sep-01, Volume: 297, Issue:9

    Topics: Bromocriptine; Ergolines; Humans; Levodopa; Parkinson Disease

1977
[Amenorrhea and bromocryptine].
    Nederlands tijdschrift voor geneeskunde, 1977, Jul-16, Volume: 121, Issue:29

    Topics: Amenorrhea; Bromocriptine; Ergolines; Female; Humans; Pituitary Neoplasms; Prolactin

1977
Bromocriptine--a versatile remedy.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1977, Jun-25, Volume: 51, Issue:26

    Topics: Acromegaly; Bromocriptine; Ergolines; Female; Galactorrhea; Humans; Lactation Disorders; Parkinson Disease; Pregnancy

1977
Bromocriptine: a rather specific stimulant of dopamine receptors regulating dopamine metabolism.
    Advances in biochemical psychopharmacology, 1977, Volume: 16

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Brain; Bromocriptine; Dopamine; Drug Interactions; Ergolines; Mice; Motor Activity; Pimozide; Receptors, Dopamine; Stimulation, Chemical

1977
A study of the effects of bromocriptine on serum prolactin, follicle stimulating hormone and luteinizing hormone and on ovarian responsiveness to exogenous gonadotrophins in anovulatory women.
    British journal of obstetrics and gynaecology, 1977, Volume: 84, Issue:6

    Topics: Adult; Anovulation; Bromocriptine; Ergolines; Estrogens; Female; Follicle Stimulating Hormone; Gonadotropins, Pituitary; Humans; Luteinizing Hormone; Ovary; Prolactin

1977
Effect of 2-bromo-alpha-ergocryptine (CB 154) on plasma prolactin, LH and testosterone levels, accessory reproductive glands and spermatogenesis in lambs during puberty.
    Biology of reproduction, 1977, Volume: 17, Issue:2

    Topics: Animals; Bromocriptine; Epididymis; Ergolines; Fructose; Luteinizing Hormone; Male; Organ Size; Prolactin; Seminal Vesicles; Sexual Maturation; Sheep; Spermatogenesis; Testis; Testosterone

1977
[Drug therapy of acromegaly].
    Horumon to rinsho. Clinical endocrinology, 1977, Volume: 25, Issue:6

    Topics: Acromegaly; Adult; Bromocriptine; Ergolines; Female; Humans; Male; Middle Aged

1977
Changes in pituitary hormones serum levels in bromocryptine-treated parkinsonian patients.
    Neuropsychobiology, 1977, Volume: 3, Issue:1

    Topics: Aged; Bromocriptine; Ergolines; Female; Gonadotropins, Pituitary; Growth Hormone; Humans; Male; Middle Aged; Parkinson Disease; Pituitary Hormones, Anterior; Thyrotropin

1977
[Bromoergocryptine in the treatment of nonpuerperal galactorrhea].
    Ugeskrift for laeger, 1977, Jul-18, Volume: 139, Issue:29

    Topics: Adult; Bromocriptine; Ergolines; Female; Galactorrhea; Humans; Lactation Disorders; Pregnancy

1977
Stimulating action of sulpiride and pimozide on prolactin release. Effect on bromocriptine, L-dopa and metergoline administration.
    Acta endocrinologica, 1977, Volume: 86, Issue:2

    Topics: Adolescent; Adult; Bromocriptine; Ergolines; Female; Humans; Levodopa; Male; Metergoline; Pimozide; Prolactin; Sulpiride

1977
Dopamine agonists and audiogenic seizures: the relationship between protection against seizures and changes in monoamine metabolism.
    Biochemical pharmacology, 1978, Volume: 27, Issue:24

    Topics: Acoustic Stimulation; Animals; Apomorphine; Biogenic Amines; Brain; Bromocriptine; Dopamine; Ergolines; Ergonovine; Female; Lysergic Acid Diethylamide; Male; Mice; Mice, Inbred DBA; Quipazine; Seizures

1978
Evaluation of the central effects of ergot alkaloids by means of electroencephalography.
    Pharmacology, 1978, Volume: 16 Suppl 1

    Topics: Animals; Behavior, Animal; Brain; Bromocriptine; Dihydroergotoxine; Electroencephalography; Ergolines; Ergot Alkaloids; Ergotamine; Mice; Rabbits; Rats; Receptors, Dopamine

1978
Role of ergot derivatives in the treatment of parkinsonism.
    Federation proceedings, 1978, Volume: 37, Issue:8

    Topics: Acetonitriles; Animals; Bromocriptine; Disease Models, Animal; Ergolines; Humans; Liver; Parkinson Disease; Pyridines; Structure-Activity Relationship

1978
Comparison between lergotrile and bromocriptine in parkinsonism.
    Annals of neurology, 1978, Volume: 3, Issue:4

    Topics: Acetonitriles; Adult; Aged; Bromocriptine; Carbidopa; Chemical Phenomena; Chemistry; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Receptors, Dopamine

1978
Mechanisms underlying the prolactin-lowering effect of meterogoline in the rat.
    Life sciences, 1978, Sep-04, Volume: 23, Issue:9

    Topics: Animals; Bromocriptine; Ergolines; Female; Male; Metergoline; Pituitary Gland, Anterior; Prolactin; Quipazine; Radioimmunoassay; Rats; Reserpine; Time Factors

1978
The influence of 2 br-alpha-ergocryptine (CB-154) and apomorphine on induced prolactin secretion in the crab eating monkey (Macaca fascicularis).
    Endocrine research communications, 1975, Volume: 2, Issue:1

    Topics: Animals; Apomorphine; Bromocriptine; Castration; Ergolines; Female; Humans; Macaca fascicularis; Ovary; Perphenazine; Prolactin; Radioimmunoassay; Thyrotropin-Releasing Hormone; Time Factors

1975
Prolactin and thyrotropin responses to thyrotropin-releasing hormone in patients with secondary amenorrhea: the effect of bromocriptine.
    The Journal of clinical endocrinology and metabolism, 1976, Volume: 42, Issue:6

    Topics: Adult; Amenorrhea; Bromocriptine; Contraceptives, Oral; Ergolines; Female; Humans; Pituitary Gland; Pregnancy; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone; Time Factors

1976
Neuropharmacological investigations with two ergot alkaloids, Hydergine and bromocriptine.
    Postgraduate medical journal, 1976, Volume: 52suppl 1

    Topics: Activity Cycles; Animals; Behavior, Animal; Bromocriptine; Dihydroergotoxine; Ergolines; Ergoloid Mesylates; Humans; Mice; Morphine; Rats; Stereotyped Behavior

1976
Inhibition of prolactin release by metergoline administration in man.
    Biomedicine / [publiee pour l'A.A.I.C.I.G.], 1977, Jan-31, Volume: 27, Issue:1

    Topics: Adult; Bromocriptine; Ergolines; Female; Growth Hormone; Humans; Kinetics; Male; Metergoline; Prolactin; Time Factors

1977
Treatment of parkinsonism.
    Advances in experimental medicine and biology, 1977, Volume: 90

    Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Bromocriptine; Carbidopa; Dopamine; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Parkinson Disease; Receptors, Dopamine

1977
Effect of bromo-ergocryptine on serum hPRL, hLH, hFSH, and estradiol 17-beta in women with galactorrhea-amenorrhea.
    Obstetrics and gynecology, 1976, Volume: 48, Issue:1

    Topics: Adult; Amenorrhea; Bromocriptine; Ergolines; Estradiol; Female; Follicle Stimulating Hormone; Galactorrhea; Humans; Lactation Disorders; Luteinizing Hormone; Middle Aged; Pregnancy; Prolactin

1976
Effects of 2-bromo-alpha-ergocryptine and pimozide on growth hormone secretion in man.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1976, Volume: 8, Issue:3

    Topics: Adolescent; Adult; Bromocriptine; Ergolines; Female; Growth Hormone; Humans; Menstruation; Pimozide; Time Factors

1976
Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.
    British journal of pharmacology, 1976, Volume: 56, Issue:1

    Topics: Amphetamine; Animals; Apomorphine; Bromocriptine; Drug Interactions; Ergolines; Humans; Hydroxydopamines; Levodopa; Male; Mice; Motor Activity; Rats; Receptors, Drug; Reserpine; Stereotyped Behavior; Substantia Nigra

1976
Galactorrhea-amenorrhea syndromes: etiology and treatment.
    Annals of internal medicine, 1976, Volume: 84, Issue:5

    Topics: Adenoma; Amenorrhea; Bromocriptine; Chiari-Frommel Syndrome; Ergolines; Female; Galactorrhea; Humans; Lactation Disorders; Pituitary Function Tests; Pituitary Neoplasms; Pregnancy; Recurrence; Syndrome

1976
Studies with bromocriptine. Part 1. "On-off" phenomena.
    Neurology, 1976, Volume: 26, Issue:6 PT 1

    Topics: Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease

1976
Serum growth hormone response to bromocriptine during a glucose tolerance test in acromegaly.
    Acta endocrinologica, 1976, Volume: 82, Issue:1

    Topics: Acromegaly; Adult; Blood Glucose; Bromocriptine; Ergolines; Ergot Alkaloids; Female; Glucose Tolerance Test; Growth Hormone; Humans; Male; Middle Aged

1976
Editorial: The many faces of bromocriptine.
    JAMA, 1976, Jun-28, Volume: 235, Issue:26

    Topics: Acromegaly; Bromocriptine; Ergolines; Female; Humans; Hypogonadism; Lactation; Lactation Disorders; Male; Parkinson Disease; Pregnancy

1976
Inhibition of lactation in rabbits by 2-Br-alpha-Ergokryptine-mesilate (CB154).
    Arzneimittel-Forschung, 1976, Volume: 26, Issue:1

    Topics: Animals; Animals, Newborn; Body Weight; Bromocriptine; Depression, Chemical; Dose-Response Relationship, Drug; Ergolines; Female; Intestinal Absorption; Lactation; Milk; Milk Ejection; Pregnancy; Prolactin; Rabbits; Species Specificity

1976
Prolactin and testosterone: independent circulating levels in hyperprolactinemic and normoprolactinemic amenorrhea. The effect of prolactin suppression by bromocriptine.
    The Journal of clinical endocrinology and metabolism, 1976, Volume: 43, Issue:1

    Topics: Adult; Amenorrhea; Bromocriptine; Depression, Chemical; Ergolines; Female; Humans; Prolactin; Testosterone

1976
Inhibitory effect of an ergoline derivative, methergoline, on growth hormone and prolactin levels in acromegalic patients.
    The Journal of clinical endocrinology and metabolism, 1976, Volume: 43, Issue:2

    Topics: Acromegaly; Adult; Aged; Bromocriptine; Cyproheptadine; Ergolines; Female; Growth Hormone; Humans; Male; Metergoline; Middle Aged; Phentolamine; Pituitary Gland; Prolactin; Serotonin Antagonists

1976
Bromocriptine increases plasma estradiol-17 beta concentration in amenorrhea patients with normal serum prolactin.
    The Journal of clinical endocrinology and metabolism, 1976, Volume: 43, Issue:2

    Topics: Amenorrhea; Bromocriptine; Ergolines; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Prolactin

1976
Proceedings: Effects of treatment with ovine prolactin and bromocriptine upon growth and exchangeable calcium in mice.
    The Journal of endocrinology, 1976, Volume: 69, Issue:3

    Topics: Animals; Bromocriptine; Calcium; Ergolines; Growth; Mice; Prolactin

1976
Letter: Bromocriptine and breast cancer.
    British medical journal, 1976, Jul-31, Volume: 2, Issue:6030

    Topics: Breast Neoplasms; Bromocriptine; Ergolines; Female; Humans

1976
Letter: Platelet and coagulation studies in patients treated with bromocriptine.
    British medical journal, 1976, Aug-28, Volume: 2, Issue:6034

    Topics: Blood Coagulation; Bromocriptine; Ergolines; Female; Fibrinolysis; Humans; Male; Parkinson Disease; Platelet Aggregation

1976
Bromocriptine in the treatment of the hyperprolactinaemia-hypogonadism syndromes.
    Postgraduate medical journal, 1976, Volume: 52suppl 1

    Topics: Bromocriptine; Ergolines; Female; Galactorrhea; Humans; Hypogonadism; Male; Pituitary Neoplasms; Pregnancy; Prolactin

1976
Successful treatment of acromegaly with bromocriptine.
    Postgraduate medical journal, 1976, Volume: 52suppl 1

    Topics: Acromegaly; Bromocriptine; Ergolines; Female; Glucose Tolerance Test; Growth Hormone; Humans; Hydroxyproline; Male

1976
Letter: Bromergocryptine and the galactorrhea-amenorrhea syndrome.
    Annals of internal medicine, 1976, Volume: 85, Issue:3

    Topics: Amenorrhea; Bromocriptine; Ergolines; Female; Galactorrhea; Humans; Lactation Disorders; Pregnancy

1976
Effect of 2 br-alpha-ergocryptin (CB 154) on serum prolactin and the clinical picture in a case of progressive gigantomastia in pregnancy.
    Annales chirurgiae et gynaecologiae, 1976, Volume: 65, Issue:4

    Topics: Adult; Breast Diseases; Bromocriptine; Carbamazepine; Diazepam; Epilepsy, Temporal Lobe; Ergolines; Female; Humans; Mephenytoin; Phenobarbital; Pregnancy; Pregnancy Complications; Prolactin

1976
Proceedings: Growth, prolactin and growth hormone in lambs treated with CB154.
    The Journal of endocrinology, 1976, Volume: 69, Issue:3

    Topics: Animals; Bromocriptine; Ergolines; Growth Hormone; Prolactin; Sheep

1976
Bromocriptine in migraine.
    Headache, 1976, Volume: 16, Issue:3

    Topics: Adult; Bromocriptine; Drug Evaluation; Ergolines; Female; Humans; Menstruation; Middle Aged; Migraine Disorders; Premenstrual Syndrome

1976
The effect of 2-bromo-alpha-ergocryptine (CB154) administration of the hormone levels, organ weights, prostatic morphology and zinc concentrations in the male rat.
    Acta endocrinologica, 1976, Volume: 83, Issue:1

    Topics: Adenylyl Cyclases; Adrenal Glands; Animals; Bromocriptine; Culture Techniques; Ergolines; Female; Luteinizing Hormone; Male; Organ Size; Prolactin; Prostate; Rats; Testis; Testosterone; Zinc

1976
Comparison of reflex effects of levodopa and bromocriptine in Parkinsonism.
    British medical journal, 1976, Jul-24, Volume: 2, Issue:6029

    Topics: Bromocriptine; Ergolines; Humans; Levodopa; Parkinson Disease; Reflex

1976
[Fall of the growth hormone levels in acromegalics after bromocryptin (author's transl)].
    Casopis lekaru ceskych, 1976, Aug-27, Volume: 115, Issue:33-34

    Topics: Acromegaly; Adolescent; Adult; Bromocriptine; Ergolines; Female; Growth Hormone; Humans; Male; Middle Aged

1976
Infertility due to hyperprolactinemia and its treatment with ergocryptine.
    Fertility and sterility, 1976, Volume: 27, Issue:11

    Topics: Bromocriptine; Ergolines; Female; Humans; Infertility, Female; Prolactin

1976
A comparison of the effects of CB-154 and lergotrile mesylate on prolactin and growth hormone secretion in mice.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1976, Volume: 8, Issue:5

    Topics: Acetonitriles; Animals; Body Weight; Bromocriptine; Dose-Response Relationship, Drug; Ergolines; Female; Growth Hormone; Mice; Mice, Inbred C57BL; Organ Size; Pituitary Gland; Prolactin

1976
Restoration of fertility in prolactin induced premature menopause.
    Irish journal of medical science, 1976, Volume: 145, Issue:7

    Topics: Adult; Bromocriptine; Ergolines; Female; Humans; Infertility, Female; Menopause, Premature; Prolactin

1976
Treatment of parkinson's disease with bromocriptine.
    The New England journal of medicine, 1976, Dec-16, Volume: 295, Issue:25

    Topics: Aged; Bromocriptine; Delusions; Dopa Decarboxylase; Drug Evaluation; Ergolines; Female; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Parkinson Disease

1976
Developments in the treatment of parkinsonism.
    The New England journal of medicine, 1976, Dec-16, Volume: 295, Issue:25

    Topics: Antiparkinson Agents; Bromocriptine; Drug Synergism; Ergolines; Humans; Parkinson Disease

1976
Induction of menstruation with bromocryptine in patients with euprolactinemic amenorrhea.
    American journal of obstetrics and gynecology, 1976, Oct-15, Volume: 126, Issue:4

    Topics: Adult; Amenorrhea; Bromocriptine; Ergolines; Female; Humans; Menstruation; Ovulation; Prolactin

1976
The influence of the prolactin inhibitor bromocriptin (CB 154) on human luteal function in vivo.
    Archiv fur Gynakologie, 1976, Sep-17, Volume: 221, Issue:2

    Topics: Adult; Bromocriptine; Corpus Luteum; Ergolines; Female; Humans; Menstruation; Progesterone; Prolactin; Time Factors

1976
Growth hormone and prolactin release in acromegalic patients following metergoline administration.
    The Journal of clinical endocrinology and metabolism, 1976, Volume: 43, Issue:6

    Topics: Acromegaly; Adult; Animals; Bromocriptine; Ergolines; Growth Hormone; Humans; Levodopa; Male; Metergoline; Middle Aged; Prolactin; Serotonin; Serotonin Antagonists

1976
Effects of pituitary graft and 2-bromo-alpha-ergocryptine on mammary DNA synthesis in mice in relation to mammary tumorigenesis.
    Journal of the National Cancer Institute, 1976, Volume: 56, Issue:5

    Topics: Animals; Bromocriptine; DNA; Ergolines; Estrus; Female; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Pituitary Gland; Pituitary Gland, Anterior; Pregnancy; Prolactin; Transplantation, Isogeneic

1976
Interaction of estrogen and prolactin in spontaneous mammary tumorigenesis of the mouse.
    Journal of toxicology and environmental health. Supplement, 1976, Volume: 1

    Topics: Animals; Bromocriptine; Drug Synergism; Ergolines; Estradiol; Estrogens; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Ovary; Pregnancy; Progesterone Congeners; Prolactin

1976
[Neuroendocrine aspects of Parkinson's disease. Therapeutic/effect of a prolactin inhibitor].
    Minerva medica, 1976, Nov-03, Volume: 67, Issue:53

    Topics: Aged; Bromocriptine; Drug Evaluation; Ergolines; Female; Humans; Middle Aged; Parkinson Disease; Prolactin

1976
Treatment of fibrocystic disease of the breast with a prolactin inhibitor: 2-Br-alpha-ergocryptine (CB-154).
    Obstetrics and gynecology, 1976, Volume: 48, Issue:6

    Topics: Adolescent; Adult; Breast Diseases; Bromocriptine; Ergolines; Female; Humans; Middle Aged; Prolactin

1976
Bromocriptine:dopamine-receptor agonist.
    American family physician, 1976, Volume: 14, Issue:6

    Topics: Acromegaly; Aged; Bromocriptine; Ergolines; Female; Humans; Infertility, Female; Parkinson Disease; Pituitary Neoplasms; Receptors, Dopamine

1976
Lack of effect of acute prolactin suppression on renal water sodium and potassium excretion during sleep.
    Hormone research, 1976, Volume: 7, Issue:1

    Topics: Adult; Body Water; Bromocriptine; Circadian Rhythm; Ergolines; Female; Humans; Male; Potassium; Prolactin; Sleep; Sodium; Urine; Wakefulness

1976
Ovarian refractoriness to gonadotropins in cases of inappropriate lactation: restoration of ovarian function with bromocryptine.
    The Journal of clinical endocrinology and metabolism, 1976, Volume: 43, Issue:6

    Topics: Amenorrhea; Bromocriptine; Ergolines; Female; Fertility; Galactorrhea; Gonadotropins, Pituitary; Humans; Lactation Disorders; Menotropins; Ovary; Ovulation; Pregnancy; Prolactin; Thyrotropin

1976
Pregnancy following bromocryptine therapy for the amenorrhoea-galactorrhoea syndrome due to a pituitary tumour.
    The Medical journal of Australia, 1976, Oct-16, Volume: 2, Issue:16

    Topics: Adenoma, Chromophobe; Adult; Amenorrhea; Bromocriptine; Ergolines; Female; Galactorrhea; Humans; Lactation Disorders; Pituitary Neoplasms; Pregnancy; Syndrome

1976
Bromocriptine potentiation of gastric acid secretion in cats.
    Clinical endocrinology, 1976, Volume: 5, Issue:6

    Topics: Animals; Bromocriptine; Cats; Ergolines; Female; Gastric Juice; Male; Pentagastrin; Vagotomy

1976
Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa.
    Journal of neurology, neurosurgery, and psychiatry, 1976, Volume: 39, Issue:11

    Topics: Aged; Bromocriptine; Dose-Response Relationship, Drug; Drug Evaluation; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Ergolines; Female; Follow-Up Studies; Growth Hormone; Humans; Levodopa; Male; Metoclopramide; Middle Aged; Parkinson Disease; Receptors, Dopamine

1976
Effect of prolactin and the anit-prolactin bromocriptin on the testosterone uptake and metabolism in androgen-sensitive and insensitive canine organs.
    Urological research, 1976, Nov-10, Volume: 4, Issue:3

    Topics: Animals; Bromocriptine; Castration; Dogs; Ergolines; Kidney; Liver; Male; Muscles; Penis; Prolactin; Prostate; Testosterone; Urethra

1976
[Effect of 2-bromo-alpha-ergocryptine on the response of the hypothalamo-hypophyseal-adrenal system to insulin hypoglycemia in man].
    Bollettino della Societa italiana di biologia sperimentale, 1976, Oct-15, Volume: 52, Issue:19

    Topics: Adolescent; Adrenal Glands; Adult; Animals; Bromocriptine; Dogs; Ergolines; Female; Humans; Hydrocortisone; Hypoglycemia; Hypothalamo-Hypophyseal System; Insulin; Male; Rats; Receptors, Dopamine

1976
[Endocrine effects of bromocryptin in patients with Parkinsonism].
    Bollettino della Societa italiana di biologia sperimentale, 1976, Oct-15, Volume: 52, Issue:19

    Topics: Aged; Bromocriptine; Ergolines; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Pituitary Hormones

1976
[Modifications of the incretory pituitary response of prolactin to sulpiride after treatment with bromocryptin].
    Bollettino della Societa italiana di biologia sperimentale, 1976, Oct-15, Volume: 52, Issue:19

    Topics: Adult; Bromocriptine; Ergolines; Female; Humans; Male; Pituitary Gland; Prolactin; Sulpiride

1976
Current concepts in drug therapy. (21) Bromocriptine "Parlodel" (Sandoz).
    The Ceylon medical journal, 1976, Volume: 21, Issue:2

    Topics: Bromocriptine; Ergolines; Female; Humans; Male

1976
Bromocriptine in the treatment of advanced breast cancer.
    Clinical oncology, 1976, Volume: 2, Issue:4

    Topics: Breast Neoplasms; Bromocriptine; Drug Evaluation; Ergolines; Female; Growth Hormone; Humans; Hypophysectomy; Prolactin

1976
[Medicamentous ablactation post partum. Comparative study between bromocryptin (Parlodel) and methallenoestrol (Vallestril) as well as 2 combination variants of both preparations].
    Gynakologische Rundschau, 1976, Volume: 16, Issue:4

    Topics: Bromocriptine; Drug Combinations; Drug Synergism; Ergolines; Estrogens, Non-Steroidal; Female; Humans; Lactation; Naphthalenes; Pregnancy; Prolactin

1976
[Treatment of Parkinson's disease with bromocriptine].
    La Nouvelle presse medicale, 1976, Apr-23, Volume: 6, Issue:17

    Topics: Aged; Bromocriptine; Drug Evaluation; Ergolines; Female; Humans; Male; Middle Aged; Parkinson Disease

1976
Bromocriptine in refractory post partum lactation.
    The Ceylon medical journal, 1976, Volume: 21, Issue:3

    Topics: Adult; Bromocriptine; Ergolines; Female; Galactorrhea; Humans; Lactation Disorders; Pregnancy

1976
Clinical studies with bromocriptine in idiopathic parkinsonism.
    Transactions of the American Neurological Association, 1976, Volume: 101

    Topics: Bromocriptine; Drug Evaluation; Ergolines; Humans; Parkinson Disease

1976
A study of the effect of bromocriptine on serum oestradiol, prolactin, and follicle stimulating hormone levels in puerperal women.
    British journal of obstetrics and gynaecology, 1975, Volume: 82, Issue:9

    Topics: Bromocriptine; Ergolines; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Pituitary Gland; Postpartum Period; Pregnancy; Prolactin; Radioimmunoassay

1975
[Use of bromoergocryptine in physiological inhibition of lactation].
    Ginecologia y obstetricia de Mexico, 1975, Volume: 37, Issue:220

    Topics: Administration, Oral; Bromocriptine; Drug Evaluation; Ergolines; Female; Humans; Infant, Newborn; Lactation; Postpartum Period; Pregnancy; Pregnancy Complications

1975
Treatment of acromegaly with bromocryptine.
    The Journal of clinical endocrinology and metabolism, 1975, Volume: 40, Issue:5

    Topics: Acromegaly; Adult; Aged; Blood Glucose; Bromocriptine; Ergolines; Fasting; Female; Growth Hormone; Humans; Male; Middle Aged; Time Factors

1975
Effects of oestrogen and bromocryptine on in vivo secretion and mitosis in prolactin cells.
    Nature, 1975, Jun-05, Volume: 255, Issue:5508

    Topics: Animals; Body Weight; Bromocriptine; Depression, Chemical; Diethylstilbestrol; Ergolines; Growth Hormone; Male; Mitosis; Organ Size; Pituitary Gland; Pituitary Gland, Anterior; Prolactin; Rats; Stimulation, Chemical

1975
Hypothermic action of bromocriptine.
    British journal of pharmacology, 1975, Volume: 54, Issue:1

    Topics: Amphetamine; Animals; Apomorphine; Body Temperature Regulation; Brain; Bromocriptine; Cold Temperature; Colon; Dopamine Antagonists; Dose-Response Relationship, Drug; Environment, Controlled; Ergolines; Hypothermia; Male; Pimozide; Rats

1975
Letter: Prolactin, bromocriptine, and haemostasis.
    British medical journal, 1975, Aug-02, Volume: 3, Issue:5978

    Topics: Animals; Blood Coagulation; Bromocriptine; Ergolines; Guinea Pigs; Mice; Prolactin; Rats

1975
[Therapy of acromegaly using bromocriptine].
    Deutsche medizinische Wochenschrift (1946), 1975, Jul-18, Volume: 100, Issue:29

    Topics: Acromegaly; Administration, Oral; Blood Glucose; Bromocriptine; Diabetes Complications; Diabetes Mellitus; Ergolines; Female; Growth Hormone; Humans; Male; Sweating; Time Factors

1975
Dopaminergic control of growth hormone secretion in normal and acromegalic subjects.
    Panminerva medica, 1975, Volume: 17, Issue:4

    Topics: Acromegaly; Amantadine; Bromocriptine; Ergolines; Growth Hormone; Humans; Hypothalamo-Hypophyseal System; Levodopa; Phentolamine; Pituitary Gland; Propranolol

1975
Serum prolactin levels of rats under continuous estrogen stimulation and 2 Br-alpha-ergocryptine (CB-154) injection.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1975, Volume: 149, Issue:2

    Topics: Animals; Body Weight; Bromocriptine; Castration; Depression, Chemical; Ergolines; Estradiol; Female; Injections, Subcutaneous; Organ Size; Organophosphorus Compounds; Ovary; Polymers; Prolactin; Rats; Stimulation, Chemical; Tartrates; Time Factors; Vaginal Smears

1975
[Two cases of amenorrhea-galactorrhea with sterility treated with CB 154 (2 bromo-alpha-ergocryptine): ovulation and pregnancy].
    Gynecologie, 1975, Volume: 26, Issue:2

    Topics: Adult; Amenorrhea; Bromocriptine; Ergolines; Female; Galactorrhea; Humans; Infertility, Female; Lactation Disorders; Ovulation; Pregnancy

1975
The acute effect of 2-bromo-a-ergocryptine (CB-154) on anterior pituitary hormones and free fatty acids in man.
    International journal of clinical pharmacology and biopharmacy, 1975, Volume: 12, Issue:1-2

    Topics: Blood Glucose; Bromocriptine; Ergolines; Fatty Acids, Nonesterified; Female; Follicle Stimulating Hormone; Growth Hormone; Humans; Hydrocortisone; Lipid Mobilization; Luteinizing Hormone; Male; Pituitary Hormones, Anterior; Prolactin

1975
The influence of prolactin and CB154 on electrolyte concentration of amniotic fluid in the rat.
    IRCS journal of medical science, 1975, Volume: 3, Issue:5

    Topics: Amniotic Fluid; Animals; Bromocriptine; Ergolines; Female; Potassium; Prolactin; Rats; Sheep; Sodium

1975
Metaclopramide and prolactin secretion in man: effects of pretreatment with L-dopa and 2-bromo-alpha-ergocryptine (CB-154).
    IRCS journal of medical science, 1975, Volume: 3, Issue:6

    Topics: Adult; Bromocriptine; Ergolines; Female; Humans; Hypothalamus; Levodopa; Male; Metoclopramide; Pituitary Gland; Prolactin

1975
Amenorrhea and galactorrhea: results of therapy with 2-Brom-alpha-ergocryptine (CB-154).
    American journal of obstetrics and gynecology, 1975, May-01, Volume: 122, Issue:1

    Topics: Adult; Amenorrhea; Breast Feeding; Bromocriptine; Ergolines; Female; Follicle Stimulating Hormone; Galactorrhea; Humans; Lactation; Lactation Disorders; Luteinizing Hormone; Pregnancy; Progesterone; Prolactin; Radioimmunoassay

1975
[Successful treatment of galactorrhea, anemorrhea and infertility with a new ergot alkaloid (2-Br-alpha-ergocryptine)].
    Nederlands tijdschrift voor geneeskunde, 1975, Apr-05, Volume: 119, Issue:14

    Topics: Adult; Amenorrhea; Bromocriptine; Ergolines; Female; Galactorrhea; Humans; Infertility; Lactation; Lactation Disorders; Male; Pregnancy; Prolactin

1975
Editorial: Galactorrhea-amenorrhea, brom-ergocryptine, and the dopamine receptor.
    The New England journal of medicine, 1975, Aug-28, Volume: 293, Issue:9

    Topics: Amenorrhea; Brain; Bromocriptine; Depression, Chemical; Dopamine; Ergolines; Female; Galactorrhea; Humans; Lactation Disorders; Male; Pregnancy; Prolactin; Receptors, Drug; Syndrome

1975
Effect of CB-154 (2 Br-a-ergocryptine) on serum follicle stimulating hormone, luteinzing hormone and prolactin in women with the amenorrhoea-galactorrhoea syndrome.
    Acta endocrinologica, 1975, Volume: 79, Issue:1

    Topics: Adult; Amenorrhea; Bromocriptine; Depression, Chemical; Ergolines; Ergot Alkaloids; Female; Follicle Stimulating Hormone; Galactorrhea; Humans; Lactation Disorders; Luteinizing Hormone; Ovulation; Pregnancy; Prolactin; Stimulation, Chemical; Time Factors

1975
Treatment of galactorrhea-amenorrhea syndrome with 2-Br-alpha-ergocryptin (CB 154). Clinical response and pattern of pituitary and steriod hormones before and during therapy.
    Archiv fur Gynakologie, 1975, Volume: 218, Issue:2

    Topics: Adult; Amenorrhea; Bromocriptine; Contraceptives, Oral; Ergolines; Estrogens; Female; Follicle Stimulating Hormone; Galactorrhea; Humans; Hypophysectomy; Lactation Disorders; Luteinizing Hormone; Pregnancy; Progesterone; Prolactin; Psychotropic Drugs; Radioimmunoassay; Syndrome

1975
Bromocriptine treatment of female infertility: report of 13 pregnancies.
    British medical journal, 1975, Dec-20, Volume: 4, Issue:5998

    Topics: Adult; Bromocriptine; Ergolines; Female; Humans; Infertility, Female; Pituitary Irradiation; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin; Vision Disorders; Visual Fields

1975
[Hyperprolactinemic amenorrhea and sterility treated with bromocriptine].
    Harefuah, 1975, Dec-01, Volume: 89, Issue:11

    Topics: Adult; Amenorrhea; Bromocriptine; Ergolines; Female; Humans; Infertility, Female; Prolactin

1975
Proceedings: Effects of prolactin and bromocriptine on the response to Moloney sarcoma virus in mice.
    The Journal of endocrinology, 1975, Volume: 67, Issue:2

    Topics: Animals; Bromocriptine; Ergolines; Mice; Mice, Inbred BALB C; Moloney murine leukemia virus; Neoplasms, Experimental; Prolactin; Rhabdomyosarcoma

1975
Proceedings: Effects of bromocriptine and prolactin on thymus growth and thymus uptake of tritiated thymidine in mice of the Swiss and Bar Harbor 129 strains.
    The Journal of endocrinology, 1975, Volume: 67, Issue:2

    Topics: Animals; Bromocriptine; Ergolines; Mice; Mice, Inbred Strains; Muscular Dystrophy, Animal; Prolactin; Thymidine; Thymus Gland

1975
Proceedings: Bromocriptine therapy of acromegaly.
    The Journal of endocrinology, 1975, Volume: 67, Issue:2

    Topics: Acromegaly; Bromocriptine; Ergolines; Humans

1975
Pharmacological characterization of CB 154.
    Triangle; the Sandoz journal of medical science, 1975, Volume: 14, Issue:3-4

    Topics: Animals; Binding Sites; Bromocriptine; Depression, Chemical; Ergolines; Female; Male; Prolactin; Rats

1975
[A patient with primary amenorrhea].
    Nederlands tijdschrift voor geneeskunde, 1975, Dec-13, Volume: 119, Issue:50

    Topics: Amenorrhea; Bromocriptine; Ergolines; Female; Gonadotropins; Humans; Prolactin

1975
Effect of five dopaminergic drugs on plasma growth hormone levels in acromegalic subjects.
    Neuroendocrinology, 1975, Volume: 19, Issue:3

    Topics: Acromegaly; Adult; Aged; Amantadine; Bromocriptine; Ergolines; Female; Growth Hormone; Humans; Levodopa; Male; Memantine; Middle Aged; Piperazines; Piribedil

1975
Luteal 20alpha-hydroxy steroid dehydrogenase and the formation of delta4-3-oxo steroids in the rat after weaning or treatment with 2-bromo-alpha-ergocryptine during lactation.
    The Biochemical journal, 1975, Volume: 152, Issue:3

    Topics: Adrenalectomy; Animals; Bromocriptine; Corpus Luteum; Ergolines; Female; Hydroxysteroid Dehydrogenases; Ketosteroids; Lactation; Ovary; Pregnancy; Prolactin; Rats; Time Factors; Weaning

1975
Editorial: Bromocriptine--a changing scene.
    British medical journal, 1975, Dec-20, Volume: 4, Issue:5998

    Topics: Acromegaly; Bromocriptine; Ergolines; Female; Humans; Lactation; Male; Pregnancy; Prolactin

1975
Effects of bromocriptine on milk secretion in the rabbit.
    The Journal of endocrinology, 1975, Volume: 67, Issue:2

    Topics: Animals; Bromocriptine; Ergolines; Female; Lactation; Pregnancy; Prolactin; Rabbits; Time Factors

1975
Successful treatment of mastodynia with the prolactin inhibitor bromocryptine (CB 154).
    Archiv fur Gynakologie, 1975, Dec-16, Volume: 220, Issue:1

    Topics: Adult; Breast Diseases; Bromocriptine; Ergolines; Female; Humans; Middle Aged; Pain; Premenstrual Syndrome; Prolactin

1975
Inhibition by dopamine agonists of dopamine accumulation following gamma-hydroxybutyrate treatment.
    European journal of pharmacology, 1975, Volume: 34, Issue:2

    Topics: Animals; Apomorphine; Brain; Bromocriptine; Codeine; Depression, Chemical; Dopamine; Ergolines; Haloperidol; Hydroxybutyrates; Male; Naphthols; Piribedil; Rats

1975
["Use of bromocriptin (CB 154) in the treatment of puerperal and pathological lactation" (author's transl)].
    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1976, Feb-17, Volume: 65, Issue:7

    Topics: Adult; Bromocriptine; Ergolines; Female; Humans; Lactation Disorders; Pregnancy; Prolactin

1976
Letter: CB-154.
    Fertility and sterility, 1976, Volume: 27, Issue:3

    Topics: Adenoma; Adult; Bromocriptine; Ergolines; Female; Humans; Infertility, Female; Pituitary Neoplasms

1976
Proceedings: Renal interactions of prolactin and bromocriptine.
    The Journal of endocrinology, 1976, Volume: 68, Issue:3

    Topics: Animals; Bromocriptine; Ergolines; Kidney; Male; Prolactin; Rats

1976
[The "problem" of stopping loctation prevention and suppression with CB 154 (author's transl)].
    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1976, Jan-13, Volume: 65, Issue:2

    Topics: Adult; Bromocriptine; Ergolines; Female; Humans; Lactation; Nausea; Parity; Pregnancy; Vomiting; Weaning

1976
Effect of bromocriptine on plasma growth hormone and glucose tolerance in chronic renal failure.
    British medical journal, 1976, Apr-10, Volume: 1, Issue:6014

    Topics: Blood Glucose; Bromocriptine; Ergolines; Glucose; Growth Hormone; Humans; Kidney Failure, Chronic

1976
[Letter: Efficacy of bromocriptine in 2 cases of levodopa-resistant parkinsonism].
    La Nouvelle presse medicale, 1976, Jan-24, Volume: 5, Issue:4

    Topics: Aged; Bromocriptine; Drug Evaluation; Ergolines; Female; Humans; Male; Middle Aged; Parkinson Disease

1976
Letter: Treatment of mania with bromocriptine.
    British medical journal, 1976, May-29, Volume: 1, Issue:6021

    Topics: Bipolar Disorder; Bromocriptine; Ergolines; Humans; Prolactin

1976
Further observations on postpartum ovarian refractoriness: effect of gonadal stimulation in women receiving bromocryptine.
    Clinical endocrinology, 1976, Volume: 5, Issue:2

    Topics: Bromocriptine; Ergolines; Estradiol; Estrogens; Female; Humans; Menotropins; Ovary; Postpartum Period; Pregnancy; Prolactin

1976
Failure to demonstrate transfer of milk prolactin into blood of milk-fed rats and calves.
    Journal of dairy science, 1976, Volume: 59, Issue:5

    Topics: Absorption; Animals; Animals, Newborn; Bromocriptine; Cattle; Colostrum; Ergolines; Female; Lactation; Male; Milk; Pregnancy; Prolactin; Rats; Species Specificity

1976
Coagulation studies in patients treated with bromocriptine.
    British medical journal, 1976, Jul-10, Volume: 2, Issue:6027

    Topics: Blood Coagulation; Blood Coagulation Tests; Bromocriptine; Ergolines; Female; Humans; Male

1976
Prophylaxis of early preneoplastic lesions of the mammary gland.
    Cancer research, 1976, Volume: 36, Issue:7 PT 2

    Topics: Animals; Bromocriptine; Ergolines; Female; Hyperplasia; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Metergoline; Mice; Mice, Inbred C3H; Parity; Precancerous Conditions; Prolactin

1976
Bromocriptine - an important advance.
    Drug and therapeutics bulletin, 1976, Apr-23, Volume: 14, Issue:9

    Topics: Acromegaly; Bromocriptine; Depression, Chemical; Ergolines; Female; Humans; Lactation; Parkinson Disease; Pregnancy; Prolactin

1976
Dopamine receptor subtypes colocalize in rat striatonigral neurons.
    Proceedings of the National Academy of Sciences of the United States of America, 1992, Nov-01, Volume: 89, Issue:21

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antisense Elements (Genetics); Base Sequence; Blotting, Southern; Bromocriptine; DNA; Ergolines; Evoked Potentials; Microscopy, Fluorescence; Molecular Sequence Data; Neostriatum; Neurons; Oligodeoxyribonucleotides; Quinpirole; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; RNA Probes; RNA, Messenger; Sodium Channels; Substantia Nigra

1992
Dopamine stimulates growth hormone release from the pituitary of goldfish, Carassius auratus, through the dopamine D1 receptors.
    Endocrinology, 1992, Volume: 130, Issue:3

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Bromocriptine; Domperidone; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Ergolines; Goldfish; Gonadotropin-Releasing Hormone; Growth Hormone; Pituitary Gland; Quinpirole; Radioimmunoassay; Receptors, Dopamine

1992
Pleuropulmonary changes during treatment of Parkinson's disease with a long-acting ergot derivative, cabergoline.
    The European respiratory journal, 1992, Volume: 5, Issue:2

    Topics: Bromocriptine; Cabergoline; Dopamine Agents; Ergolines; Humans; Lung Diseases; Male; Middle Aged; Parkinson Disease; Pleural Effusion

1992
Antidepressant-like effects of dopamine agonists in an animal model of depression.
    Biological psychiatry, 1992, May-01, Volume: 31, Issue:9

    Topics: Animals; Arousal; Brain; Bromocriptine; Depressive Disorder; Disease Models, Animal; Dopamine Agents; Dose-Response Relationship, Drug; Drinking; Ergolines; Helplessness, Learned; Male; Motivation; Quinpirole; Rats; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Taste

1992
Opposite influences of dopaminergic receptor subtypes on penile erection.
    General pharmacology, 1992, Volume: 23, Issue:4

    Topics: Animals; Apomorphine; Bromocriptine; Dopamine Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Ergolines; Male; Parasympatholytics; Parasympathomimetics; Penile Erection; Quinpirole; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2

1992
Effect of mesulergine on prolactin secretion and dopamine D2 receptors-adaptive changes in diethylstilbestrol-induced hyperplasia of the rat anterior pituitary.
    Endocrine regulations, 1992, Volume: 26, Issue:1

    Topics: Animals; Antiparkinson Agents; Bromocriptine; Diethylstilbestrol; Dose-Response Relationship, Drug; Ergolines; Female; Hyperplasia; Hyperprolactinemia; Pergolide; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Wistar; Receptors, Dopamine D2; Spiperone; Time Factors; Tritium

1992
The effect of mesulergine on prolactin secretion and anterior pituitary cells morphology in diethylstilboestrol-treated female Wistar rats.
    Histology and histopathology, 1992, Volume: 7, Issue:1

    Topics: Animals; Antiparkinson Agents; Bromocriptine; Cell Division; Diethylstilbestrol; Drug Interactions; Ergolines; Female; Hyperprolactinemia; Immunohistochemistry; Pergolide; Pituitary Gland, Anterior; Prolactin; Rats

1992
Cabergoline in the long-term therapy of hyperprolactinemic disorders.
    Acta endocrinologica, 1992, Volume: 126, Issue:6

    Topics: Adolescent; Adult; Aged; Bromocriptine; Cabergoline; Drug Resistance; Ergolines; Female; Humans; Hyperprolactinemia; Male; Menstruation Disturbances; Middle Aged; Ovulation; Pituitary Neoplasms; Prolactinoma

1992
Differential effects of dopamine agonists upon stimulated limbic and striatal dopamine release: in vivo voltammetric data.
    British journal of pharmacology, 1991, Volume: 102, Issue:1

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Bromocriptine; Corpus Striatum; Dopamine; Dopamine Agents; Electrochemistry; Electrophysiology; Ergolines; In Vitro Techniques; Limbic System; Male; Microelectrodes; Nucleus Accumbens; Pergolide; Piperidines; Quinpirole; Rats; Rats, Inbred Strains; Stereotaxic Techniques

1991
Dopamine receptors mediating inhibition of the cyclic adenosine monophosphate generating system in the rat renal cortex.
    Journal of autonomic pharmacology, 1991, Volume: 11, Issue:2

    Topics: Animals; Benzazepines; Bromocriptine; Cyclic AMP; Dopamine; Dopamine Agents; Ergolines; In Vitro Techniques; Kidney Cortex; Male; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine

1991
Absence of postsynaptic DA2 dopamine receptors in the dog renal vasculature.
    European journal of pharmacology, 1991, May-17, Volume: 197, Issue:2-3

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Bromocriptine; Dogs; Dopamine; Dopamine Agents; Ergolines; Fenoldopam; Histamine Antagonists; Male; Quinpirole; Receptors, Dopamine; Renal Circulation; Sympatholytics; Synapses; Vasodilation

1991
Pharmacological characterization of dopamine receptors in parasympathetic innervation of rat heart.
    European journal of pharmacology, 1991, Jul-23, Volume: 200, Issue:1

    Topics: Acetylcholine; Animals; Apomorphine; Bradycardia; Bromocriptine; Decerebrate State; Dopamine Agents; Electric Stimulation; Ergolines; Heart; Heart Rate; Male; Pergolide; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Vagus Nerve

1991
Role of genotype and dopamine receptors in behaviour of inbred mice in a forced swimming test.
    Psychopharmacology, 1991, Volume: 105, Issue:4

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Analysis of Variance; Animals; Behavior, Animal; Benzazepines; Bromocriptine; Depression; Dopamine Agents; Ergolines; Genotype; Mice; Mice, Inbred Strains; Quinpirole; Receptors, Dopamine; Sulpiride; Swimming

1991
Evaluation of dopamine receptor involvement in rat feeding behaviour.
    General pharmacology, 1991, Volume: 22, Issue:6

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Appetite Depressants; Bromocriptine; Dopamine Agents; Dose-Response Relationship, Drug; Ergolines; Feeding Behavior; Male; Quinpirole; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Reserpine; Serotonin Antagonists

1991
Different effects of direct and indirect dopamine receptor agonists on immobility time in reserpine-treated mice.
    General pharmacology, 1991, Volume: 22, Issue:6

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Bromocriptine; Bupropion; Dopamine Agents; Dopamine Antagonists; Ergolines; Injections, Subcutaneous; Male; Mice; Motor Activity; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Reserpine; Sulpiride; Swimming

1991
Differential effects of dopamine agonists on locomotion in intact and reserpine-treated mice.
    General pharmacology, 1991, Volume: 22, Issue:6

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Methyltyrosine; Animals; Apomorphine; Benzazepines; Bromocriptine; Dopamine Agents; Dose-Response Relationship, Drug; Ergolines; Male; Methyltyrosines; Mice; Motor Activity; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Reserpine; Sulpiride; Tyrosine 3-Monooxygenase

1991
Effect of AT II on the exploratory behaviour of rats. Interactions with elymoclavine and bromocryptine.
    Acta physiologica et pharmacologica Bulgarica, 1991, Volume: 17, Issue:2-3

    Topics: Angiotensin II; Animals; Behavior, Animal; Bromocriptine; Ergolines; Exploratory Behavior; Male; Motor Activity; Rats; Rats, Inbred Strains

1991
Differential ability of selective and non-selective dopamine agonists to induce climbing in the rat indicates the involvement of both D-1 and D-2 receptors in this behaviour.
    Psychopharmacology, 1990, Volume: 100, Issue:1

    Topics: Amphetamine; Animals; Apomorphine; Benzazepines; Bromocriptine; Clonidine; Dopamine Agents; Ergolines; Female; Levodopa; Motor Activity; Pergolide; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior; Sulpiride

1990
Age-related changes of dopamine sensitive cyclic AMP generation in the rat frontal cortex.
    Mechanisms of ageing and development, 1990, May-15, Volume: 54, Issue:1

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Aging; Animals; Apomorphine; Benzazepines; Bromocriptine; Cyclic AMP; Dopamine; Dopamine Agents; Dopamine Antagonists; Ergolines; Fenoldopam; Frontal Lobe; Male; Quinpirole; Rats; Rats, Inbred Strains

1990
Alpha-2 adrenergic activity of bromocriptine and quinpirole in chicken pineal gland. Effects on melatonin synthesis and [3H]rauwolscine binding.
    The Journal of pharmacology and experimental therapeutics, 1990, Volume: 255, Issue:3

    Topics: Animals; Arylamine N-Acetyltransferase; Binding Sites; Bromocriptine; Chickens; Clonidine; Dopamine Agents; Ergolines; Male; Melatonin; Membranes; Pineal Gland; Quinpirole; Receptors, Adrenergic, alpha; Retina; Tritium; Yohimbine

1990
In vivo interaction of cabergoline with rat brain dopamine receptors labelled with [3H]N-n-propylnorapomorphine.
    European journal of pharmacology, 1990, Oct-23, Volume: 187, Issue:3

    Topics: Administration, Oral; Animals; Apomorphine; Brain Chemistry; Bromocriptine; Cabergoline; Dopamine Agents; Dose-Response Relationship, Drug; Ergolines; Female; In Vitro Techniques; Injections, Intravenous; Kinetics; Rats; Rats, Inbred Strains; Receptors, Dopamine

1990
New perspectives in medical management of hyperprolactinemia.
    Endocrinologia experimentalis, 1990, Volume: 24, Issue:1-2

    Topics: Adenoma; Bromocriptine; Cabergoline; Delayed-Action Preparations; Empty Sella Syndrome; Ergolines; Female; Humans; Hyperprolactinemia; Male; Pituitary Neoplasms

1990
[Hyperprolactinemia syndrome in men].
    Sovetskaia meditsina, 1990, Issue:4

    Topics: Adult; Bromocriptine; Ergolines; Humans; Hyperprolactinemia; Infertility, Male; Lisuride; Male; Middle Aged; Oligospermia; Prolactin; Syndrome

1990
Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
    Molecular pharmacology, 1985, Volume: 28, Issue:2

    Topics: Adenylyl Cyclases; Animals; Benzazepines; Bromocriptine; Butaclamol; Corpus Striatum; Dopamine; Enzyme Activation; Ergolines; Guanine Nucleotides; Norepinephrine; Potassium; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sodium; Spiperone; Sulpiride

1985
Duodenal ulcer induced by MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine).
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1985, Volume: 180, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amylases; Animals; Bicarbonates; Bromocriptine; Dose-Response Relationship, Drug; Duodenal Ulcer; Duodenum; Ergolines; Female; Gastric Acid; Gastric Emptying; Gastrointestinal Motility; Monoamine Oxidase Inhibitors; Pancreas; Pyridines; Rats; Rats, Inbred Strains; Trypsin

1985
D-2 dopaminergic agonists and adenosine 3',5'-monophosphate directly regulate the synthesis of alpha-melanocyte-stimulating hormone-like peptides by cultured rat melanotrophs.
    Endocrinology, 1986, Volume: 118, Issue:3

    Topics: 1-Methyl-3-isobutylxanthine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 8-Bromo Cyclic Adenosine Monophosphate; Animals; Benzamides; Benzazepines; Bromocriptine; Cells, Cultured; Chemical Precipitation; Cholera Toxin; Chromatography, High Pressure Liquid; Colforsin; Cyclic AMP; Dopamine; Ergolines; Immunologic Techniques; Melanocyte-Stimulating Hormones; Pituitary Gland; Pro-Opiomelanocortin; Quinpirole; Rats; Receptors, Dopamine; Spiperone

1986
Hypothalamic D2 receptors mediate the preferential release of somatostatin-28 in response to dopaminergic stimulation.
    Endocrinology, 1986, Volume: 119, Issue:4

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Bromocriptine; Butaclamol; Domperidone; Dopamine; Ergolines; Hypothalamus; Male; Metoclopramide; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Somatostatin; Somatostatin-28

1986
Effectiveness and tolerability of long term treatment with cabergoline, a new long-lasting ergoline derivative, in hyperprolactinemic patients.
    The Journal of clinical endocrinology and metabolism, 1989, Volume: 69, Issue:4

    Topics: Adenoma; Adult; Amenorrhea; Bromocriptine; Cabergoline; Dopamine Agents; Ergolines; Female; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactin

1989
[Effectiveness of lysenyl-forte treatment in acromegaly and hyperprolactinemia syndrome].
    Klinicheskaia meditsina, 1989, Volume: 67, Issue:9

    Topics: Acromegaly; Adolescent; Adult; Aged; Aged, 80 and over; Bromocriptine; Drug Evaluation; Ergolines; Female; Humans; Hyperprolactinemia; Lisuride; Male; Middle Aged; Syndrome

1989
Effect of pentobarbitone sodium and bromocriptine on follicular oestradiol production in the rat.
    Journal of reproduction and fertility, 1989, Volume: 86, Issue:1

    Topics: Animals; Bromocriptine; Chorionic Gonadotropin; Diestrus; Ergolines; Estradiol; Female; Luteinizing Hormone; Ovarian Follicle; Pentobarbital; Proestrus; Prolactin; Rats; Rats, Inbred Strains

1989
Dopamine D2 agonist-induced behavioural depression is reversed by dopamine D1 agonists.
    Journal of neural transmission, 1989, Volume: 75, Issue:3

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Bromocriptine; Dose-Response Relationship, Drug; Ergolines; Indoles; Male; Mice; Motor Activity; Phenanthridines; Quinpirole; Receptors, Dopamine

1989
Differential action of bromocriptine on nigrostriatal versus mesolimbic dopaminergic neurons.
    Journal of neural transmission, 1987, Volume: 68, Issue:1-2

    Topics: 4-Butyrolactone; Animals; Apomorphine; Bromocriptine; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Ergolines; Limbic System; Male; Nucleus Accumbens; Olfactory Bulb; Prolactin; Rats; Time Factors

1987
Climbing and stereotyped behaviours in mice require the stimulation of D-1 dopamine receptors.
    European journal of pharmacology, 1988, Mar-29, Volume: 148, Issue:2

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Apomorphine; Appetite Depressants; Behavior, Animal; Benzazepines; Bromocriptine; Ergolines; Male; Mice; Mice, Inbred Strains; Piribedil; Quinpirole; Receptors, Dopamine; Stereotyped Behavior

1988
D2 dopamine receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in rat striatum.
    Neuroscience letters, 1985, Aug-30, Volume: 59, Issue:2

    Topics: Adenylyl Cyclases; Animals; Benzazepines; Bromocriptine; Butyrophenones; Colforsin; Corpus Striatum; Ergolines; In Vitro Techniques; Male; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Spiperone

1985
Excitation by dopamine D-2 receptor agonists, bromocriptine and LY 171555, in caudate nucleus neurons activated by nigral stimulation.
    Life sciences, 1986, May-19, Volume: 38, Issue:20

    Topics: Animals; Benzazepines; Bromocriptine; Cats; Caudate Nucleus; Domperidone; Electric Stimulation; Ergolines; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D2; Substantia Nigra

1986
Interactions between endogenous dopamine and dopamine agonists at release modulatory receptors: multiple effects of neuronal uptake inhibitors on transmitter release.
    The Journal of pharmacology and experimental therapeutics, 1986, Volume: 238, Issue:2

    Topics: Acetylcholine; alpha-Methyltyrosine; Animals; Apomorphine; Bromocriptine; Cocaine; Corpus Striatum; Dopamine; Electric Stimulation; Ergolines; Haloperidol; In Vitro Techniques; Methyltyrosines; Neurotransmitter Uptake Inhibitors; Nomifensine; Quinpirole; Rabbits; Receptors, Dopamine; Reserpine

1986
Synergistic effects of D1 and D2 dopamine agonists on turning behaviour in rats.
    Brain research, 1986, Oct-08, Volume: 384, Issue:2

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Bromocriptine; Ergolines; Male; Motor Activity; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Rotation

1986
Striatal cholinergic function reflects differences in D-2 dopaminergic receptor activation.
    Life sciences, 1987, Oct-05, Volume: 41, Issue:14

    Topics: Acetylcholine; Animals; Bromocriptine; Corpus Striatum; Ergolines; Female; Lisuride; Pimozide; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Sulpiride

1987
Dopaminergic agents selectively alter the post-translational processing of beta-endorphin in the intermediate pituitary of the rat.
    The Journal of pharmacology and experimental therapeutics, 1987, Volume: 243, Issue:1

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; beta-Endorphin; Bromocriptine; Domperidone; Dopamine Antagonists; Ergolines; Haloperidol; Male; Pituitary Gland; Protein Processing, Post-Translational; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine

1987
The dopamine D2 receptor agonists, quinpirole and bromocriptine produce conditioned place preferences.
    Progress in neuro-psychopharmacology & biological psychiatry, 1988, Volume: 12, Issue:2-3

    Topics: Animals; Bromocriptine; Conditioning, Psychological; Dose-Response Relationship, Drug; Ergolines; Male; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Reference Values

1988
Dopaminergic modulation of hippocampal noradrenaline release. Evidence for alpha 2-antagonistic effects of some dopamine receptor agonists and antagonists.
    Naunyn-Schmiedeberg's archives of pharmacology, 1985, Volume: 330, Issue:2

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Bromocriptine; Cocaine; Dopamine; Electric Stimulation; Ergolines; Hippocampus; In Vitro Techniques; Norepinephrine; Quinpirole; Rabbits; Receptors, Adrenergic, alpha; Receptors, Dopamine; Serotonin; Yohimbine

1985
The medical treatment of the hypersecreting pituitary gland.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1985, Volume: 12, Issue:3

    Topics: Adenoma; Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Bromocriptine; Cyproheptadine; Ergolines; Female; Humans; Male; Middle Aged; Pergolide; Pituitary Gland; Pituitary Neoplasms; Prolactin; Valproic Acid

1985
Variability and selectivity of anterior pituitary response to dopamine agonists throughout the normal menstrual cycle.
    American journal of obstetrics and gynecology, 1986, Volume: 154, Issue:2

    Topics: Bromocriptine; Dopamine; Dopamine Antagonists; Ergolines; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menstrual Cycle; Pergolide; Pituitary Gland, Anterior; Pituitary Hormone-Releasing Hormones; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone

1986
Dopaminergic inhibition of tyrosinase activity in hair follicular melanocytes of the mouse.
    The Journal of endocrinology, 1986, Volume: 111, Issue:2

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Aging; Animals; Benzazepines; Bromocriptine; Catechol Oxidase; Depression, Chemical; Dopamine; Ergolines; Female; Hair; Haloperidol; Male; Melanocytes; Mice; Mice, Inbred C3H; Monophenol Monooxygenase; Quinpirole; Skin; Spiperone; Sulpiride

1986
Dopamine agonists as primary treatment in Parkinson's disease.
    Advances in neurology, 1987, Volume: 45

    Topics: Antiparkinson Agents; Bromocriptine; Disability Evaluation; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Lisuride; Long-Term Care; Parkinson Disease; Pergolide; Receptors, Dopamine

1987
Puerperal lactation, gonadotropin release and estradiol release: effects of metergoline and bromocriptine.
    Gynecologic and obstetric investigation, 1987, Volume: 24, Issue:3

    Topics: Adult; Bromocriptine; Ergolines; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Lactation; Luteinizing Hormone; Metergoline; Ovulation; Postpartum Period; Pregnancy; Prolactin

1987
Effects of 8-OH-DPAT, lisuride and some ergot-related compounds on the acoustic startle response in the rat.
    Psychopharmacology, 1985, Volume: 85, Issue:4

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Bromocriptine; Ergolines; Lisuride; Male; Metergoline; Methiothepin; Naphthalenes; Pergolide; Quinpirole; Rats; Rats, Inbred Strains; Reflex, Startle; Tetrahydronaphthalenes

1985
Pleuropulmonary disease during bromocriptine treatment of Parkinson's disease.
    Archives of internal medicine, 1988, Volume: 148, Issue:10

    Topics: Aged; Antiparkinson Agents; Bromocriptine; Ergolines; Humans; Lung Diseases; Male; Middle Aged; Parkinson Disease; Pleural Diseases; Radiography

1988
Prolactin stimulation tests: different response patterns after bromocriptine, lisuride, and metergoline treatment of puerperal women.
    Obstetrics and gynecology, 1988, Volume: 71, Issue:1

    Topics: Adult; Bromocriptine; Ergolines; Female; Humans; Lisuride; Metergoline; Metoclopramide; Postpartum Period; Pregnancy; Prolactin

1988
Inhibitory effect of cabergoline on the development of estrogen-induced prolactin-secreting adenomas of the pituitary.
    European journal of pharmacology, 1988, Jun-22, Volume: 151, Issue:1

    Topics: Adenoma; Animals; Antineoplastic Agents; Body Weight; Bromocriptine; Cabergoline; DNA, Neoplasm; Ergolines; Estrogens; Female; Mitosis; Pituitary Neoplasms; Prolactin; Rats

1988
Depletion of catecholamines reveals inhibitory effects of bromocryptine and lysuride on neostriatal neurones recorded intracellularly in vitro.
    Neuropharmacology, 1988, Volume: 27, Issue:6

    Topics: Animals; Bromocriptine; Catecholamines; Corpus Striatum; Electrodes; Ergolines; In Vitro Techniques; Lisuride; Male; Membrane Potentials; Neurons; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reserpine; Substantia Nigra

1988
On the mode of action of six putative dopamine receptor agonists on suppression of exploratory behaviour in rats.
    Psychopharmacology, 1987, Volume: 91, Issue:2

    Topics: Animals; Bromocriptine; Ergolines; Exploratory Behavior; Habituation, Psychophysiologic; Male; Motor Activity; Piperidines; Rats; Rats, Inbred Strains; Receptors, Dopamine

1987
Synthesis and dopaminergic activity of trans-6-methyl-7a,8,9,10,11,11a-hexahydro-7H-pyrrolo[3,2,1-gh]- 4,7-phenanthroline and trans-1,2,3,4,4a,5,6,10b-octahydro-4,7-phenanthroline derivatives.
    Journal of medicinal chemistry, 1986, Volume: 29, Issue:6

    Topics: Animals; Bromocriptine; Ergolines; Male; Phenanthrolines; Prolactin; Pyrroles; Rats; Receptors, Dopamine; Structure-Activity Relationship

1986
Effect of clonidine, quipazine, and LY 53857 on the prolactin-suppressant action of bromocriptine in rats.
    American journal of veterinary research, 1986, Volume: 47, Issue:5

    Topics: Animals; Bromocriptine; Clonidine; Drug Interactions; Ergolines; Male; Pituitary Gland, Anterior; Prolactin; Quinolines; Quipazine; Rats; Rats, Inbred Strains; Serotonin Antagonists

1986
Dystonia-Parkinson syndrome: differential effects of levodopa and dopamine agonists.
    Clinical neuropharmacology, 1986, Volume: 9, Issue:3

    Topics: Adult; Bromocriptine; Carbidopa; Dystonia; Ergolines; Humans; Levodopa; Meige Syndrome; Middle Aged; Parkinson Disease; Pergolide; Torticollis

1986
Animal model of depression: imipramine, bromocriptine and lisuride alleviate motor depression.
    Activitas nervosa superior, 1986, Volume: 28, Issue:1

    Topics: Adjustment Disorders; Animals; Bromocriptine; Disease Models, Animal; Ergolines; Female; Imipramine; Lisuride; Male; Motor Activity; Rats; Rats, Inbred Strains

1986
Discordant responses of prolactinoma to two different dopamine agonists.
    Clinical endocrinology, 1986, Volume: 24, Issue:4

    Topics: Adult; Bromocriptine; Drug Resistance; Ergolines; Female; Humans; Pergolide; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed

1986
Long-lasting prolactin-lowering effect of cabergoline, a new dopamine agonist, in hyperprolactinemic patients.
    The Journal of clinical endocrinology and metabolism, 1986, Volume: 63, Issue:4

    Topics: Adult; Aged; Blood Pressure; Bromocriptine; Cabergoline; Ergolines; Female; Growth Hormone; Humans; Hyperprolactinemia; Male; Middle Aged; Time Factors

1986
Ultrastructural morphometry of prolactin secreting adenomas treated with dopamine agonists.
    Pathology, research and practice, 1986, Volume: 181, Issue:3

    Topics: Adenoma; Adolescent; Adult; Bromocriptine; Cell Nucleolus; Cell Nucleus; Dopamine; Endoplasmic Reticulum; Ergolines; Ergot Alkaloids; Exocytosis; Female; Humans; Lisuride; Male; Mitochondria; Organoids; Pituitary Neoplasms; Prolactin

1986
[Somnambulism as a result of dopaminomimetics?].
    Acta neurologica, 1986, Volume: 8, Issue:4

    Topics: Adult; Bromocriptine; Ergolines; Female; Humans; Lisuride; Somnambulism

1986
Behavioral effects of long-term neuroleptic treatment in Cebus monkeys.
    Psychopharmacology. Supplementum, 1985, Volume: 2

    Topics: Animals; Apomorphine; Behavior, Animal; Bromocriptine; Cebus; Dextroamphetamine; Dopamine; Ergolines; Haloperidol; Humans; Mastication; Pergolide; Receptors, Dopamine; Stereotyped Behavior

1985
Intolerance of bromocriptine: is metergoline a satisfactory alternative?
    British medical journal (Clinical research ed.), 1985, Jun-15, Volume: 290, Issue:6484

    Topics: Bromocriptine; Drug Hypersensitivity; Ergolines; Female; Humans; Male; Menstruation; Metergoline; Prolactin

1985
Management of prolactinomas. A reappraisal.
    The Australian & New Zealand journal of obstetrics & gynaecology, 1985, Volume: 25, Issue:3

    Topics: Adenoma; Bromocriptine; Ergolines; Female; Humans; Lisuride; Metergoline; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Radiotherapy Dosage; Radiotherapy, High-Energy; Time Factors

1985
[Dopaminergic agonists in Parkinson disease].
    La Revue du praticien, 1986, Jan-21, Volume: 36, Issue:5

    Topics: Aged; Bromocriptine; Dopamine; Ergolines; Humans; Levodopa; Lisuride; Parkinson Disease; Pergolide; Piribedil

1986
Prolactin cell carcinoma of the pituitary. Clinicopathologic, immunohistochemical, and ultrastructural study of a case with cranial and extracranial metastases.
    Cancer, 1985, Feb-01, Volume: 55, Issue:3

    Topics: Biological Assay; Brain Neoplasms; Bromocriptine; Combined Modality Therapy; Ergolines; Female; Histocytochemistry; Hormones; Humans; Microscopy, Electron; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Pergolide; Pituitary Neoplasms; Prolactin

1985
Chronic agonist therapy for Parkinson's disease: a 5-year study of bromocriptine and pergolide.
    Neurology, 1985, Volume: 35, Issue:5

    Topics: Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Ergolines; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Nausea; Outcome and Process Assessment, Health Care; Parkinson Disease; Pergolide; Time Factors

1985
Three-year observation of mesulergine (CU 32-085) in advanced and newly treated parkinsonism.
    Journal of neurology, 1985, Volume: 232, Issue:1

    Topics: Adult; Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease

1985
Low doses of dopamine agonists in the long-term treatment of macroprolactinomas.
    The New England journal of medicine, 1985, Sep-12, Volume: 313, Issue:11

    Topics: Adenoma; Adult; Aged; Bromocriptine; Ergolines; Female; Humans; Lisuride; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Radiography; Receptors, Dopamine

1985
The effect of dopamine agonist therapy on large functionless pituitary tumours.
    Clinical endocrinology, 1985, Volume: 22, Issue:5

    Topics: Adenoma, Chromophobe; Adult; Bromocriptine; Dopamine; Ergolines; Female; Humans; Male; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactin; Prospective Studies

1985
Effect of the new ergot derivative terguride on plasma PRL and GH levels in patients with pathological hyperprolactinemia or acromegaly.
    Journal of endocrinological investigation, 1985, Volume: 8, Issue:2

    Topics: Acromegaly; Adolescent; Adult; Bromocriptine; Ergolines; Female; Growth Hormone; Humans; Lisuride; Male; Middle Aged; Prolactin; Time Factors

1985
[Hyperprolactinemia and prolactinomas. Results of surgical and drug therapy].
    Deutsche medizinische Wochenschrift (1946), 1985, Oct-11, Volume: 110, Issue:41

    Topics: Adolescent; Adult; Aged; Bromocriptine; Dopamine; Drug Therapy, Combination; Ergolines; Female; Humans; Hyperprolactinemia; Lisuride; Male; Middle Aged; Paraneoplastic Endocrine Syndromes; Prolactin

1985
Antitumor activity of FCE 21336, a new prolactin lowering drug, on the MXT mouse mammary carcinoma.
    Cancer letters, 1985, Sep-15, Volume: 28, Issue:2

    Topics: Animals; Antineoplastic Agents; Bromocriptine; Cabergoline; Dose-Response Relationship, Drug; Ergolines; Female; Mammary Neoplasms, Experimental; Mice; Prolactin

1985
Dopamine agonists in hyperprolactinemia.
    Fertility and sterility, 1985, Volume: 44, Issue:4

    Topics: Bromocriptine; Ergolines; Humans; Hyperprolactinemia; Pergolide

1985
[Oral lisuride in Parkinson's disease].
    Medicina clinica, 1985, Sep-21, Volume: 85, Issue:8

    Topics: Adult; Aged; Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Ergolines; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease

1985
[Results of different types of treatment in prolactin adenoma].
    Medicina clinica, 1985, Dec-14, Volume: 85, Issue:20

    Topics: Adenoma; Bromocriptine; Ergolines; Female; Humans; Male; Metergoline; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin

1985
Treatment of parkinsonism with bromocriptine.
    Lancet (London, England), 1974, Dec-07, Volume: 2, Issue:7893

    Topics: Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Parkinson Disease

1974
Effects of inhibitors of pituitary prolactin release on testicular cholesterol stores, seminal vesicles weight, fertility, and lactation in mice.
    Biology of reproduction, 1974, Volume: 11, Issue:3

    Topics: Animals; Bromocriptine; Cholesterol; Depression, Chemical; Ergolines; Female; Fertility; Lactation; Male; Mice; Organ Size; Pregnancy; Prolactin; Seminal Vesicles; Testis

1974
Dopamine agonists and Parkinson's disease.
    Clinical neurology and neurosurgery, 1984, Volume: 86, Issue:3

    Topics: Antiparkinson Agents; Apomorphine; Brain; Bromocriptine; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Neurons; Parkinson Disease; Pergolide; Piribedil; Receptors, Dopamine

1984
Clinical course and outcome of pregnancy in twenty-five patients with pituitary microadenomas.
    American journal of obstetrics and gynecology, 1980, Feb-01, Volume: 136, Issue:3

    Topics: Adenoma; Adult; Amenorrhea; Bromocriptine; Ergolines; Female; Galactorrhea; Humans; Infant, Newborn; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin

1980
Cross tolerance between two dopaminergic ergot derivatives--bromocriptine and lergotrile.
    British journal of clinical pharmacology, 1980, Volume: 9, Issue:1

    Topics: Aged; Blood Pressure; Bromocriptine; Drug Tolerance; Ergolines; Heart Rate; Humans; Levodopa; Male; Middle Aged; Parkinson Disease

1980
Inhibition of apomorphine-, bromocriptine- and lergotrile-induced circling behaviour in rats by subsequent haloperidol administration.
    Neuropharmacology, 1980, Volume: 19, Issue:1

    Topics: Animals; Apomorphine; Behavior; Bromocriptine; Clozapine; Ergolines; Haloperidol; Humans; Male; Rats; Stereotyped Behavior; Time Factors

1980
Bromocriptine and CF 25-397 in the treatment of tardive dyskinesia.
    Archives of neurology, 1980, Volume: 37, Issue:4

    Topics: Adult; Antipsychotic Agents; Bromocriptine; Double-Blind Method; Dyskinesia, Drug-Induced; Ergolines; Female; Humans; Male; Pyridines

1980
Reinstatement of estrous cycles in middle-aged spontaneously persistent estrous rats: importance of circulating prolactin and the resulting facilitative action of progesterone.
    Endocrinology, 1980, Volume: 106, Issue:6

    Topics: Aging; Animals; Bromocriptine; Ergolines; Estrus; Female; Luteinizing Hormone; Pregnancy; Progesterone; Prolactin; Pseudopregnancy; Rats

1980
Neuropharmacology of synthetic ergot derivatives in man.
    Advances in biochemical psychopharmacology, 1980, Volume: 23

    Topics: Animals; Brain; Bromocriptine; Ergolines; Ergot Alkaloids; Humans; Peripheral Nerves; Prolactin; Receptors, Neurotransmitter

1980
Progress in the pharmacotherapy of Parkinsonism.
    Advances in biochemical psychopharmacology, 1980, Volume: 23

    Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Bromocriptine; Dopamine Antagonists; Ergolines; Humans; Monoamine Oxidase Inhibitors; Parkinson Disease; Receptors, Dopamine

1980
Psychiatric effects of bromocriptine and lergotrile in Parkinsonian patients.
    Advances in biochemical psychopharmacology, 1980, Volume: 23

    Topics: Aged; Bromocriptine; Cognition Disorders; Confusion; Dose-Response Relationship, Drug; Electroencephalography; Ergolines; Female; Humans; Male; Mental Disorders; Middle Aged; Parkinson Disease; Personality Disorders; Psychoses, Substance-Induced; Schizophrenia

1980
Central monoamine synapses as sites of action for ergot drugs.
    Advances in biochemical psychopharmacology, 1980, Volume: 23

    Topics: 5-Hydroxytryptophan; Animals; Apomorphine; Behavior, Animal; Binding, Competitive; Brain; Bromocriptine; Catecholamines; Ergolines; Ergot Alkaloids; Male; Mice; Rats; Receptors, Neurotransmitter

1980
Anorectic effect of lisuride and other ergot derivatives in the rat.
    European journal of pharmacology, 1980, Jun-13, Volume: 64, Issue:2-3

    Topics: Animals; Apomorphine; Appetite Depressants; Bromocriptine; Dose-Response Relationship, Drug; Eating; Ergolines; Ergot Alkaloids; Haloperidol; Humans; Lisuride; Male; Motor Activity; Pimozide; Rats; Receptors, Dopamine; Stereotyped Behavior; Time Factors

1980
Differential behavioral and biochemical effects of four dopaminergic agonists.
    Psychopharmacology, 1980, Volume: 68, Issue:2

    Topics: Animals; Apomorphine; Behavior, Animal; Brain Chemistry; Bromocriptine; Dopamine; Ergolines; Haloperidol; Male; Methyltyrosines; Mice; Motor Skills; Piribedil

1980
Inhibition of neurotransmitter receptor binding by ergot derivatives.
    Journal of neuroscience research, 1981, Volume: 6, Issue:1

    Topics: Adrenergic alpha-Antagonists; Animals; Brain; Bromocriptine; Dioxanes; Ergolines; Ergot Alkaloids; gamma-Aminobutyric Acid; Lysergic Acid Diethylamide; Male; Metergoline; Organ Specificity; Quinuclidinyl Benzilate; Rats; Receptors, Neurotransmitter; Serotonin; Spiperone; Structure-Activity Relationship; Synapses

1981
Lisuride and cerebral electrical activity in the rabbit.
    Il Farmaco; edizione scientifica, 1981, Volume: 36, Issue:5

    Topics: Animals; Antipsychotic Agents; Behavior; Brain; Bromocriptine; Electroencephalography; Ergolines; Lisuride; Rabbits

1981
Physiologic disposition of pergolide.
    Clinical pharmacology and therapeutics, 1981, Volume: 30, Issue:2

    Topics: Adult; Animals; Bromocriptine; Chromatography, High Pressure Liquid; Ergolines; Feces; Humans; Male; Middle Aged; Pergolide

1981
Treatment of hyperprolactinaemia with pergolide mesylate: acute effects and preliminary evaluation of long-term treatment.
    Lancet (London, England), 1981, Sep-26, Volume: 2, Issue:8248

    Topics: Administration, Oral; Adult; Bromocriptine; Depression, Chemical; Ergolines; Female; Follicle Stimulating Hormone; Growth Hormone; Humans; Luteinizing Hormone; Male; Pergolide; Prolactin; Time Factors

1981
Bromocriptine enhances guanylate cyclase activity.
    Endocrinology, 1981, Volume: 109, Issue:4

    Topics: Animals; Bromocriptine; Dopamine; Dose-Response Relationship, Drug; Ergolines; Female; Guanylate Cyclase; Kinetics; Ovary; Pituitary Gland; Rats; Rats, Inbred Strains

1981
Akinetic mutism from hypothalamic damage: successful treatment with dopamine agonists.
    Neurology, 1981, Volume: 31, Issue:11

    Topics: Adult; Akinetic Mutism; Bromocriptine; Carbidopa; Ergolines; Humans; Hypothalamic Neoplasms; Hypothalamus; Levodopa; Male; Methylphenidate; Postoperative Complications

1981
Low CSF GABA in Parkinsonian patients who respond poorly to therapy or suffer from the "on-off" phenomenon.
    Annals of neurology, 1982, Volume: 11, Issue:1

    Topics: Antiparkinson Agents; Bromocriptine; Carbidopa; Ergolines; Female; gamma-Aminobutyric Acid; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prognosis; Radioligand Assay

1982
Stereotyped responses of rats to two 2-halogenoergolines: 2-bromo-alpha-ergocryptine and lergotrile.
    Israel journal of medical sciences, 1982, Volume: 18, Issue:1

    Topics: Animals; Apomorphine; Bromocriptine; Drug Interactions; Ergolines; Fenclonine; Haloperidol; Humans; Male; Methyldopa; Methyltyrosines; Rats; Stereotyped Behavior; Stimulation, Chemical

1982
Pergolide-induced circling in rats with 6-hydroxydopamine lesions in the nigrostriatal pathway.
    Neurology, 1982, Volume: 32, Issue:12

    Topics: Animals; Behavior, Animal; Brain Diseases; Bromocriptine; Ergolines; Female; Hydroxydopamines; Oxidopamine; Parkinson Disease; Pergolide; Rats; Rats, Inbred Strains

1982
Effects of three dopamine agonists on cage climbing behavior.
    Psychopharmacology, 1983, Volume: 79, Issue:4

    Topics: Animals; Behavior, Animal; Bromocriptine; Ergolines; Male; Mice; Mice, Inbred Strains; Motor Activity; Pergolide

1983
Somatostatin depletion of the gut and pancreas induced by cysteamine is not prevented by vagotomy or by dopamine agonists.
    Regulatory peptides, 1983, Volume: 6, Issue:1

    Topics: Animals; Bromocriptine; Cysteamine; Duodenum; Ergolines; Female; Hypothalamus; Pancreas; Rats; Rats, Inbred Strains; Somatostatin; Stomach; Vagotomy

1983
Effects of agonists and antagonists of D1 and D2 dopamine receptors on self-stimulation of the medial prefrontal cortex in the rat.
    Pharmacology, biochemistry, and behavior, 1983, Volume: 19, Issue:2

    Topics: Animals; Apomorphine; Bromocriptine; Cerebral Cortex; Dose-Response Relationship, Drug; Ergolines; Functional Laterality; Male; Pimozide; Rats; Rats, Inbred Strains; Receptors, Dopamine; Self Stimulation; Spiperone; Sulpiride; Synaptic Transmission

1983
Action of apomorphine, bromocriptine and lergotrile on gamma-aminobutyric acid and acetylcholine release in nucleus accumbens and corpus striatum.
    Journal of neural transmission, 1983, Volume: 58, Issue:3-4

    Topics: Acetylcholine; Afferent Pathways; Animals; Apomorphine; Bromocriptine; Bucladesine; Corpus Striatum; Culture Techniques; Dose-Response Relationship, Drug; Ergolines; gamma-Aminobutyric Acid; Male; Molindone; Muridae; Nucleus Accumbens; Receptors, Dopamine; Septal Nuclei; Sulpiride; Synaptic Transmission

1983
Cardiovascular effects of bromocriptine and lergotrile in renal and spontaneously hypertensive rats.
    Archives internationales de pharmacodynamie et de therapie, 1983, Volume: 266, Issue:1

    Topics: Animals; Blood Pressure; Bromocriptine; Ergolines; Heart Rate; Hypertension; Hypertension, Renal; Male; Rats; Rats, Inbred Strains

1983
Ocular hypotensive action of ergoline derivatives in rabbits: effects of sympathectomy and domperidone pretreatment.
    Current eye research, 1984, Volume: 3, Issue:2

    Topics: Administration, Topical; Animals; Bromocriptine; Domperidone; Ergolines; Eye; Ganglia, Sympathetic; Intraocular Pressure; Male; Pergolide; Rabbits; Sympathectomy

1984
Dopamine analog-induced hyperglycemia in rats: involvement of the adrenal medulla and the endocrine pancreas.
    The Journal of pharmacology and experimental therapeutics, 1984, Volume: 228, Issue:3

    Topics: Adrenal Medulla; Animals; Apomorphine; Blood Glucose; Bromocriptine; Dextroamphetamine; Dihydroxyphenylalanine; Dopamine; Ergolines; Indans; Insulin; Islets of Langerhans; Male; Pergolide; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Dopamine; Tetrahydronaphthalenes

1984
Mouse locomotor activity: an in vivo test for dopamine autoreceptor activation.
    The Journal of pharmacology and experimental therapeutics, 1984, Volume: 229, Issue:3

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Bromocriptine; Ergolines; Female; Methods; Mice; Motor Activity; Receptors, Dopamine; Sulpiride

1984
Effect of dopamine agonist withdrawal after long-term therapy in prolactinomas. Studies with high-definition computerised tomography.
    Lancet (London, England), 1984, Jul-28, Volume: 2, Issue:8396

    Topics: Adult; Aged; Bromocriptine; Dopamine; Ergolines; Female; Humans; Male; Middle Aged; Pergolide; Pituitary Function Tests; Pituitary Neoplasms; Pregnancy; Prolactin; Sella Turcica; Tomography, X-Ray Computed

1984
Hypotensive action and alpha-adrenolytic properties of a new dopaminergic agonist, CU 32-085, in the rat.
    Archives internationales de pharmacodynamie et de therapie, 1984, Volume: 272, Issue:1

    Topics: Adrenergic alpha-Antagonists; Anesthesia; Animals; Antihypertensive Agents; Antiparkinson Agents; Blood Pressure; Bromocriptine; Clonidine; Epinephrine; Ergolines; Female; Heart Rate; Hemodynamics; Male; Methoxamine; Norepinephrine; Rats; Rats, Inbred Strains; Receptors, Dopamine

1984
Urinary excretion of free catecholamines in long-term treatment with dopaminergic agonists.
    Experimental and clinical endocrinology, 1984, Volume: 84, Issue:2

    Topics: Acromegaly; Adult; Aged; Blood Pressure; Bromocriptine; Dopamine; Epinephrine; Ergolines; Female; Humans; Lisuride; Male; Middle Aged; Norepinephrine; Somatostatin

1984
Therapeutic experience with the new dopamine agonist CU 32-085 in advanced Parkinson's disease.
    Journal of neurology, 1983, Volume: 230, Issue:1

    Topics: Adult; Aged; Amantadine; Antiparkinson Agents; Bromocriptine; Carboxy-Lyases; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parasympatholytics; Parkinson Disease

1983
Non-opiate beta-endorphin fragments and dopamine--VI. Behavioural analysis of the interaction between gamma-type endorphins and dopaminergic systems in the nucleus accumbens of rats.
    Neuropharmacology, 1984, Volume: 23, Issue:5

    Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; beta-Endorphin; Bromocriptine; Dopamine; Endorphins; Ergolines; Fluphenazine; gamma-Endorphin; Haloperidol; Male; Motor Activity; Nucleus Accumbens; Rats; Rats, Inbred Strains; Septal Nuclei; Sulpiride

1984
Dopamine agonists in Parkinson's disease.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1984, Volume: 11, Issue:1 Suppl

    Topics: Bromocriptine; Dopamine; Drug Therapy, Combination; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Parkinson Disease; Pergolide; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2

1984
[Follow-up of the effect of prolactin-lowering substances].
    Acta Universitatis Palackianae Olomucensis Facultatis Medicae, 1981, Volume: 101

    Topics: Adult; Amenorrhea; Bromocriptine; Ergolines; Female; Humans; Hyperprolactinemia; Infertility, Female; Lisuride; Menstruation; Prolactin

1981
Evaluation and treatment of hyperprolactinaemia in women of childbearing age.
    Acta Universitatis Palackianae Olomucensis Facultatis Medicae, 1981, Volume: 101

    Topics: Adenoma; Adult; Amenorrhea; Bromocriptine; Ergolines; Female; Galactorrhea; Humans; Hyperprolactinemia; Lisuride; Pituitary Neoplasms; Pregnancy; Prolactin

1981
Neurochemical effects of some ergot derivatives: a basis for their antiparkinson actions.
    Journal of neural transmission, 1981, Volume: 51, Issue:1-2

    Topics: Acetylcholine; Adenylyl Cyclases; Animals; Antiparkinson Agents; Brain; Bromocriptine; Cerebral Cortex; Corpus Striatum; Cyclic AMP; Dopamine; Ergolines; In Vitro Techniques; Kinetics; Male; Nitriles; Norepinephrine; Rats

1981
Dopamine agonists in the treatment of Parkinson's disease.
    Advances in neurology, 1983, Volume: 37

    Topics: Blood Pressure; Bromocriptine; Disability Evaluation; Domperidone; Dopamine; Ergolines; Follow-Up Studies; Humans; Levodopa; Parkinson Disease; Pleural Effusion; Receptors, Neurotransmitter; Time Factors

1983
Hormonal regulation of testicular LH/hCG receptors in rat.
    Experimental and clinical endocrinology, 1983, Volume: 82, Issue:1

    Topics: Animals; Bromocriptine; Chorionic Gonadotropin; Ergolines; Estradiol; Gonadotropins, Equine; Hormones; Male; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, LH; Testis; Testosterone

1983
Effect of dopaminergic drugs on hypothalamic and pituitary immunoreactive beta-endorphin concentrations in the rat.
    Life sciences, 1983, Oct-24, Volume: 33, Issue:17

    Topics: Animals; beta-Endorphin; beta-Lipotropin; Bromocriptine; Endorphins; Ergolines; Hypothalamus; Lisuride; Male; Pituitary Gland; Rats; Rats, Inbred Strains; Receptors, Dopamine

1983
In vitro selectivity of lisuride and other ergot derivatives for alpha 1- and alpha 2-adrenoceptors.
    European journal of pharmacology, 1984, Jan-13, Volume: 97, Issue:1-2

    Topics: Animals; Bromocriptine; Clonidine; Dose-Response Relationship, Drug; Ergolines; Ergot Alkaloids; Guinea Pigs; Ileum; In Vitro Techniques; Lisuride; Muscle Contraction; Receptors, Adrenergic, alpha; Spleen

1984
Mesulergine, a new dopamine agonist: effects on anterior pituitary function and kinetics.
    Clinical pharmacology and therapeutics, 1984, Volume: 36, Issue:5

    Topics: Absorption; Adult; Analysis of Variance; Biological Availability; Bromocriptine; Ergolines; Humans; Male; Pituitary Gland, Anterior; Pituitary Hormone-Releasing Hormones; Prolactin; Radioimmunoassay

1984
Autoreceptors mediate the inhibition of dopamine synthesis by bromocriptine and lisuride in rats.
    European journal of pharmacology, 1983, Aug-05, Volume: 91, Issue:4

    Topics: 4-Butyrolactone; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Brain Chemistry; Bromocriptine; Dihydroxyphenylalanine; Dopamine; Dose-Response Relationship, Drug; Ergolines; Lisuride; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sulpiride; Time Factors

1983
Long-term monolayer culture of human anterior pituitary cells: functional validation of a method.
    Fertility and sterility, 1984, Volume: 41, Issue:1

    Topics: Bromocriptine; Cells, Cultured; Ergolines; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Methods; Pergolide; Pituitary Gland, Anterior; Prolactin; Thyrotropin-Releasing Hormone; Time Factors

1984
Psychotic reactions during treatment of pituitary tumours with dopamine agonists.
    British medical journal (Clinical research ed.), 1984, Oct-27, Volume: 289, Issue:6452

    Topics: Acromegaly; Adenoma; Adult; Bromocriptine; Ergolines; Female; Humans; Lisuride; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Psychoses, Substance-Induced

1984
On some central effects of elymoclavine.
    Acta physiologica et pharmacologica Bulgarica, 1984, Volume: 10, Issue:4

    Topics: Animals; Bromocriptine; Catalepsy; Central Nervous System; Corpus Striatum; Ergolines; Exploratory Behavior; Haloperidol; Humans; Hydroxydopamines; Mice; Oxidopamine; Pimozide; Rats; Receptors, Dopamine; Seizures; Stereotyped Behavior; Sympathetic Nervous System

1984
[Bromocriptine and methergoline in the inhibition of puerperal lactation].
    Minerva ginecologica, 1984, Volume: 36, Issue:6

    Topics: Adolescent; Adult; Bromocriptine; Depression, Chemical; Drug Evaluation; Ergolines; Estradiol; Female; Humans; Lactation; Metergoline; Postpartum Period; Pregnancy; Prolactin; Time Factors

1984
Enhancement of the cyclic motor activity of the ovine small intestine by lysergic acid derivatives. Mechanism and significance.
    Gastroenterology, 1984, Volume: 87, Issue:5

    Topics: Action Potentials; Animals; Bromocriptine; Duodenum; Ergolines; Gastrointestinal Motility; Intestine, Small; Lysergic Acid; Methylergonovine; Methysergide; Periodicity; Pyloric Antrum; Serotonin; Serotonin Antagonists; Sheep; Vagotomy

1984
Mechanism of action and tolerance of mesulergine.
    Clinical pharmacology and therapeutics, 1984, Volume: 36, Issue:5

    Topics: Adenoma; Administration, Oral; Adult; Animals; Blood Pressure; Bromocriptine; Cells, Cultured; Dopamine Antagonists; Drug Evaluation; Ergolines; Female; Humans; Hypotension; Male; Menstruation; Middle Aged; Nausea; Pituitary Neoplasms; Prolactin; Radioimmunoassay; Random Allocation; Rats

1984
Bromocriptine and lisuride in dystonias.
    Neurology, 1984, Volume: 34, Issue:1

    Topics: Bromocriptine; Dystonia; Ergolines; Humans; Lisuride

1984
Pergolide versus bromocriptine.
    Neurology, 1984, Volume: 34, Issue:2

    Topics: Bromocriptine; Ergolines; Humans; Parkinson Disease; Pergolide

1984
Metergoline and bromocriptine in the management of tumoral and idiopathic hyperprolactinemia.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1983, Volume: 15, Issue:8

    Topics: Adenoma; Adult; Amenorrhea; Anovulation; Bromocriptine; Ergolines; Female; Galactorrhea; Humans; Metergoline; Middle Aged; Pituitary Neoplasms; Pregnancy; Prolactin

1983
A comparison of the potencies of various dopamine receptor agonists in models for pre- and postsynaptic receptor activity.
    Naunyn-Schmiedeberg's archives of pharmacology, 1983, Volume: 324, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; 4-Butyrolactone; Animals; Behavior, Animal; Bromocriptine; Dopamine; Ergolines; Homovanillic Acid; Models, Neurological; Motor Activity; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine

1983
Treatment of Parkinson's disease with 8-alpha-amino-ergoline, CU 32-085.
    Neurology, 1983, Volume: 33, Issue:4

    Topics: Activities of Daily Living; Adult; Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Ergolines; Female; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Psychomotor Performance; Receptors, Dopamine

1983
Therapeutic results with a new ergoline derivate (8-alpha-amino-ergoline, CU 32-085) in parkinsonian patients.
    Advances in neurology, 1984, Volume: 40

    Topics: Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease

1984
Bromocriptine and lisuride in Parkinson's disease.
    Advances in neurology, 1984, Volume: 40

    Topics: Adult; Aged; Bromocriptine; Carboxy-Lyases; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease

1984
Serum prolactin and ovarian function after discontinuation of drug treatment for hyperprolactinaemia: a study with bromocriptine and metergoline.
    British journal of obstetrics and gynaecology, 1984, Volume: 91, Issue:3

    Topics: Adenoma; Amenorrhea; Bromocriptine; Ergolines; Female; Humans; Metergoline; Ovulation; Pituitary Neoplasms; Progesterone; Prolactin; Prospective Studies; Recurrence

1984
Dopaminergic treatment of acromegaly: different effects on hormone secretion and tumor size.
    The Journal of clinical endocrinology and metabolism, 1984, Volume: 58, Issue:6

    Topics: Acromegaly; Adenoma; Adult; Aged; Bromocriptine; Ergolines; Female; Growth Hormone; Humans; Lisuride; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed

1984
Hyperprolactinemic primary amenorrhea: case report with successful prolactin-lowering treatment and review of the literature.
    Gynecologic and obstetric investigation, 1980, Volume: 11, Issue:6

    Topics: Adult; Amenorrhea; Bromocriptine; Ergolines; Female; Follicle Stimulating Hormone; Galactorrhea; Humans; Lactation Disorders; Luteinizing Hormone; Metergoline; Pregnancy; Progesterone; Prolactin; Sulpiride; Thyrotropin-Releasing Hormone

1980
Influence of prolactin and growth hormone on rat mammary tumors induced by N-nitrosomethylurea.
    Cancer research, 1982, Volume: 42, Issue:1

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Bromocriptine; Ergolines; Female; Growth Hormone; Hypophysectomy; Male; Mammary Neoplasms, Experimental; Methylnitrosourea; Nitrosourea Compounds; Pergolide; Prolactin; Rats

1982
Binding of antiparkinsonian ergot derivatives to the dopamine receptor.
    Psychopharmacology, 1981, Volume: 75, Issue:2

    Topics: Animals; Antiparkinson Agents; Apomorphine; Bromocriptine; Caudate Nucleus; Ergolines; Lisuride; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone

1981
Effect of bromocriptine and metergoline in the treatment of hyperprolactinaemic states.
    Acta endocrinologica, 1982, Volume: 100, Issue:1

    Topics: Adenoma; Adolescent; Adult; Bromocriptine; Ergolines; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menopause; Metergoline; Middle Aged; Pituitary Neoplasms; Pregnancy; Progesterone; Prolactin; Testosterone

1982
Growth hormone and changes in the secretion of thyrotropic hormone after thyrotropin-releasing hormone (TRH): ineffectiveness of dopaminergic stimulation.
    Endokrinologie, 1982, Volume: 80, Issue:2

    Topics: Acromegaly; Adult; Bromocriptine; Ergolines; Female; Growth Hormone; Humans; Lisuride; Male; Middle Aged; Receptors, Dopamine; Thyrotropin; Thyrotropin-Releasing Hormone; Triiodothyronine

1982
Bromocriptine and lisuride in Parkinson disease.
    Annals of neurology, 1983, Volume: 13, Issue:1

    Topics: Aged; Bromocriptine; Carbidopa; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Lisuride; Middle Aged; Parkinson Disease

1983
Progressive supranuclear palsy: clinical features and response to treatment in 16 patients.
    Annals of neurology, 1983, Volume: 13, Issue:3

    Topics: Aged; Bromocriptine; Bulbar Palsy, Progressive; Ergolines; Female; Follow-Up Studies; Humans; Male; Middle Aged; Parkinson Disease; Pergolide

1983
Comparative efficacy of pergolide and bromocriptine in patients with advanced Parkinson's disease.
    Advances in neurology, 1983, Volume: 37

    Topics: Aged; Bromocriptine; Disability Evaluation; Drug Evaluation; Ergolines; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide; Time Factors

1983
Dopa dose-dependent sexual deviation.
    The British journal of psychiatry : the journal of mental science, 1983, Volume: 142

    Topics: Antiparkinson Agents; Bromocriptine; Carbidopa; Ergolines; Humans; Male; Middle Aged; Paraphilic Disorders; Parkinson Disease; Pergolide

1983
Bromocriptine--lisuride cross tolerance.
    Italian journal of neurological sciences, 1983, Volume: 4, Issue:1

    Topics: Aged; Bromocriptine; Drug Tolerance; Ergolines; Humans; Lisuride; Male; Middle Aged; Parkinson Disease

1983
Dopaminergic inhibition of prolactin synthesis and prolactin messenger RNA accumulation in cultured pituitary cells.
    The Journal of biological chemistry, 1980, Sep-10, Volume: 255, Issue:17

    Topics: Animals; Bromocriptine; DNA; Dopamine; Epinephrine; Ergolines; Female; Kinetics; Norepinephrine; Nucleic Acid Hybridization; Pituitary Gland; Prolactin; Protein Biosynthesis; Rats; RNA, Messenger

1980
Ergot drugs suppress plasma prolactin and lactation but not aggression in parturient mice.
    Hormones and behavior, 1980, Volume: 14, Issue:4

    Topics: Aggression; Animals; Body Weight; Bromocriptine; Ergolines; Ergot Alkaloids; Female; Humans; Lactation; Male; Mice; Pregnancy; Prolactin; Sucking Behavior

1980
Bromocriptine and alpha-ergocryptine do not inhibit oxytocin secretion in the lactating rat.
    The Journal of endocrinology, 1981, Volume: 89, Issue:1

    Topics: Animals; Bromocriptine; Ergolines; Female; Lactation; Oxytocin; Pregnancy; Prolactin; Rats; Secretory Rate

1981
The effect of ergocornine, bromocriptine, D-6-methyl-8-ergolinylacetamide and D-6-propyl-8-ergolinylacetamide on the prolactin secretion in goats. Comparison of potency and duration of effect.
    Arzneimittel-Forschung, 1982, Volume: 32, Issue:4

    Topics: Animals; Bromocriptine; Dose-Response Relationship, Drug; Ergolines; Female; Goats; Lactation; Pregnancy; Prolactin; Time Factors

1982
Ergot drugs suppress plasma levels of prolactin (PRL) but not growth hormone (GH), luteinizing hormone (LH) or corticosterone (CORT) in parturient mice.
    Pharmacology, biochemistry, and behavior, 1982, Volume: 17, Issue:4

    Topics: Animals; Bromocriptine; Corticosterone; Ergolines; Female; Growth Hormone; Labor, Obstetric; Lactation; Luteinizing Hormone; Mice; Pregnancy; Prolactin

1982
Possible involvement of dopamine in the release of prolactin-like hormone from bullfrog pituitary gland.
    General and comparative endocrinology, 1980, Volume: 41, Issue:2

    Topics: Animals; Bromocriptine; Dopamine; Ergolines; Metamorphosis, Biological; Organ Culture Techniques; Pimozide; Pituitary Gland, Anterior; Prolactin; Rana catesbeiana; Tail

1980
Long-term treatment of acromegaly with lisuride: differences of effect on growth hormone and somatomedin.
    Endokrinologie, 1981, Volume: 78, Issue:2-3

    Topics: Acromegaly; Adult; Alkaline Phosphatase; Blood Glucose; Bone and Bones; Bromocriptine; Ergolines; Female; Glucose Tolerance Test; Growth Hormone; Humans; Hydroxyproline; Insulin; Isoenzymes; Lisuride; Male; Somatomedins

1981
Metergoline as a lactation inhibitor.
    The Journal of reproductive medicine, 1982, Volume: 27, Issue:4

    Topics: Bromocriptine; Dose-Response Relationship, Drug; Ergolines; Female; Humans; Lactation; Metergoline; Postpartum Period; Pregnancy; Prolactin; Time Factors

1982
Effect of haloperidol pre- and post-treatment on the ability of pergolide and bromocriptine to antagonize the gamma-butyrolactone-induced increase in brain dopamine in rats.
    Biochemical pharmacology, 1982, Jun-15, Volume: 31, Issue:12

    Topics: 4-Butyrolactone; Animals; Brain Chemistry; Bromocriptine; Dopamine; Ergolines; Furans; Haloperidol; Pergolide; Rats; Rats, Inbred Strains

1982
Effects of pergolide and bromocriptine on male rat sexual behavior.
    Journal of neural transmission, 1982, Volume: 54, Issue:3-4

    Topics: Animals; Bromocriptine; Ergolines; Male; Pergolide; Rats; Sexual Behavior, Animal

1982
Locomotor hypokinesia in the reserpine-treated rat: drug effects from the corpus striatum and nucleus accumbens.
    Pharmacology, biochemistry, and behavior, 1982, Volume: 17, Issue:2

    Topics: Animals; Antiparkinson Agents; Apomorphine; Bromocriptine; Corpus Striatum; Ergolines; Locomotion; Male; Motor Activity; Nucleus Accumbens; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reserpine; Septal Nuclei

1982
Pergolide, a potent long-acting dopamine-receptor agonist.
    Clinical pharmacology and therapeutics, 1980, Volume: 27, Issue:5

    Topics: Adult; Blood Pressure; Bromocriptine; Circadian Rhythm; Dose-Response Relationship, Drug; Ergolines; Ergot Alkaloids; Growth Hormone; Hormones; Humans; Male; Middle Aged; Myocardial Contraction; Pergolide; Perphenazine; Prolactin; Receptors, Dopamine; Time Factors

1980
Lisuride in parkinsonism.
    Neurology, 1981, Volume: 31, Issue:4

    Topics: Adult; Aged; Bromocriptine; Double-Blind Method; Ergolines; Humans; Lisuride; Middle Aged; Movement; Parkinson Disease; Placebos; Reaction Time; Receptors, Serotonin; Sleep

1981
[Comparative clinical evaluation of the effectiveness of methergoline and bromocriptine in inhibiting puerperal lactation].
    Rivista italiana di ginecologia, 1980, Volume: 59, Issue:2-3

    Topics: Adult; Bromocriptine; Ergolines; Female; Humans; Lactation; Metergoline; Pregnancy

1980
Treatment of hyperprolactinemic states with different drugs: a study with bromocriptine, metergoline, and lisuride.
    Fertility and sterility, 1982, Volume: 37, Issue:1

    Topics: Adenoma; Adolescent; Adult; Amenorrhea; Bromocriptine; Erectile Dysfunction; Ergolines; Female; Galactorrhea; Humans; Lisuride; Male; Metergoline; Middle Aged; Ovarian Function Tests; Pituitary Neoplasms; Pregnancy; Prolactin; Visual Fields

1982
Beneficial effects of lisuride in Meige disease.
    Neurology, 1982, Volume: 32, Issue:4

    Topics: Apomorphine; Bromocriptine; Ergolines; Female; Humans; Lisuride; Lymphedema; Male; Middle Aged

1982
[Experience obtained from prolactin-inhibiting therapy for functional sterility (author's transl)].
    Zentralblatt fur Gynakologie, 1980, Volume: 102, Issue:20

    Topics: Amenorrhea; Bromocriptine; Ergolines; Female; Galactorrhea; Humans; Infertility, Female; Lisuride; Oligomenorrhea; Pregnancy; Prolactin

1980
Two new dopamine agonists that are long acting in vivo but short acting in vitro.
    Clinical endocrinology, 1980, Volume: 13, Issue:6

    Topics: Animals; Bromocriptine; Dose-Response Relationship, Drug; Ergolines; In Vitro Techniques; Male; Pergolide; Prolactin; Rats; Secretory Rate; Time Factors

1980
The effects of lisuride and some other dopaminergic agonists on receptor binding in human brain.
    Journal of neural transmission, 1981, Volume: 51, Issue:1-2

    Topics: Brain; Bromocriptine; Ergolines; Humans; Kinetics; Lisuride; Receptors, Dopamine; Spiperone

1981
Characterization of normal and supersensitive dopamine receptors: effects of ergot drugs and neuropeptides.
    Journal of neural transmission, 1981, Volume: 51, Issue:1-2

    Topics: Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Brain; Bromocriptine; Caudate Nucleus; Corpus Striatum; Ergolines; Kinetics; Organ Specificity; Pergolide; Putamen; Rats; Receptors, Dopamine

1981
On the stereochemistry of dopaminergic ergoline derivatives.
    Molecular pharmacology, 1981, Volume: 19, Issue:3

    Topics: Apomorphine; Bromocriptine; Dopamine; Ergolines; Molecular Conformation; Stereoisomerism

1981
Size reduction of macroprolactinomas by bromocriptine or lisuride treatment.
    The Journal of clinical endocrinology and metabolism, 1981, Volume: 53, Issue:4

    Topics: Adolescent; Adult; Bromocriptine; Ergolines; Female; Humans; Lisuride; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed

1981
[Inhibition of puerperal lactation with bromocriptine and methergoline. Clinical evaluation].
    Rivista italiana di ginecologia, 1980, Volume: 59, Issue:4-5

    Topics: Adolescent; Adult; Bromocriptine; Ergolines; Female; Humans; Lactation; Metergoline; Pregnancy

1980
Lactation-inhibiting and prolactin-lowering effect of lisuride and bromocriptine: a comparative study.
    European journal of obstetrics, gynecology, and reproductive biology, 1981, Volume: 12, Issue:5

    Topics: Bromocriptine; Double-Blind Method; Ergolines; Female; Humans; Lactation; Lisuride; Postpartum Period; Pregnancy; Prolactin

1981
Lisuride in the treatment of Parkinsonism.
    Acta neurologica Scandinavica, 1980, Volume: 62, Issue:6

    Topics: Administration, Oral; Aged; Bromocriptine; Drug Therapy, Combination; Ergolines; Humans; Injections, Intravenous; Levodopa; Lisuride; Middle Aged; Parkinson Disease

1980
Effect of octreotide on circulating IGF-I chromatographic profile: evidence for an inhibitory action on the formation of the 150-kDa ternary complex.
    Clinical endocrinology, 1995, Volume: 42, Issue:2

    Topics: Acromegaly; Adult; Bromocriptine; Cabergoline; Carrier Proteins; Ergolines; Growth Hormone; Humans; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Middle Aged; Octreotide

1995
In vivo effect of cabergoline, a dopamine agonist, on estrogen-induced rat pituitary tumors.
    Endocrine journal, 1995, Volume: 42, Issue:2

    Topics: Animals; Antineoplastic Agents; Bromocriptine; Cabergoline; Cytoplasmic Granules; Dopamine Agonists; Endoplasmic Reticulum; Ergolines; Estradiol; Female; Microscopy, Electron; Organ Size; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred F344

1995
Suggestive evidence for a DA D3 receptor-mediated increase in the release of oxytocin in the male rat.
    Neuroreport, 1995, Jun-19, Volume: 6, Issue:9

    Topics: Animals; Bromocriptine; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Male; Oxytocin; Prolactin; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Sex Factors; Tetrahydronaphthalenes

1995
Effect of cabergoline, a dopamine agonist, on estrogen-induced rat pituitary tumors: in vitro culture studies.
    Endocrine journal, 1995, Volume: 42, Issue:3

    Topics: Animals; Antineoplastic Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Estradiol; Female; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred F344; Tumor Cells, Cultured

1995
X-ray crystal structure and conformational analysis of N-(3-dimethylaminopropyl)-N-(ethylaminocarbonyl)-6-(2-propenyl)er goline -8 beta-carboxamide (Cabergoline): comparison with bromocriptine and lisuride and a hypothesis for its high dopaminergic activi
    Farmaco (Societa chimica italiana : 1989), 1995, Volume: 50, Issue:3

    Topics: Bromocriptine; Cabergoline; Crystallography, X-Ray; Dopamine Agonists; Ergolines; Lisuride; Molecular Conformation; Structure-Activity Relationship

1995
Possible sites of dopaminergic inhibition of gonadotropin release from the pituitary of a teleost fish, tilapia.
    Molecular and cellular endocrinology, 1995, Volume: 109, Issue:1

    Topics: Animals; Apomorphine; Arachidonic Acid; Bromocriptine; Calcimycin; Calcium; Cells, Cultured; Colforsin; Cyclic AMP; Diglycerides; Dopamine; Dopamine Agonists; Ergolines; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Ionomycin; Pituitary Gland; Quinpirole; Signal Transduction; Tilapia

1995
Drenching sweats as an off phenomenon in Parkinson's disease: treatment and relation to plasma levodopa profile.
    Annals of neurology, 1995, Volume: 37, Issue:1

    Topics: Aged; Bromocriptine; Cabergoline; Chorea; Dopamine Agonists; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Monitoring, Physiologic; Parkinson Disease; Pergolide; Sweating

1995
Lack of cross-sensitization between the locomotor-activating effects of bromocriptine and those of cocaine or heroin.
    Psychopharmacology, 1993, Volume: 110, Issue:4

    Topics: Animals; Bromocriptine; Cocaine; Cues; Dopamine Agonists; Environment; Ergolines; Heroin; Male; Motor Activity; Quinpirole; Rats; Receptors, Dopamine D2

1993
Involvement of D1 dopamine receptor mechanism in ischemia-induced impairment of CA1 presynaptic fiber spikes in rat hippocampal slices.
    Brain research, 1994, Nov-28, Volume: 665, Issue:1

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Action Potentials; Analysis of Variance; Animals; Benzazepines; Brain Ischemia; Bromocriptine; Dopamine Agonists; Ergolines; Hippocampus; In Vitro Techniques; Male; Nerve Fibers; Presynaptic Terminals; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D1; Sulpiride

1994
Opposing roles for D-1 and D-2 dopamine receptors in the regulation of lower esophageal sphincter motility in the rat.
    Life sciences, 1994, Volume: 54, Issue:15

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Bromocriptine; Dihydroergotoxine; Dopamine; Dopamine Agents; Ergolines; Esophagogastric Junction; Fenoldopam; In Vitro Techniques; Male; Peristalsis; Phentolamine; Prazosin; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2

1994
Cabergoline treated hyperprolactinaemia results in pregnancy in a bromocriptine intolerant patient after seventeen years of infertility.
    British journal of obstetrics and gynaecology, 1994, Volume: 101, Issue:4

    Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agents; Ergolines; Female; Humans; Hyperprolactinemia; Infertility, Female; Pregnancy

1994
Progress in the management of hyperprolactinemia.
    The New England journal of medicine, 1994, Oct-06, Volume: 331, Issue:14

    Topics: Amenorrhea; Bromocriptine; Cabergoline; Dopamine Agents; Ergolines; Female; Humans; Hyperprolactinemia

1994
Comparative analysis of the behaviors evoked by bromocriptine and quinpirole (LY 171555) in adult cats.
    Progress in neuro-psychopharmacology & biological psychiatry, 1994, Volume: 18, Issue:3

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Behavior, Animal; Bromocriptine; Cats; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Ergolines; Female; Male; Quinpirole; Receptors, Dopamine D2

1994
Structural elucidation of two novel ergot alkaloid impurities in alpha-ergokryptine and bromokryptine.
    Acta pharmaceutica Hungarica, 1994, Volume: 64, Issue:3

    Topics: Bromocriptine; Chromatography, High Pressure Liquid; Drug Contamination; Ergolines; Ergot Alkaloids; Magnetic Resonance Spectroscopy; Molecular Structure

1994
High affinity of ergopeptides for cytochromes P450 3A. Importance of their peptide moiety for P450 recognition and hydroxylation of bromocriptine.
    European journal of biochemistry, 1994, Aug-01, Volume: 223, Issue:3

    Topics: Animals; Bromocriptine; Cytochrome P-450 CYP2E1; Cytochrome P-450 Enzyme System; Dexamethasone; Dihydroergotamine; Ergolines; Humans; Hydroxylation; Isoenzymes; Lysergic Acid; Microsomes, Liver; Mixed Function Oxygenases; NADP; Oxidation-Reduction; Peptides; Rats; Recombinant Proteins; Saccharomyces cerevisiae; Substrate Specificity

1994
Regulation of striatal aromatic L-amino acid decarboxylase: effects of blockade or activation of dopamine receptors.
    European journal of pharmacology, 1993, Jul-20, Volume: 238, Issue:2-3

    Topics: Animals; Antipsychotic Agents; Aromatic-L-Amino-Acid Decarboxylases; Benzazepines; Bromocriptine; Corpus Striatum; Cycloheximide; Dextroamphetamine; Dopamine D2 Receptor Antagonists; Drug Interactions; Ergolines; Flupenthixol; Male; Pimozide; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Remoxipride; Stereoisomerism

1993
Depression of the monosynaptic reflex by apomorphine or bromocriptine is not mediated by D1/D2 receptors.
    Neuropharmacology, 1993, Volume: 32, Issue:8

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzamides; Bromocriptine; Decerebrate State; Depression, Chemical; Dopamine Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Ergolines; Male; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Reflex, Monosynaptic; Sulpiride; Synaptic Transmission

1993
Rapid identification of ergot derivatives by 1H-NMR spectroscopy.
    Journal of pharmaceutical and biomedical analysis, 1994, Volume: 12, Issue:1

    Topics: Bromocriptine; Ergolines; Ergotamine; Magnetic Resonance Spectroscopy; Reference Standards; Stereoisomerism

1994
Mass spectrometry as an aid to the identification of ergots and dihydroergots: comparison of hard and soft ionization techniques.
    Journal of pharmaceutical and biomedical analysis, 1994, Volume: 12, Issue:1

    Topics: Bromocriptine; Ergolines; Ergotamine; Ergotamines; Molecular Weight; Spectrometry, Mass, Fast Atom Bombardment

1994
Vaginal cabergoline in the treatment of hyperprolactinemic patients intolerant to oral dopaminergics.
    Fertility and sterility, 1996, Volume: 65, Issue:2

    Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Vagina

1996
Differential effects of three dopamine receptor agonists in MPTP-treated monkeys.
    Journal of neural transmission. Parkinson's disease and dementia section, 1995, Volume: 10, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Macaca fascicularis; Parkinson Disease, Secondary; Pergolide

1995
Effects of selective serotonin and dopamine agonists on plasma levels of glucose, insulin and glucagon in the rat.
    Neuroendocrinology, 1996, Volume: 63, Issue:3

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Blood Glucose; Bromocriptine; Buspirone; Dopamine Agonists; Ergolines; Glucagon; Insulin; Male; Quinpirole; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists; Tetrahydronaphthalenes

1996
Effects of dopamine agonists and antagonists on cocaine-induced operant responding for a cocaine-associated stimulus.
    Psychopharmacology, 1996, Volume: 126, Issue:4

    Topics: Animals; Benzazepines; Bromocriptine; Cocaine; Conditioning, Operant; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Ergolines; Male; Raclopride; Rats; Rats, Wistar; Reinforcement, Psychology; Salicylamides; Self Administration

1996
Dopamine receptor affinities in vitro and stereotypic activities in vivo of cabergoline in rats.
    Biological & pharmaceutical bulletin, 1996, Volume: 19, Issue:9

    Topics: Animals; Benzazepines; Binding, Competitive; Bromocriptine; Cabergoline; Dopamine Agonists; Dopamine Antagonists; Ergolines; In Vitro Techniques; Male; Pergolide; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereotyped Behavior

1996
Effect of different dopaminergic agents in the treatment of acromegaly.
    The Journal of clinical endocrinology and metabolism, 1997, Volume: 82, Issue:2

    Topics: Acromegaly; Adult; Aminoquinolines; Bromocriptine; Cabergoline; Delayed-Action Preparations; Dopamine Agonists; Ergolines; Female; Human Growth Hormone; Humans; Male; Middle Aged; Prolactin

1997
Late development of resistance to bromocriptine in a patient with macroprolactinoma.
    Hormone research, 1998, Volume: 49, Issue:5

    Topics: Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance, Neoplasm; Ergolines; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma

1998
Therapeutic effects of dopamine D1/D2 receptor agonists on detrusor hyperreflexia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian cynomolgus monkeys.
    The Journal of pharmacology and experimental therapeutics, 1998, Volume: 286, Issue:1

    Topics: Animals; Bromocriptine; Dopamine Agonists; Ergolines; Macaca fascicularis; Male; MPTP Poisoning; Parkinson Disease, Secondary; Pergolide; Receptors, Dopamine D1; Receptors, Dopamine D2; Reflex; Triazoles; Urinary Bladder; Urination

1998
Pharmacological effects of BAM-1120, a novel ergoline derivative, on central dopaminergic functions in rats.
    Methods and findings in experimental and clinical pharmacology, 1998, Volume: 20, Issue:7

    Topics: Animals; Bromocriptine; Dopamine; Dopamine Agents; Dopamine Agonists; Ergolines; Estradiol; Female; Hyperprolactinemia; Lisuride; Male; Rats; Rats, Wistar; Reserpine; Rotation; Stereotyped Behavior; Sympathectomy, Chemical; Sympatholytics

1998
New hyperprolactinemia and anovulation model in common marmoset (Callithrix jacchus) and effect of cabergoline.
    European journal of pharmacology, 1999, Feb-26, Volume: 368, Issue:1

    Topics: Animals; Anovulation; Bromocriptine; Cabergoline; Callithrix; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Ergolines; Estradiol; Female; Hyperprolactinemia; Menstrual Cycle; Progesterone; Prolactin; Sulpiride; Time Factors

1999
Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients.
    The Journal of clinical endocrinology and metabolism, 1999, Volume: 84, Issue:7

    Topics: Adenoma; Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance; Drug Tolerance; Ergolines; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Pituitary Neoplasms; Pregnancy; Retrospective Studies; Sex Characteristics

1999
Ergocryptine and other ergot alkaloids stimulate the release of [3H]dopamine from rat striatal synaptosomes.
    Journal of animal science, 1999, Volume: 77, Issue:7

    Topics: Animals; Bromocriptine; Corpus Striatum; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Ergonovine; Ergotamine; Male; Rats; Rats, Sprague-Dawley; Synaptosomes

1999
Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization.
    Clinical endocrinology, 2000, Volume: 52, Issue:3

    Topics: Adolescent; Adult; Aminoquinolines; Analysis of Variance; Biomarkers; Bone Density; Bone Remodeling; Bromocriptine; Cabergoline; Case-Control Studies; Collagen; Collagen Type I; Dopamine Agonists; Ergolines; Female; Femur Neck; Humans; Longitudinal Studies; Lumbar Vertebrae; Male; Middle Aged; Osteocalcin; Osteoporosis; Peptides; Pituitary Neoplasms; Prolactinoma; Regression Analysis

2000
Comparative effects of repeated administration of dopamine agonists on circling behavior in rats.
    Journal of neural transmission (Vienna, Austria : 1996), 2000, Volume: 107, Issue:10

    Topics: Animals; Benzothiazoles; Brain; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Administration Schedule; Ergolines; Indoles; Male; Motor Activity; Oxidopamine; Parkinsonian Disorders; Pergolide; Pramipexole; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Dopamine D1; Receptors, Dopamine D2; Thiazoles

2000
Use of the dopamine agonists bromocriptine and cabergoline in the management of risperidone-induced hyperprolactinemia in patients with psychotic disorders.
    Journal of endocrinological investigation, 2000, Volume: 23, Issue:11

    Topics: Adult; Antipsychotic Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Hypogonadism; Male; Middle Aged; Prolactin; Psychotic Disorders; Risperidone

2000
Treatment versus no treatment of transient hyperprolactinemia in patients undergoing intracytoplasmic sperm injection programs.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2000, Volume: 14, Issue:6

    Topics: Adult; Bromocriptine; Cabergoline; Chorionic Gonadotropin; Dopamine Agonists; Embryo Transfer; Ergolines; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Hyperprolactinemia; Luteolytic Agents; Oocytes; Prolactin; Retrospective Studies; Sperm Injections, Intracytoplasmic; Treatment Outcome; Triptorelin Pamoate

2000
Pituitary adenomas in childhood and adolescence. Clinical analysis of 10 cases.
    Journal of endocrinological investigation, 2001, Volume: 24, Issue:2

    Topics: Acromegaly; Adenoma; Adolescent; Amenorrhea; Bromocriptine; Cabergoline; Child; Ergolines; Female; Headache; Human Growth Hormone; Humans; Male; Neoplasm Recurrence, Local; Octreotide; Pituitary Neoplasms; Prolactinoma; Puberty, Delayed; Radiotherapy; Treatment Outcome; Vision Disorders; Visual Fields

2001
Laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method.
    The Journal of clinical endocrinology and metabolism, 2001, Volume: 86, Issue:6

    Topics: Adult; Bromocriptine; Cabergoline; Cohort Studies; Ergolines; Female; Fertility; Headache; Humans; Magnetic Resonance Imaging; Medical Records; Menstruation; Menstruation Disturbances; Middle Aged; Pituitary Gland; Polyethylene Glycols; Prolactin; Tomography, X-Ray Computed

2001
Efficacy and tolerability of dopamine agonists in a parkinsonian population.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2001, Volume: 22, Issue:1

    Topics: Age of Onset; Aged; Aging; Benzothiazoles; Bromocriptine; Dopamine Agonists; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Drug Tolerance; Ergolines; Female; Follow-Up Studies; Humans; Indoles; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Retrospective Studies; Thiazoles; Treatment Outcome

2001
Cabergoline and hyperprolactinaemia: new preparation. Better than bromocriptine.
    Prescrire international, 2000, Volume: 9, Issue:45

    Topics: Bromocriptine; Clinical Trials as Topic; Dopamine Agonists; Ergolines; Female; France; Humans; Hyperprolactinemia; Menstruation Disturbances; Treatment Outcome

2000
Successful treatment of a large macroprolactinoma with cabergoline during pregnancy.
    Pituitary, 2001, Volume: 4, Issue:3

    Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma

2001
The novel use of very high doses of cabergoline and a combination of testosterone and an aromatase inhibitor in the treatment of a giant prolactinoma.
    The Journal of clinical endocrinology and metabolism, 2002, Volume: 87, Issue:10

    Topics: Adult; Anastrozole; Aromatase Inhibitors; Bromocriptine; Cabergoline; Dopamine Agonists; Enzyme Inhibitors; Ergolines; Hormone Replacement Therapy; Humans; Magnetic Resonance Imaging; Male; Nitriles; Pituitary Neoplasms; Prolactin; Prolactinoma; Sexual Dysfunction, Physiological; Testosterone; Treatment Outcome; Triazoles

2002
Prolactinomas, dopamine agonists and headache: two case reports.
    European journal of neurology, 2003, Volume: 10, Issue:2

    Topics: Adult; Amenorrhea; Anti-Inflammatory Agents, Non-Steroidal; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Headache; Humans; Indomethacin; Magnetic Resonance Imaging; Pituitary Neoplasms; Prolactin; Prolactinoma; Radiography

2003
Effects of dopamine agonists bromocriptine, pergolide, cabergoline, and SKF-38393 on GDNF, NGF, and BDNF synthesis in cultured mouse astrocytes.
    Life sciences, 2003, Jun-20, Volume: 73, Issue:5

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Astrocytes; Blotting, Northern; Brain-Derived Neurotrophic Factor; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Ergolines; Glial Cell Line-Derived Neurotrophic Factor; Mice; Mice, Inbred ICR; Nerve Growth Factor; Nerve Growth Factors; Pergolide; Receptors, Dopamine D1; Receptors, Dopamine D2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors

2003
[Clinical and therapeutic aspects of prolactinoma in men].
    Arquivos de neuro-psiquiatria, 2003, Volume: 61, Issue:4

    Topics: Adolescent; Adult; Age of Onset; Biomarkers; Bromocriptine; Cabergoline; Chi-Square Distribution; Dopamine Agonists; Ergolines; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Pituitary Neoplasms; Prolactin; Prolactinoma; Statistics, Nonparametric; Treatment Outcome

2003
Prolactinoma presenting as painful postganglionic Horner syndrome.
    Neurology, 2004, Apr-27, Volume: 62, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain; Bromocriptine; Cabergoline; Carotid Arteries; Dopamine Agonists; Ergolines; Horner Syndrome; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Migraine Disorders; Neoplasm Recurrence, Local; p-Hydroxyamphetamine; Pituitary Neoplasms; Prolactin; Prolactinoma; Remission Induction

2004
Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table.
    Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:11

    Topics: Adult; Adverse Drug Reaction Reporting Systems; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Domperidone; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Ergolines; Ergot Alkaloids; Feasibility Studies; Female; Follow-Up Studies; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Therapeutic Equivalency; Thiazoles

2004
Cardiopulmonary complications of ergot-derivative dopamine agonists.
    The Journal of clinical psychiatry, 2004, Volume: 65, Issue:10

    Topics: Antipsychotic Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Heart Valve Diseases; Humans; Hyperprolactinemia; Pergolide; Pulmonary Fibrosis; Risperidone

2004
Valvular heart disease and fibrotic reactions may be related to ergot dopamine agonists, but non-ergot agonists may also not be spared.
    Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:12

    Topics: Aortic Valve; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Fibrosis; Heart Valve Diseases; Humans; Parkinson Disease; Pergolide

2004
Nelson's syndrome: complete remission with cabergoline but not with bromocriptine or cyproheptadine treatment.
    Hormone research, 2004, Volume: 62, Issue:6

    Topics: Adenoma; Adrenalectomy; Adrenocorticotropic Hormone; Adult; Bromocriptine; Cabergoline; Cyproheptadine; Dopamine Agonists; Ergolines; Female; Hormone Replacement Therapy; Humans; Magnetic Resonance Imaging; Nelson Syndrome; Pituitary Neoplasms

2004
Dopamine agonist treatment before and after the birth reduces prolactin concentration but does not impair paternal responsiveness in Djungarian hamsters, Phodopus campbelli.
    Hormones and behavior, 2005, Volume: 47, Issue:3

    Topics: Animals; Bromocriptine; Cabergoline; Cricetinae; Dopamine Agonists; Ergolines; Female; Male; Parturition; Paternal Behavior; Phodopus; Pregnancy; Prolactin; Receptors, Dopamine D1; Receptors, Dopamine D2

2005
Effectiveness of adding dopamine agonist therapy to long-acting somatostatin analogues in the management of acromegaly.
    European journal of endocrinology, 2005, Volume: 152, Issue:4

    Topics: Acromegaly; Adult; Aged; Aged, 80 and over; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Prolactin; Retrospective Studies; Somatostatin

2005
The clinical characteristics of headache in patients with pituitary tumours.
    Brain : a journal of neurology, 2005, Volume: 128, Issue:Pt 8

    Topics: Adenoma; Adult; Aminoquinolines; Antineoplastic Agents, Hormonal; Bromocriptine; Cabergoline; Disability Evaluation; Dopamine Agonists; Ergolines; Female; Headache; Humans; Male; Migraine Disorders; Octreotide; Peptides, Cyclic; Pituitary Neoplasms; Severity of Illness Index; Somatostatin; Time Factors

2005
The use of high-dose daily cabergoline in an adolescent patient with macroprolactinoma.
    Journal of pediatric hematology/oncology, 2005, Volume: 27, Issue:6

    Topics: Bromocriptine; Cabergoline; Child; Dopamine Agonists; Ergolines; Humans; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactinoma; Treatment Outcome

2005
Long-term remission following withdrawal of dopamine agonist therapy in subjects with microprolactinomas.
    Clinical endocrinology, 2005, Volume: 63, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Recurrence; Remission Induction; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome

2005
Surgical outcomes in hyporesponsive prolactinomas: analysis of patients with resistance or intolerance to dopamine agonists.
    Pituitary, 2005, Volume: 8, Issue:1

    Topics: Adult; Aged; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance; Ergolines; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactin; Prolactinoma; Remission Induction; Retrospective Studies; Treatment Outcome

2005
Potential for long-term remission of microprolactinoma after withdrawal of dopamine-agonist therapy.
    Nature clinical practice. Endocrinology & metabolism, 2006, Volume: 2, Issue:3

    Topics: Adolescent; Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma

2006
Clinical presentation and response to therapy in patients with massive prolactin hypersecretion.
    Pituitary, 2007, Volume: 10, Issue:1

    Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactin; Prolactinoma; Testosterone

2007
Growth hormone excess with onset in adolescence: clinical appearance and long-term treatment outcome.
    Clinical endocrinology, 2007, Volume: 66, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Agents, Hormonal; Body Height; Body Mass Index; Bromocriptine; Cabergoline; Combined Modality Therapy; Ergolines; Female; Growth Hormone; Growth Hormone-Secreting Pituitary Adenoma; Headache; Hormone Antagonists; Humans; Insulin Resistance; Insulin-Like Growth Factor I; Male; Menstruation Disturbances; Octreotide; Peptides, Cyclic; Pituitary Neoplasms; Retrospective Studies; Somatostatin; Treatment Outcome

2007
Prolactin and autoimmune diseases in humans.
    Acta bio-medica : Atenei Parmensis, 2007, Volume: 78 Suppl 1

    Topics: Aminoquinolines; Animals; Arthritis, Rheumatoid; Autoimmune Diseases; Bromocriptine; Cabergoline; Cyclosporine; Dopamine Agonists; Double-Blind Method; Drug Therapy, Combination; Ergolines; Female; Humans; Hyperprolactinemia; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Mice; Mice, Knockout; Penicillamine; Prednisone; Prolactin; Rats; Receptors, Prolactin

2007
Dopaminergic treatment of nonfunctioning pituitary adenomas.
    Nature clinical practice. Endocrinology & metabolism, 2007, Volume: 3, Issue:8

    Topics: Adenoma; Bromocriptine; Cabergoline; Dopamine Agents; Dopamine Agonists; Ergolines; Humans; Pituitary Neoplasms; Prolactin

2007
Remarkable effects of cabergoline in a patient with huge prolactinoma resistant to high-dose bromocriptine: case report.
    Surgical neurology, 2008, Volume: 69, Issue:1

    Topics: Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance, Neoplasm; Ergolines; Humans; Male; Pituitary Neoplasms; Prolactinoma; Treatment Outcome

2008
The frequency of cardiac valvular regurgitation in Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2008, May-15, Volume: 23, Issue:7

    Topics: Aged; Aortic Valve Insufficiency; Azepines; Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Male; Mitral Valve Insufficiency; Parkinson Disease; Pergolide; Pramipexole; Prevalence

2008
Clinical profile and long term follow up of children and adolescents with prolactinomas.
    Pituitary, 2009, Volume: 12, Issue:3

    Topics: Adolescent; Amenorrhea; Bromocriptine; Cabergoline; Child; Dopamine Agonists; Ergolines; Female; Galactorrhea; Humans; Male; Pregnancy; Prolactin; Prolactinoma; Retrospective Studies; Treatment Outcome; Young Adult

2009
High risk factors for valvular heart disease from dopamine agonists in patients with Parkinson's disease.
    Journal of neural transmission (Vienna, Austria : 1996), 2009, Volume: 116, Issue:2

    Topics: Age Factors; Aged; Benzothiazoles; Bromocriptine; Cabergoline; Case-Control Studies; Dopamine Agonists; Echocardiography; Ergolines; Female; Heart Valve Diseases; Humans; Hypertension; Male; Parkinson Disease; Pergolide; Pramipexole; Risk Factors

2009
Cardiac and noncardiac fibrotic reactions caused by ergot-and nonergot-derived dopamine agonists.
    Movement disorders : official journal of the Movement Disorder Society, 2009, Jan-15, Volume: 24, Issue:1

    Topics: Aged; Aged, 80 and over; Apomorphine; Benzothiazoles; Bromocriptine; Cabergoline; Databases, Factual; Dopamine Agonists; Endomyocardial Fibrosis; Ergolines; Female; Fibrosis; Heart Valve Diseases; Humans; Indoles; Male; Middle Aged; Pergolide; Pericarditis; Pleural Diseases; Pramipexole; Pulmonary Fibrosis; Retroperitoneal Fibrosis; Tetrahydronaphthalenes; Thiophenes; United States

2009
Dopamine agonists and hyperprolactinaemia.
    BMJ (Clinical research ed.), 2009, Mar-03, Volume: 338

    Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Heart Valve Diseases; Humans; Hyperprolactinemia

2009
Dopamine agonists, Dopplers and doubt: cabergoline-associated cardiac valvulopathy.
    Internal medicine journal, 2009, Volume: 39, Issue:4

    Topics: Antiparkinson Agents; Bromocriptine; Cabergoline; Case-Control Studies; Cross-Sectional Studies; Dopamine Agonists; Ergolines; Female; Heart Valve Diseases; Humans; Hyperprolactinemia; Male; Parkinson Disease; Pergolide; Prolactin; Serotonin 5-HT2 Receptor Agonists; Ultrasonography

2009
Non-surgical management of cystic prolactinomas.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2009, Volume: 16, Issue:11

    Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Follow-Up Studies; Gadolinium; Hormones; Humans; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactinoma; Retrospective Studies; Young Adult

2009
Comparative efficacy of bromocriptine, cabergoline and thyroxine in inducing oestrus in bitches.
    Veterinary research communications, 2010, Volume: 34, Issue:1

    Topics: Animals; Bromocriptine; Cabergoline; Dogs; Ergolines; Estrous Cycle; Female; Fertilization; Hormone Antagonists; Litter Size; Progesterone; Prolactin; Thyroxine

2010
Management of prolactinomas in Brazil: an electronic survey.
    Pituitary, 2010, Volume: 13, Issue:3

    Topics: Brazil; Bromocriptine; Cabergoline; Data Collection; Dopamine Agonists; Ergolines; Female; Humans; Pregnancy; Prolactinoma

2010
Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas.
    The Journal of clinical endocrinology and metabolism, 2010, Volume: 95, Issue:6

    Topics: Adult; Birth Weight; Bromocriptine; Cabergoline; Cohort Studies; Dopamine Agonists; Drug Resistance; Ergolines; Female; Humans; Hyperprolactinemia; Infertility, Female; Magnetic Resonance Imaging; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Progesterone; Prolactin; Prolactinoma

2010
Comparison of cabergoline and bromocriptine in patients with asymptomatic incidental hyperprolactinemia undergoing ICSI-ET.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2010, Volume: 26, Issue:7

    Topics: Adult; Bromocriptine; Cabergoline; Databases, Factual; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Infertility, Female; Pregnancy; Pregnancy Rate; Retrospective Studies; Sperm Injections, Intracytoplasmic; Treatment Outcome

2010
BMI and metabolic profile in patients with prolactinoma before and after treatment with dopamine agonists.
    Obesity (Silver Spring, Md.), 2011, Volume: 19, Issue:4

    Topics: Adult; Aftercare; Aged; Blood Glucose; Body Composition; Body Mass Index; Body Weight; Bromocriptine; Cabergoline; Cholesterol, HDL; Cholesterol, LDL; Dopamine Agonists; Ergolines; Female; Humans; Insulin; Insulin Resistance; Leptin; Male; Metabolic Syndrome; Metabolome; Middle Aged; Obesity; Prevalence; Prolactinoma; Waist Circumference; Weight Gain; Young Adult

2011
Effect of dopaminergic drug treatment on surgical findings in prolactinomas.
    Pituitary, 2011, Volume: 14, Issue:1

    Topics: Adenoma; Adolescent; Adult; Aged; Bromocriptine; Cabergoline; Child; Dopamine Agents; Ergolines; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Retrospective Studies; Young Adult

2011
Disorganized schizophrenia does not deteriorate with dopamine agonists cabergoline and bromocriptine used for ablactation.
    Pharmacopsychiatry, 2011, Volume: 44, Issue:2

    Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Lactation; Mastitis; Schizophrenia, Disorganized

2011
Pituitary tumors: cabergoline versus bromocriptine: a meta-analysis?
    Nature reviews. Endocrinology, 2011, Volume: 7, Issue:5

    Topics: Antineoplastic Agents; Bromocriptine; Cabergoline; Ergolines; Humans; Meta-Analysis as Topic; Pituitary Neoplasms; Treatment Outcome

2011
Long term follow-up of patients with prolactinomas and outcome of dopamine agonist withdrawal: a single center experience.
    Pituitary, 2012, Volume: 15, Issue:1

    Topics: Adolescent; Adult; Aged; Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prolactinoma; Treatment Outcome; Young Adult

2012
A comparison of cabergoline and bromocriptine on the risk of valvular heart disease in patients with prolactinomas.
    Pituitary, 2012, Volume: 15, Issue:1

    Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Echocardiography; Ergolines; Female; Heart Valve Diseases; Humans; Male; Middle Aged; Prolactinoma

2012
[Prescription of ergot derivatives for lactation inhibition in France: Current practices].
    Journal de gynecologie, obstetrique et biologie de la reproduction, 2012, Volume: 41, Issue:2

    Topics: Bromocriptine; Cabergoline; Dihydroergocryptine; Dopamine Agonists; Ergolines; Ergot Alkaloids; Female; France; Humans; Lactation; Lisuride; Practice Patterns, Physicians'; Prolactin; Surveys and Questionnaires

2012
No clinically significant valvular regurgitation in long-term cabergoline treatment for prolactinoma.
    Clinical endocrinology, 2012, Volume: 77, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Cross-Sectional Studies; Echocardiography; Ergolines; Female; Humans; Male; Middle Aged; Prolactinoma; Retrospective Studies; Tricuspid Valve Insufficiency; Young Adult

2012
Increased prevalence of subclinical cardiac valve fibrosis in patients with prolactinomas on long-term bromocriptine and cabergoline treatment.
    European journal of endocrinology, 2012, Volume: 167, Issue:1

    Topics: Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Case-Control Studies; Dopamine Agonists; Echocardiography; Ergolines; Female; Fibrosis; Heart Valve Diseases; Heart Valves; Humans; Male; Middle Aged; Pituitary Neoplasms; Prevalence; Prolactinoma; Prospective Studies

2012
[Gender effect on cardiomyopathy].
    Giornale italiano di cardiologia (2006), 2012, Volume: 13, Issue:6

    Topics: Bromocriptine; Cabergoline; Cardiomyopathies; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; Cardiomyopathy, Restrictive; Dopamine Agonists; Ergolines; Evidence-Based Medicine; Female; Genetic Counseling; Humans; Phenotype; Pregnancy; Pregnancy Complications, Cardiovascular; Prognosis; Prolactin; Risk Assessment; Risk Factors; Sex Factors; Treatment Outcome

2012
Optimal effective doses of cabergoline and bromocriptine and valvular leasions in men with prolactinomas.
    Neuro endocrinology letters, 2012, Volume: 33, Issue:3

    Topics: Adult; Aged; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Female; Heart Valve Diseases; Humans; Male; Middle Aged; Pituitary Neoplasms; Prevalence; Prolactinoma; Retrospective Studies; Risk Factors; Ultrasonography; Young Adult

2012
Medically treated prolactin-secreting pituitary adenomas: when should we operate?
    British journal of neurosurgery, 2013, Volume: 27, Issue:1

    Topics: Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Ergolines; Female; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Postmenopause; Premenopause; Prolactinoma; Prospective Studies; Retrospective Studies; Sphenoid Bone; Time Factors; Treatment Failure

2013
Real-world comorbidities and treatment patterns of patients with acromegaly in two large US health plan databases.
    Pituitary, 2013, Volume: 16, Issue:3

    Topics: Acromegaly; Adult; Bromocriptine; Cabergoline; Databases, Factual; Ergolines; Female; Human Growth Hormone; Humans; Male; Middle Aged; Octreotide; Peptides, Cyclic; Retrospective Studies; Somatostatin; United States

2013
Short-term pharmacological suppression of the hyperprolactinemia of infertile hCG-overproducing female mice persistently restores their fertility.
    Endocrinology, 2012, Volume: 153, Issue:12

    Topics: Animals; Bromocriptine; Cabergoline; Chorionic Gonadotropin; Disease Models, Animal; Ergolines; Female; Fertility; Gene Expression Regulation; Humans; Hyperprolactinemia; Infertility; Mice; Mice, Transgenic; Ovulation; Phenotype; Time Factors

2012
Risk of thromboembolic events in patients with prolactinomas compared with patients with nonfunctional pituitary adenomas.
    Pituitary, 2013, Volume: 16, Issue:4

    Topics: Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Ergolines; Female; Humans; Male; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Thromboembolism; Young Adult

2013
Hyperprolactinemia in children: clinical features and long-term results.
    Journal of pediatric endocrinology & metabolism : JPEM, 2012, Volume: 25, Issue:11-12

    Topics: Adolescent; Bromocriptine; Cabergoline; Child; Combined Modality Therapy; Ergolines; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactinoma; Retrospective Studies; Treatment Outcome

2012
[Visual outcome in patients with macroprolactinoma treated with dopamine agonists].
    Revista medica de Chile, 2013, Volume: 141, Issue:6

    Topics: Adolescent; Adult; Bromocriptine; Cabergoline; Child; Dopamine Agonists; Ergolines; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Prolactinoma; Retrospective Studies; Vision Disorders; Visual Acuity; Visual Fields; Young Adult

2013
Occlusal treatment with bite splint improves dyskinesia in Parkinson's disease patient: a case report.
    The Bulletin of Tokyo Dental College, 2013, Volume: 54, Issue:3

    Topics: Activities of Daily Living; Antiparkinson Agents; Bromocriptine; Cabergoline; Clonidine; Dyskinesias; Ergolines; Female; Hand Strength; Humans; Levodopa; Middle Aged; Motor Skills; Occlusal Splints; Parkinson Disease; Posture

2013
[Inhibition of lactation: end to the bromocriptin, long life to the carbergolin?].
    Gynecologie, obstetrique & fertilite, 2014, Volume: 42, Issue:4

    Topics: Bromocriptine; Cabergoline; Cardiovascular Diseases; Ergolines; Female; France; Hormone Antagonists; Humans; Lactation

2014
Women with prolactinomas presented at the postmenopausal period.
    Endocrine, 2014, Volume: 47, Issue:3

    Topics: Aged; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Follicle Stimulating Hormone; Humans; Hyperprolactinemia; Luteinizing Hormone; Middle Aged; Pituitary Neoplasms; Postmenopause; Prolactin; Prolactinoma; Retrospective Studies; Treatment Outcome

2014
Young female with acromegaloid features and pituitary macroadenoma: what is your diagnosis?
    Boletin de la Asociacion Medica de Puerto Rico, 2014, Volume: 106, Issue:1

    Topics: Acanthosis Nigricans; Acromegaly; Adult; Bromocriptine; Cabergoline; Diagnosis, Differential; Ergolines; Female; Gastrointestinal Diseases; Hirsutism; Human Growth Hormone; Humans; Hyperprolactinemia; Insulin; Insulin Resistance; Insulin-Like Growth Factor I; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy Complications, Neoplastic; Prognathism; Prolactinoma

2014
A case of iatrogenic severe mitral regurgitation.
    Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 2013, Volume: 80, Issue:3

    Topics: Antineoplastic Agents; Bromocriptine; Cabergoline; Drug Therapy, Combination; Ergolines; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Hormone Antagonists; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Pituitary Neoplasms; Prolactinoma; Treatment Outcome

2013
Comparison of efficacy of bromocriptine and cabergoline to GnRH agonist in a rat endometriosis model.
    Archives of gynecology and obstetrics, 2015, Volume: 291, Issue:5

    Topics: Adult; Animals; Antineoplastic Agents; Bromocriptine; Cabergoline; Disease Models, Animal; Dopamine Agonists; Endometriosis; Endometrium; Ergolines; Female; Gonadotropin-Releasing Hormone; Humans; Laparotomy; Leuprolide; Prospective Studies; Random Allocation; Rats; Rats, Wistar; Triptorelin Pamoate

2015
Retrospective comparison of cabergoline and bromocriptine effects in hyperprolactinemia: a single center experience.
    Journal of endocrinological investigation, 2015, Volume: 38, Issue:4

    Topics: Adolescent; Adult; Aged; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Young Adult

2015
Treatment outcome results from the Bulgarian Acromegaly Database: adjuvant dopamine agonist therapy is efficient in less than one fifth of non-irradiated patients.
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2015, Volume: 123, Issue:1

    Topics: Acromegaly; Adolescent; Adult; Aged; Bromocriptine; Bulgaria; Cabergoline; Child; Databases, Factual; Dopamine Agonists; Ergolines; Female; Follow-Up Studies; Humans; Male; Middle Aged; Radiotherapy; Remission Induction; Retrospective Studies; Somatostatin

2015
[Pituitary apoplexy in a pregnant woman with cystic microprolactinoma].
    Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2015, Volume: 62, Issue:4

    Topics: Adult; Bromocriptine; Cabergoline; Combined Modality Therapy; Contraindications; Dopamine Agonists; Drug Substitution; Ergolines; Female; Headache; Hormone Replacement Therapy; Humans; Hydrocortisone; Hypophysectomy; Infant, Newborn; Male; Pituitary Apoplexy; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy Complications, Neoplastic; Prolactinoma; Thyroxine; Vision Disorders

2015
Different Effects of Metformin on the Hypothalamic-Pituitary-Thyroid Axis in Bromocriptine- and Cabergoline-treated Patients with Hashimoto's Thyroiditis and Glucose Metabolism Abnormalities.
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2015, Volume: 123, Issue:9

    Topics: Adult; Bromocriptine; Cabergoline; Ergolines; Female; Glucose Metabolism Disorders; Hashimoto Disease; Humans; Hypothalamo-Hypophyseal System; Metformin; Middle Aged; Thyroid Gland

2015
Cost-Effectiveness Analysis of Microscopic and Endoscopic Transsphenoidal Surgery Versus Medical Therapy in the Management of Microprolactinoma in the United States.
    World neurosurgery, 2016, Volume: 87

    Topics: Adult; Aged; Bromocriptine; Cabergoline; Cost-Benefit Analysis; Decision Support Techniques; Decision Trees; Ergolines; Female; Health Care Costs; Hormone Antagonists; Humans; Hyperprolactinemia; Life Expectancy; Male; Medicare; Microsurgery; Middle Aged; Monte Carlo Method; Neuroendoscopy; Pituitary Neoplasms; Prolactinoma; Quality-Adjusted Life Years; Sphenoid Sinus; Time Factors; Treatment Outcome; United States

2016
Inhibiting the onset of lactation. Is cabergoline an alternative to bromocriptine?
    Prescrire international, 2015, Volume: 24, Issue:165

    Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Europe; Female; France; Humans; Lactation

2015
Withdrawal of dopamine agonist therapy in prolactinomas: In which patients and when?
    Pituitary, 2016, Volume: 19, Issue:3

    Topics: Adolescent; Adult; Aged; Bromocriptine; Cabergoline; Deprescriptions; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Neoplasm Recurrence, Local; Patient Selection; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Time Factors; Tumor Burden; Young Adult

2016
Prolactinomas: evolution after menopause.
    Archives of endocrinology and metabolism, 2016, Volume: 60, Issue:1

    Topics: Adenoma; Adult; Bromocriptine; Cabergoline; Disease Progression; Dopamine Agonists; Ergolines; Female; Humans; Menopause; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Treatment Outcome; Withholding Treatment

2016
Giant prolactinomas larger than 60 mm in size: a cohort of massive and aggressive prolactin-secreting pituitary adenomas.
    Pituitary, 2016, Volume: 19, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Child; Ergolines; Female; Galactorrhea; Headache; Hormone Antagonists; Humans; Male; Middle Aged; Neurosurgical Procedures; Pituitary Neoplasms; Prolactinoma; Sexual Dysfunction, Physiological; Treatment Outcome; Tumor Burden; Vision Disorders; Young Adult

2016
Treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists.
    European journal of endocrinology, 2016, Volume: 175, Issue:1

    Topics: Adenoma; Adult; Aged; Bromocriptine; Cabergoline; Disease Progression; Dopamine Agonists; Ergolines; Female; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Receptors, Dopamine; Receptors, Estrogen; Treatment Outcome

2016
Dopa-testotoxicosis: disruptive hypersexuality in hypogonadal men with prolactinomas treated with dopamine agonists.
    Endocrine, 2017, Volume: 55, Issue:2

    Topics: Adult; Aged; Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Humans; Hypogonadism; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Retrospective Studies; Sexual Dysfunction, Physiological

2017
SURGICAL OUTCOMES OF PROLACTINOMAS IN RECENT ERA: RESULTS OF A HETEROGENOUS GROUP.
    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2017, Volume: 23, Issue:1

    Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurosurgical Procedures; Pituitary Neoplasms; Prolactinoma; Remission Induction; Retrospective Studies; Treatment Failure; Treatment Outcome; Tumor Burden; Young Adult

2017
10-year follow-up study comparing primary medical vs. surgical therapy in women with prolactinomas.
    Endocrine, 2017, Volume: 55, Issue:1

    Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Follow-Up Studies; Humans; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Treatment Outcome; Young Adult

2017
Macroprolactinomas and Nonfunctioning Pituitary Adenomas and Pregnancy Outcomes.
    Obstetrics and gynecology, 2017, Volume: 129, Issue:1

    Topics: Adenoma; Adult; Amenorrhea; Antineoplastic Agents; Bromocriptine; Cabergoline; Case-Control Studies; Cesarean Section; Dopamine Agonists; Ergolines; Female; Galactorrhea; Humans; Incidence; Pituitary Neoplasms; Pre-Eclampsia; Preconception Care; Pregnancy; Pregnancy Complications, Neoplastic; Premature Birth; Prolactinoma; Prospective Studies; Stillbirth; United Kingdom; Vision Disorders; Young Adult

2017
MRI follow-up is unnecessary in patients with macroprolactinomas and long-term normal prolactin levels on dopamine agonist treatment.
    European journal of endocrinology, 2017, Volume: 176, Issue:3

    Topics: Adult; Aminoquinolines; Belgium; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Follow-Up Studies; France; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies

2017
Prolactinoma management: predictors of remission and recurrence after dopamine agonists withdrawal.
    Pituitary, 2017, Volume: 20, Issue:4

    Topics: Adolescent; Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Male; Middle Aged; Prolactin; Prolactinoma; Retrospective Studies; Young Adult

2017
Pregnancy and Tumor Outcomes in Women with Prolactinoma.
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2017, Volume: 125, Issue:10

    Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Outcome Assessment, Health Care; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Prolactinoma; Retrospective Studies; Young Adult

2017
Best candidates for dopamine agonist withdrawal in patients with prolactinomas.
    Pituitary, 2017, Volume: 20, Issue:5

    Topics: Adolescent; Adult; Aged; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Prolactinoma; Retrospective Studies; Young Adult

2017
The efficacy of medical treatment in patients with acromegaly in clinical practice.
    Endocrine journal, 2018, Jan-30, Volume: 65, Issue:1

    Topics: Acromegaly; Adenoma; Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Cohort Studies; Dopamine Agonists; Drug Resistance, Neoplasm; Ergolines; Female; Follow-Up Studies; Growth Hormone-Secreting Pituitary Adenoma; Hospitals, University; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Neoplasm Grading; Republic of Korea; Retrospective Studies; Somatostatin; Tumor Burden

2018
Failure of a second temozolomide cycle in a patient with a prolactin-secreting pituitary carcinoma.
    Endocrinologia, diabetes y nutricion, 2017, Volume: 64, Issue:10

    Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Bromocriptine; Cabergoline; Combined Modality Therapy; Dacarbazine; Drug Substitution; Ergolines; Fatal Outcome; Headache; Humans; Hyperprolactinemia; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactin; Prolactinoma; Proton Therapy; Temozolomide

2017
Impact of menopause on outcomes in prolactinomas after dopamine agonist treatment withdrawal.
    Clinical endocrinology, 2018, Volume: 89, Issue:3

    Topics: Adolescent; Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Menopause; Postmenopause; Prolactin; Prolactinoma; Retrospective Studies; Withholding Treatment; Young Adult

2018
Long-term low-dose cabergoline usage: Another association with cardiac valvulopathy.
    Echocardiography (Mount Kisco, N.Y.), 2023, Volume: 40, Issue:1

    Topics: Bromocriptine; Cabergoline; Ergolines; Heart Valve Diseases; Humans; Middle Aged; Pituitary Neoplasms

2023
Italian Guidelines for the Management of Prolactinomas.
    Endocrine, metabolic & immune disorders drug targets, 2023, Volume: 23, Issue:12

    Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Humans; Pituitary Neoplasms; Prolactin; Prolactinoma

2023